Year,LocationAbbr,LocationDesc,DataSource,PriorityArea1,PriorityArea2,PriorityArea3,PriorityArea4,Category,Topic,Indicator,Break_Out_Category,Break_Out,Data_Value_Type,Data_Value_Unit,Data_Value,Data_Value_Footnote_Symbol,Data_Value_Footnote,Confidence_limit_Low,Confidence_limit_High,CategoryId,TopicId,IndicatorID,BreakOutCategoryId,BreakOutId,LocationID,GeoLocation
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,45-64,Percentage,%,72.3,,,55.9,84.3,C2,T8,NH010,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,65+,Percentage,%,88.3,,,81.4,92.8,C2,T8,NH010,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,75+,Percentage,%,87.8,,,81.2,92.4,C2,T8,NH010,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Gender,Male,Percentage,%,76.9,,,57.7,89,C2,T8,NH010,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Gender,Female,Percentage,%,73.8,,,61.2,83.4,C2,T8,NH010,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Overall,Overall,Percentage,%,75.7,,,62.5,85.3,C2,T8,NH010,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,78.3,,,56.9,90.8,C2,T8,NH010,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67.9,,,56.1,77.8,C2,T8,NH010,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,71.4,,,29.8,93.6,C2,T8,NH010,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Hispanic,Percentage,%,54.8,,,38.6,70.1,C2,T8,NH010,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Aspirin use,Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Other,Percentage,%,85.7,,,58,96.3,C2,T8,NH010,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH020,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.2,,,9.3,15.9,C2,T9,NH020,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,37.9,,,33.7,42.4,C2,T9,NH020,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.2,,,66.3,73.8,C2,T9,NH020,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,38.2,,,34.7,41.9,C2,T9,NH020,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,77.6,,,73.4,81.4,C2,T9,NH020,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,29.3,,,25.3,33.5,C2,T9,NH020,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30,,,27.7,32.5,C2,T9,NH020,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.9,,,27.1,32.8,C2,T9,NH020,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.3,,,24.9,32,C2,T9,NH020,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,40.5,,,38.4,42.6,C2,T9,NH020,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.5,,,25.9,31.2,C2,T9,NH020,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,30.3,,,20,43.1,C2,T9,NH020,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,3.3,,,2.1,5.1,C2,T9,NH020,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,10.4,,,8.9,12.1,C2,T9,NH020,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,37.6,,,33,42.5,C2,T9,NH020,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.6,,,67.8,73.3,C2,T9,NH020,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,37.8,,,34.6,41.1,C2,T9,NH020,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,75.8,,,72.9,78.5,C2,T9,NH020,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,27.7,,,25.3,30.2,C2,T9,NH020,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.7,,,29,32.4,C2,T9,NH020,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.4,,,27.7,31.2,C2,T9,NH020,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28,,,26.1,30,C2,T9,NH020,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.6,,,39.4,45.7,C2,T9,NH020,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.9,,,22.1,25.9,C2,T9,NH020,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,29.9,,,21.7,39.6,C2,T9,NH020,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH020,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.4,,,10.7,14.4,C2,T9,NH020,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,42.7,,,38.3,47.3,C2,T9,NH020,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.1,,,65.8,74.1,C2,T9,NH020,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.7,,,38.4,45,C2,T9,NH020,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,74.2,,,68.7,78.9,C2,T9,NH020,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32,,,29,35.1,C2,T9,NH020,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.5,,,28.2,32.9,C2,T9,NH020,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.4,,,29.2,33.6,C2,T9,NH020,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.3,,,27.7,33,C2,T9,NH020,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,41.5,,,38.1,45.1,C2,T9,NH020,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,29.2,,,26,32.6,C2,T9,NH020,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,32.2,,,25.2,40.2,C2,T9,NH020,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,4.3,,,2.5,7.2,C2,T9,NH020,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,11.7,,,9.3,14.7,C2,T9,NH020,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.8,,,35.8,43.9,C2,T9,NH020,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,68.9,,,66.7,71.1,C2,T9,NH020,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,39.9,,,36.9,42.9,C2,T9,NH020,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,71.8,,,69.1,74.3,C2,T9,NH020,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,31.1,,,28.5,33.9,C2,T9,NH020,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.7,,,28.1,31.3,C2,T9,NH020,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.6,,,28.8,32.5,C2,T9,NH020,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.4,,,27.3,31.7,C2,T9,NH020,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.8,,,39.8,45.9,C2,T9,NH020,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.2,,,20.6,26,C2,T9,NH020,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,31.1,,,24.7,38.3,C2,T9,NH020,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,2.8,,,1.9,4.2,C2,T9,NH020,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,13.2,,,11.5,15.2,C2,T9,NH020,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.8,,,37.3,42.3,C2,T9,NH020,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.2,,,65.1,74.8,C2,T9,NH020,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.2,,,39.3,43.2,C2,T9,NH020,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,76.1,,,73,78.9,C2,T9,NH020,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,31.4,,,30,32.9,C2,T9,NH020,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.5,,,28.9,32.2,C2,T9,NH020,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.1,,,29.8,32.4,C2,T9,NH020,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.4,,,28.5,32.4,C2,T9,NH020,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.2,,,38.9,45.5,C2,T9,NH020,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.2,,,24.8,31.9,C2,T9,NH020,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,24.3,,,20.7,28.4,C2,T9,NH020,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH020,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,10.7,,,9.5,12.1,C2,T9,NH020,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.5,,,35.2,44,C2,T9,NH020,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,71.3,,,67.6,74.7,C2,T9,NH020,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41,,,37.5,44.5,C2,T9,NH020,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,76.9,,,73.4,80.1,C2,T9,NH020,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,30.8,,,28.2,33.5,C2,T9,NH020,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.1,,,27.3,31,C2,T9,NH020,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30,,,28.2,31.9,C2,T9,NH020,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.8,,,26.4,31.4,C2,T9,NH020,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.2,,,38.9,45.6,C2,T9,NH020,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH020,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,27.8,,,25.8,30,C2,T9,NH020,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,31.3,,,26.8,36.2,C2,T9,NH020,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH020,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.6,,,10.1,15.5,C2,T9,NH020,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,40.6,,,37.6,43.7,C2,T9,NH020,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,67.3,,,63.5,71,C2,T9,NH020,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.9,,,39.4,44.5,C2,T9,NH020,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,77,,,73.9,79.9,C2,T9,NH020,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,30.8,,,28.7,33.1,C2,T9,NH020,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.5,,,27.9,31.3,C2,T9,NH020,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28.8,31.7,C2,T9,NH020,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29,,,27.4,30.7,C2,T9,NH020,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,43.4,,,41.7,45.2,C2,T9,NH020,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,25.5,,,22.4,28.9,C2,T9,NH020,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.8,,,22,32.3,C2,T9,NH020,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,27.1,,,23.9,30.5,C2,T9,NH020,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,2.5,,,1.5,4,C2,T9,NH020,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.9,,,11,15.1,C2,T9,NH020,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,41.2,,,38.2,44.2,C2,T9,NH020,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,69.5,,,66.6,72.3,C2,T9,NH020,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,42.8,,,40.2,45.3,C2,T9,NH020,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,75.1,,,70.4,79.3,C2,T9,NH020,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32,,,30,34,C2,T9,NH020,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.6,,,27.2,32.1,C2,T9,NH020,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.8,,,29.1,32.6,C2,T9,NH020,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.9,,,27.9,32,C2,T9,NH020,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.4,,,39.4,45.4,C2,T9,NH020,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,27.1,,,24.1,30.3,C2,T9,NH020,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,25.2,31.1,C2,T9,NH020,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,29.1,,,25.8,32.6,C2,T9,NH020,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,60.8,,,47.3,72.7,C2,T9,NH021,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75,,,67.9,80.9,C2,T9,NH021,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,67.9,,,64.3,71.3,C2,T9,NH021,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,70.5,,,66.4,74.3,C2,T9,NH021,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,66.5,,,63,69.7,C2,T9,NH021,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,63.9,,,58.3,69.2,C2,T9,NH021,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,61,,,50.3,70.8,C2,T9,NH021,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,64.2,,,57.8,70.2,C2,T9,NH021,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,65.5,,,58.9,71.5,C2,T9,NH021,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,66.9,,,54.6,77.2,C2,T9,NH021,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,53,,,40.4,65.2,C2,T9,NH021,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,53.8,,,43.4,63.9,C2,T9,NH021,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,58.1,,,50.3,65.5,C2,T9,NH021,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,72.2,,,67.6,76.5,C2,T9,NH021,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,74.2,,,71.1,77,C2,T9,NH021,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,71.7,,,68.3,74.8,C2,T9,NH021,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,72.7,,,68.4,76.6,C2,T9,NH021,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,56.9,,,53.9,60,C2,T9,NH021,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,74.5,,,67.9,80.1,C2,T9,NH021,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,63.5,,,60,66.9,C2,T9,NH021,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,61.8,,,55.2,68,C2,T9,NH021,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,75.5,,,70,80.3,C2,T9,NH021,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,45,,,34.6,55.8,C2,T9,NH021,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,43.4,,,33.1,54.4,C2,T9,NH021,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,58.3,,,37,76.9,C2,T9,NH021,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,66.5,,,57.2,74.7,C2,T9,NH021,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75.1,,,69,80.3,C2,T9,NH021,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,79.7,,,75.7,83.2,C2,T9,NH021,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,77,,,73.5,80.2,C2,T9,NH021,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,74.6,,,69.3,79.2,C2,T9,NH021,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,68,,,61.7,73.8,C2,T9,NH021,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,68.7,,,57.5,78,C2,T9,NH021,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,67.6,,,61.2,73.4,C2,T9,NH021,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,67.9,,,58.1,76.4,C2,T9,NH021,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,66.6,,,56.4,75.5,C2,T9,NH021,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,63.5,,,54.7,71.5,C2,T9,NH021,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,76.7,,,55.9,89.6,C2,T9,NH021,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,41.2,,,25.3,59.3,C2,T9,NH021,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,60.3,,,52.4,67.8,C2,T9,NH021,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,81,,,76.8,84.6,C2,T9,NH021,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,82.4,,,78.8,85.6,C2,T9,NH021,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,80.1,,,76.9,83,C2,T9,NH021,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,77.6,,,71.3,82.8,C2,T9,NH021,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,64.2,,,59.6,68.5,C2,T9,NH021,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,83.1,,,74.1,89.4,C2,T9,NH021,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,68.8,,,64.4,72.9,C2,T9,NH021,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,67.1,,,61.8,72.1,C2,T9,NH021,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,73.1,,,66.6,78.7,C2,T9,NH021,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,60.9,,,52.8,68.5,C2,T9,NH021,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,72.3,,,55.9,84.3,C2,T9,NH021,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,73,,,62.1,81.6,C2,T9,NH021,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,80.4,,,77.7,82.9,C2,T9,NH021,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,83.1,,,80.5,85.4,C2,T9,NH021,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,81,,,79.3,82.6,C2,T9,NH021,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,82.8,,,78.3,86.6,C2,T9,NH021,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,68.6,,,60.2,75.9,C2,T9,NH021,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,83,,,77,87.6,C2,T9,NH021,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,74.4,,,67.1,80.6,C2,T9,NH021,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76.8,,,66.7,84.5,C2,T9,NH021,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,75.4,,,67.8,81.7,C2,T9,NH021,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,58.9,,,53.6,64,C2,T9,NH021,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,73.4,,,39.6,92.1,C2,T9,NH021,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,66.6,,,57.7,74.4,C2,T9,NH021,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,84,,,80.4,87,C2,T9,NH021,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,85.4,,,81,88.9,C2,T9,NH021,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,83.3,,,80.2,85.9,C2,T9,NH021,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,84.7,,,79.4,88.9,C2,T9,NH021,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,70,,,62.2,76.8,C2,T9,NH021,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,80.8,,,74,86.1,C2,T9,NH021,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,74.2,,,68.7,79,C2,T9,NH021,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,73.6,,,65.5,80.4,C2,T9,NH021,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,81.7,,,75,87,C2,T9,NH021,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH021,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,64.7,,,54.2,73.9,C2,T9,NH021,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,71.6,,,59.1,81.5,C2,T9,NH021,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,71.1,,,61.7,79,C2,T9,NH021,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,82.9,,,77.6,87.2,C2,T9,NH021,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,87.5,,,84.1,90.3,C2,T9,NH021,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,83.6,,,79.8,86.9,C2,T9,NH021,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,87.3,,,82.9,90.7,C2,T9,NH021,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,69.3,,,64.1,74.1,C2,T9,NH021,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,81.9,,,74.8,87.3,C2,T9,NH021,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,75.1,,,70.2,79.4,C2,T9,NH021,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,74.1,,,65.8,80.9,C2,T9,NH021,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,82.4,,,77.3,86.5,C2,T9,NH021,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,59.7,,,48.8,69.7,C2,T9,NH021,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,71.2,,,58.1,81.5,C2,T9,NH021,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,61.8,,,44.9,76.2,C2,T9,NH021,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH021,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,78.5,,,74.3,82.1,C2,T9,NH021,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,84.3,,,80.9,87.2,C2,T9,NH021,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,88.2,,,84.6,91,C2,T9,NH021,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,85.5,,,82.6,88,C2,T9,NH021,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,87.6,,,81,92.2,C2,T9,NH021,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,76.5,,,71.4,81,C2,T9,NH021,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,86.8,,,83.6,89.4,C2,T9,NH021,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,80.6,,,77.5,83.4,C2,T9,NH021,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,83.6,,,80.3,86.5,C2,T9,NH021,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,80.6,,,74.3,85.6,C2,T9,NH021,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,68.2,,,53.3,80.2,C2,T9,NH021,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,74.1,,,64.1,82,C2,T9,NH021,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension awareness among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,72.7,,,59.5,82.8,C2,T9,NH021,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,43,,,31.4,55.5,C2,T9,NH022,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,65.6,,,59.2,71.5,C2,T9,NH022,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,60,,,53.8,66,C2,T9,NH022,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,61.1,,,55.5,66.5,C2,T9,NH022,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,58.1,,,50.6,65.3,C2,T9,NH022,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,46.9,,,40.6,53.3,C2,T9,NH022,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,51.1,,,42.4,59.7,C2,T9,NH022,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,48.8,,,42.8,54.9,C2,T9,NH022,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.7,,,46.1,55.4,C2,T9,NH022,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,52.1,,,41.1,62.8,C2,T9,NH022,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,34.8,,,26.1,44.7,C2,T9,NH022,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,36.4,,,26.2,48,C2,T9,NH022,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,42.3,,,35.4,49.6,C2,T9,NH022,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,61.3,,,57.1,65.3,C2,T9,NH022,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,67.1,,,62.2,71.7,C2,T9,NH022,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,61.9,,,58.3,65.3,C2,T9,NH022,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,65.8,,,59.4,71.7,C2,T9,NH022,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,45.1,,,41.8,48.5,C2,T9,NH022,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,63.1,,,56.2,69.5,C2,T9,NH022,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,51.8,,,48.4,55.2,C2,T9,NH022,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.6,,,44.7,54.5,C2,T9,NH022,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,60.8,,,57.4,64.1,C2,T9,NH022,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,33.4,,,25.3,42.8,C2,T9,NH022,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,40.9,,,30,52.8,C2,T9,NH022,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,51.5,,,39.2,63.6,C2,T9,NH022,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,61.8,,,54.6,68.5,C2,T9,NH022,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,74,,,69.6,77.9,C2,T9,NH022,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,66.5,,,61.7,71,C2,T9,NH022,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,66.7,,,60.8,72.1,C2,T9,NH022,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,54,,,46.5,61.3,C2,T9,NH022,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,58.8,,,47.9,68.9,C2,T9,NH022,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,55,,,47.8,62.1,C2,T9,NH022,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,55.3,,,45,65.3,C2,T9,NH022,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,55.8,,,47.8,63.5,C2,T9,NH022,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,48.4,,,38.7,58.3,C2,T9,NH022,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,60,,,42.1,75.6,C2,T9,NH022,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,40.5,,,33.5,47.8,C2,T9,NH022,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,70.2,,,66.2,74,C2,T9,NH022,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,77.7,,,74.2,80.8,C2,T9,NH022,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,70.7,,,67.2,73.9,C2,T9,NH022,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,72.1,,,66.4,77.1,C2,T9,NH022,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,48.6,,,44.5,52.6,C2,T9,NH022,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,74.5,,,66.8,80.9,C2,T9,NH022,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,54.1,,,49.8,58.3,C2,T9,NH022,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,52.6,,,45.5,59.6,C2,T9,NH022,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65,,,58.4,71,C2,T9,NH022,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,41.4,,,31.2,52.4,C2,T9,NH022,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,53.6,,,40.2,66.5,C2,T9,NH022,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,57.3,,,48.2,66.1,C2,T9,NH022,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,71.1,,,67.3,74.6,C2,T9,NH022,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,79.7,,,77.2,82,C2,T9,NH022,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,73.7,,,71.5,75.9,C2,T9,NH022,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,79.4,,,75.2,83,C2,T9,NH022,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,56.3,,,49.8,62.6,C2,T9,NH022,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,73,,,67.2,78.2,C2,T9,NH022,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,63.2,,,57.7,68.4,C2,T9,NH022,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,64.9,,,57.6,71.7,C2,T9,NH022,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65.3,,,58.2,71.7,C2,T9,NH022,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,52.1,,,45.9,58.2,C2,T9,NH022,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,39.4,,,25.5,55.3,C2,T9,NH022,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,56,,,47,64.6,C2,T9,NH022,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,77.8,,,72.8,82.1,C2,T9,NH022,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,82,,,78.2,85.3,C2,T9,NH022,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,78.1,,,74.6,81.1,C2,T9,NH022,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,81.2,,,75.7,85.7,C2,T9,NH022,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,59.7,,,52.9,66.1,C2,T9,NH022,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,75.4,,,67.3,82,C2,T9,NH022,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,65.8,,,59.9,71.2,C2,T9,NH022,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,66.3,,,59,72.9,C2,T9,NH022,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,70.9,,,62.1,78.4,C2,T9,NH022,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH022,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,55.7,,,46.4,64.7,C2,T9,NH022,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,64.7,,,52.8,75,C2,T9,NH022,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,54.6,,,46.2,62.7,C2,T9,NH022,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75.4,,,68.9,81,C2,T9,NH022,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,84,,,79.9,87.4,C2,T9,NH022,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,77,,,72.7,80.8,C2,T9,NH022,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,83.7,,,77.8,88.2,C2,T9,NH022,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,55.2,,,50.1,60.3,C2,T9,NH022,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,73.7,,,65.7,80.3,C2,T9,NH022,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,63.7,,,58.6,68.6,C2,T9,NH022,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,65.9,,,57.9,73.2,C2,T9,NH022,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,68.8,,,63,74.1,C2,T9,NH022,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48.7,,,38.6,58.9,C2,T9,NH022,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,55.7,,,42.3,68.3,C2,T9,NH022,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,43.5,,,34.6,52.8,C2,T9,NH022,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH022,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,57.5,,,50.1,64.6,C2,T9,NH022,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75.8,,,70.7,80.2,C2,T9,NH022,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,82.6,,,77.9,86.4,C2,T9,NH022,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,76.8,,,72.4,80.8,C2,T9,NH022,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,80.9,,,74.2,86.1,C2,T9,NH022,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,60.6,,,54.1,66.8,C2,T9,NH022,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,72.4,,,66.1,77.9,C2,T9,NH022,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,60.4,70.2,C2,T9,NH022,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,69.3,,,61.3,76.3,C2,T9,NH022,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,63.6,,,59.4,67.5,C2,T9,NH022,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48.2,,,40.8,55.6,C2,T9,NH022,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,58.4,,,48.9,67.3,C2,T9,NH022,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,58.7,,,49.4,67.4,C2,T9,NH022,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.6,,,20,39.2,C2,T9,NH023,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.6,,,34,45.4,C2,T9,NH023,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,24.2,,,19.8,29.3,C2,T9,NH023,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,27.4,37.6,C2,T9,NH023,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,16.2,,,12.4,20.9,C2,T9,NH023,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.4,,,22.5,35,C2,T9,NH023,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,27,,,20.8,34.2,C2,T9,NH023,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,27.3,,,22.7,32.3,C2,T9,NH023,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.5,,,26,35.5,C2,T9,NH023,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.3,,,16.1,30.1,C2,T9,NH023,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,15.3,,,9.5,23.9,C2,T9,NH023,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.8,,,23.5,34.7,C2,T9,NH023,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,38.9,,,34.3,43.7,C2,T9,NH023,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,32.1,,,28.8,35.7,C2,T9,NH023,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,35.3,,,32.2,38.5,C2,T9,NH023,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,30.6,,,24.8,37,C2,T9,NH023,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.3,,,24.3,32.6,C2,T9,NH023,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,42.9,,,36,50,C2,T9,NH023,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,33.1,,,29.4,37,C2,T9,NH023,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33,,,28.1,38.3,C2,T9,NH023,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.5,,,28.5,36.8,C2,T9,NH023,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,19,,,11.1,30.6,C2,T9,NH023,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,20.4,,,11.7,33.3,C2,T9,NH023,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,41.8,,,30.4,54.3,C2,T9,NH023,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.3,,,33.2,45.7,C2,T9,NH023,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,38.6,,,34.4,42.9,C2,T9,NH023,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,40.3,,,36,44.8,C2,T9,NH023,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,28.6,,,23.5,34.2,C2,T9,NH023,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,36.8,,,29.9,44.2,C2,T9,NH023,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,38.5,,,28.4,49.7,C2,T9,NH023,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,36.2,,,29.5,43.6,C2,T9,NH023,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,38.1,,,28.2,49,C2,T9,NH023,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.5,,,27.2,36.2,C2,T9,NH023,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.2,,,22.8,34.4,C2,T9,NH023,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,34.4,,,24.4,46.1,C2,T9,NH023,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,30.9,,,23.9,39,C2,T9,NH023,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,48.2,,,43.7,52.7,C2,T9,NH023,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,43.9,,,40.5,47.5,C2,T9,NH023,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,44.7,,,41.7,47.8,C2,T9,NH023,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,39.1,,,33.3,45.2,C2,T9,NH023,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,34.3,,,30.1,38.7,C2,T9,NH023,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,51.4,,,41.6,61,C2,T9,NH023,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,37.2,,,33.3,41.2,C2,T9,NH023,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,37.9,,,31.8,44.3,C2,T9,NH023,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.1,,,33.2,43.2,C2,T9,NH023,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,27.7,,,20.1,37,C2,T9,NH023,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.7,,,29.4,55.1,C2,T9,NH023,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,47.8,,,39.2,56.5,C2,T9,NH023,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,49.6,,,44.7,54.6,C2,T9,NH023,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,48.1,,,44.3,51.9,C2,T9,NH023,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,49.5,,,46.6,52.4,C2,T9,NH023,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,43.2,,,38.7,47.7,C2,T9,NH023,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.9,,,35,47.1,C2,T9,NH023,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,53.7,,,46,61.2,C2,T9,NH023,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46,,,40.3,51.8,C2,T9,NH023,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.1,,,44,56.3,C2,T9,NH023,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,40,,,33.5,46.9,C2,T9,NH023,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,37.2,,,32.1,42.5,C2,T9,NH023,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,21.5,,,14.8,30.1,C2,T9,NH023,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,36,,,27.9,45,C2,T9,NH023,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57.1,,,52.5,61.6,C2,T9,NH023,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,55.1,,,50.6,59.5,C2,T9,NH023,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.5,,,51.2,57.8,C2,T9,NH023,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,50.2,,,44.1,56.4,C2,T9,NH023,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.5,,,34.3,47.1,C2,T9,NH023,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.2,,,49.1,63,C2,T9,NH023,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.5,,,41.3,51.8,C2,T9,NH023,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.7,,,43.4,56.1,C2,T9,NH023,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,43.4,,,34.7,52.7,C2,T9,NH023,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH023,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,21.5,35.8,C2,T9,NH023,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,44.7,,,32.4,57.6,C2,T9,NH023,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,45.9,,,35.5,56.7,C2,T9,NH023,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,56.3,,,49.6,62.8,C2,T9,NH023,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,50.1,,,45,55.2,C2,T9,NH023,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,53.2,,,48.4,57.8,C2,T9,NH023,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,41.7,,,33.5,50.4,C2,T9,NH023,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,39.6,,,34.3,45.2,C2,T9,NH023,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,55.6,,,46.9,64,C2,T9,NH023,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.8,,,40.8,53,C2,T9,NH023,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.3,,,41.4,59.2,C2,T9,NH023,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.3,,,38.8,52,C2,T9,NH023,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,35.6,,,26,46.5,C2,T9,NH023,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,39.4,,,25.3,55.4,C2,T9,NH023,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,33.7,,,25.9,42.4,C2,T9,NH023,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NH023,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,46.3,,,39.9,52.9,C2,T9,NH023,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57,,,49.7,64,C2,T9,NH023,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,54.1,,,49.2,58.9,C2,T9,NH023,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.8,,,49.6,59.9,C2,T9,NH023,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,47.4,,,39.1,55.8,C2,T9,NH023,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,45,,,38.4,51.7,C2,T9,NH023,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.7,,,50.3,62.8,C2,T9,NH023,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,49.6,,,44.4,54.9,C2,T9,NH023,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,55.7,,,47.4,63.8,C2,T9,NH023,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.9,,,34.4,45.6,C2,T9,NH023,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,34.5,,,26.4,43.6,C2,T9,NH023,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,40.6,,,33.1,48.5,C2,T9,NH023,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.3,,,28.9,54.9,C2,T9,NH023,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,27.7,,,23,33,C2,T9,NH024,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,33.7,,,30.2,37.4,C2,T9,NH024,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,34.2,,,31.9,36.6,C2,T9,NH024,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,21.6,,,18.2,25.3,C2,T9,NH024,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,31.5,,,29.1,33.9,C2,T9,NH024,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,17,,,13.7,20.8,C2,T9,NH024,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,39.2,,,36.2,42.2,C2,T9,NH024,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.6,,,20.7,24.6,C2,T9,NH024,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31,,,29.1,32.9,C2,T9,NH024,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,31.5,,,28.9,34.1,C2,T9,NH024,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29,,,26.4,31.9,C2,T9,NH024,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31.5,,,29.1,34,C2,T9,NH024,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,30.4,,,22.9,39,C2,T9,NH024,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,28.2,,,24.7,32.1,C2,T9,NH024,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,29.9,36.1,C2,T9,NH024,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,32.9,,,30.3,35.7,C2,T9,NH024,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.6,,,15.8,21.9,C2,T9,NH024,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,30.4,,,28.4,32.4,C2,T9,NH024,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,16,,,13.1,19.3,C2,T9,NH024,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,37.9,,,35,40.8,C2,T9,NH024,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,21.4,,,19.5,23.5,C2,T9,NH024,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.7,,,28,31.5,C2,T9,NH024,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30,,,28,32.1,C2,T9,NH024,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,27.5,,,23.3,32.1,C2,T9,NH024,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,29.3,,,26.9,31.9,C2,T9,NH024,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,40,,,32.1,48.5,C2,T9,NH024,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,24.3,,,20.9,28.1,C2,T9,NH024,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,30.7,,,26.7,34.9,C2,T9,NH024,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,32.3,,,29.1,35.7,C2,T9,NH024,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18,,,14.8,21.7,C2,T9,NH024,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,28.9,,,26.8,31.1,C2,T9,NH024,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,16.8,,,14.4,19.6,C2,T9,NH024,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,30.6,36.1,C2,T9,NH024,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.6,,,21.1,24.1,C2,T9,NH024,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,28,,,26.3,29.9,C2,T9,NH024,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.2,,,25.5,31,C2,T9,NH024,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.3,,,24.2,28.5,C2,T9,NH024,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.4,,,23.2,29.7,C2,T9,NH024,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,32.4,,,25.5,40.2,C2,T9,NH024,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,28.4,,,22.5,35,C2,T9,NH024,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,31.6,,,28.2,35.3,C2,T9,NH024,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,29.9,,,26,34.1,C2,T9,NH024,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,17.4,,,15.7,19.1,C2,T9,NH024,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,27.6,,,25,30.4,C2,T9,NH024,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,18,,,16,20.3,C2,T9,NH024,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.9,,,31.7,36.2,C2,T9,NH024,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,21.6,,,18.2,25.5,C2,T9,NH024,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,27.9,,,25.6,30.3,C2,T9,NH024,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.9,,,25.8,32.1,C2,T9,NH024,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.2,,,23.2,29.5,C2,T9,NH024,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31.2,,,28.7,33.9,C2,T9,NH024,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,18,,,13.3,23.8,C2,T9,NH024,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,25.2,,,20.4,30.7,C2,T9,NH024,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,28.9,,,25.5,32.5,C2,T9,NH024,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,29.7,,,27.1,32.4,C2,T9,NH024,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.4,,,15,22.3,C2,T9,NH024,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,27.2,,,25.7,28.7,C2,T9,NH024,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,15.7,,,13.1,18.9,C2,T9,NH024,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.2,,,30.9,35.6,C2,T9,NH024,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,20.4,,,18.2,22.8,C2,T9,NH024,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,26.9,,,25,28.8,C2,T9,NH024,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.9,,,24.2,29.7,C2,T9,NH024,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.5,,,21.4,25.8,C2,T9,NH024,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.4,,,24.6,32.5,C2,T9,NH024,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,28,,,21.8,35.3,C2,T9,NH024,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,22.2,,,17.6,27.5,C2,T9,NH024,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,29.7,,,26.6,32.9,C2,T9,NH024,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,28,,,24.9,31.4,C2,T9,NH024,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,15.5,,,13.2,18.1,C2,T9,NH024,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,25.6,,,23.4,27.9,C2,T9,NH024,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.7,,,11.7,16,C2,T9,NH024,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32.1,,,29.9,34.5,C2,T9,NH024,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,19.1,,,17,21.3,C2,T9,NH024,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.7,,,23.8,27.8,C2,T9,NH024,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,25.5,,,23.2,27.9,C2,T9,NH024,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,25.5,,,22.2,29,C2,T9,NH024,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH024,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,27.1,,,24.9,29.5,C2,T9,NH024,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,25.2,,,19.5,32,C2,T9,NH024,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,25.8,,,21.5,30.6,C2,T9,NH024,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,30.4,,,27.7,33.2,C2,T9,NH024,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,31,,,27.2,35.1,C2,T9,NH024,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.8,,,14.6,23.9,C2,T9,NH024,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,28.1,,,25.9,30.4,C2,T9,NH024,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.3,,,11.2,15.6,C2,T9,NH024,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,31.2,35.5,C2,T9,NH024,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.4,,,19.7,25.3,C2,T9,NH024,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,28,,,26,30.2,C2,T9,NH024,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.3,,,26.5,32.2,C2,T9,NH024,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.7,,,21.5,28.3,C2,T9,NH024,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,25.3,,,21.5,29.4,C2,T9,NH024,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.7,,,21.2,28.6,C2,T9,NH024,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,28.3,,,24.5,32.5,C2,T9,NH024,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,23.6,,,20.6,26.9,C2,T9,NH024,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,24.6,,,21.2,28.4,C2,T9,NH024,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,26.3,,,24,28.6,C2,T9,NH024,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.2,,,16.2,20.4,C2,T9,NH024,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,24.1,,,22.3,26,C2,T9,NH024,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.4,,,10.6,16.9,C2,T9,NH024,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,29.4,,,27.2,31.7,C2,T9,NH024,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,18.5,,,16.8,20.2,C2,T9,NH024,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,23.9,,,22.7,25.3,C2,T9,NH024,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,23.3,,,21.5,25.1,C2,T9,NH024,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.1,,,21.9,26.4,C2,T9,NH024,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,21.7,,,18.8,25,C2,T9,NH024,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.8,,,23.7,30.2,C2,T9,NH024,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Hypertension,Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,22.7,,,19.4,26.4,C2,T9,NH024,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,21-24,Percentage,%,3,,,0.8,10.1,C2,T10,NH060,BOC03,AGE03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,25-44,Percentage,%,14.7,,,12,17.8,C2,T10,NH060,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,45-64,Percentage,%,62.3,,,59.1,65.4,C2,T10,NH060,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,65+,Percentage,%,88.1,,,85.8,90,C2,T10,NH060,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,35+,Percentage,%,62.6,,,60.7,64.5,C2,T10,NH060,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,75+,Percentage,%,79.3,,,73.8,83.9,C2,T10,NH060,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Gender,Male,Percentage,%,50,,,48.2,51.8,C2,T10,NH060,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Gender,Female,Percentage,%,39.4,,,36.5,42.4,C2,T10,NH060,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Overall,Overall,Percentage,%,44.6,,,43.4,45.8,C2,T10,NH060,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,44.2,,,42.6,45.8,C2,T10,NH060,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,51.6,,,49,54.2,C2,T10,NH060,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH060,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Hispanic,Percentage,%,42.1,,,36.9,47.4,C2,T10,NH060,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Other,Percentage,%,43.8,,,37.6,50,C2,T10,NH060,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,21-24,Percentage,%,3.3,,,1.3,8.3,C2,T10,NH060,BOC03,AGE03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,25-44,Percentage,%,11.7,,,9.5,14.4,C2,T10,NH060,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,45-64,Percentage,%,65.7,,,59.4,71.5,C2,T10,NH060,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,65+,Percentage,%,88.7,,,86.6,90.6,C2,T10,NH060,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,35+,Percentage,%,62.6,,,58.8,66.3,C2,T10,NH060,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Age,75+,Percentage,%,78.8,,,73.6,83.2,C2,T10,NH060,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Gender,Male,Percentage,%,48.2,,,46.1,50.4,C2,T10,NH060,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Gender,Female,Percentage,%,41.5,,,38.2,44.9,C2,T10,NH060,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Overall,Overall,Percentage,%,44.7,,,42.6,46.8,C2,T10,NH060,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,43.7,,,41,46.4,C2,T10,NH060,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,54.2,,,50.4,57.9,C2,T10,NH060,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,41,,,36.5,45.5,C2,T10,NH060,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Hispanic,Percentage,%,43.6,,,37.8,49.5,C2,T10,NH060,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of recommended statin therapy for cholesterol management among US adults (21+) (Percentage); NHANES,Race,Other,Percentage,%,43.3,,,39.1,47.7,C2,T10,NH060,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,21-24,Percentage,%,60.8,,,12.1,94.6,C2,T10,NH061,BOC03,AGE03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,25-44,Percentage,%,51.9,,,40.6,63,C2,T10,NH061,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,45-64,Percentage,%,58.7,,,54.9,62.3,C2,T10,NH061,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,65+,Percentage,%,67.8,,,64.2,71.2,C2,T10,NH061,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,35+,Percentage,%,62.5,,,59.9,65,C2,T10,NH061,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,75+,Percentage,%,75.7,,,72.7,78.4,C2,T10,NH061,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Male,Percentage,%,56.2,,,47.1,64.9,C2,T10,NH061,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Female,Percentage,%,53.1,,,44.8,61.3,C2,T10,NH061,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Overall,Overall,Percentage,%,54.8,,,48.5,60.9,C2,T10,NH061,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,61.5,,,52.6,69.6,C2,T10,NH061,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44.1,,,40.2,48.1,C2,T10,NH061,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH061,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Hispanic,Percentage,%,42.9,,,34.7,51.4,C2,T10,NH061,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Other,Percentage,%,34.9,,,24.4,47.2,C2,T10,NH061,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,21-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T10,NH061,BOC03,AGE03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,25-44,Percentage,%,46.7,,,33.7,60.1,C2,T10,NH061,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,45-64,Percentage,%,61.5,,,55.4,67.1,C2,T10,NH061,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,65+,Percentage,%,70.4,,,66.5,74.1,C2,T10,NH061,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,35+,Percentage,%,64.3,,,60.7,67.8,C2,T10,NH061,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,75+,Percentage,%,77.6,,,69.4,84.1,C2,T10,NH061,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Male,Percentage,%,57.8,,,49.4,65.7,C2,T10,NH061,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Female,Percentage,%,57.5,,,51.1,63.7,C2,T10,NH061,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Overall,Overall,Percentage,%,56.9,,,51.9,61.7,C2,T10,NH061,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,59.3,,,51.7,66.5,C2,T10,NH061,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.9,,,48.5,70.2,C2,T10,NH061,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,58.1,,,45.9,69.4,C2,T10,NH061,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Hispanic,Percentage,%,38.8,,,21.9,58.9,C2,T10,NH061,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Other,Percentage,%,56.5,,,42.9,69.2,C2,T10,NH061,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.2,,,3.1,8.8,C2,T10,NH063,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.6,,,10.9,16.8,C2,T10,NH063,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.3,,,19.7,25.1,C2,T10,NH063,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,25.6,,,23.6,27.7,C2,T10,NH063,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,21.2,,,18.5,24.2,C2,T10,NH063,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.7,,,18,23.7,C2,T10,NH063,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.4,,,15.2,19.8,C2,T10,NH063,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.5,,,16.1,21.2,C2,T10,NH063,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.2,,,16.2,20.3,C2,T10,NH063,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19,,,16.9,21.4,C2,T10,NH063,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,14.2,,,11.7,17,C2,T10,NH063,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.7,,,13.8,17.9,C2,T10,NH063,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.9,,,11.2,22,C2,T10,NH063,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.7,6,C2,T10,NH063,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,12.8,,,10.8,15.2,C2,T10,NH063,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.7,,,19.7,26.2,C2,T10,NH063,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,19.4,,,16.1,23.2,C2,T10,NH063,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.6,,,17.5,21.8,C2,T10,NH063,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,19.7,,,16.4,23.5,C2,T10,NH063,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,15.8,,,13.4,18.5,C2,T10,NH063,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.6,,,15.1,18.2,C2,T10,NH063,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.5,,,14.9,18.2,C2,T10,NH063,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.3,,,14.2,18.6,C2,T10,NH063,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,16.2,,,12.7,20.3,C2,T10,NH063,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,14.8,,,11.9,18.2,C2,T10,NH063,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,23.9,,,16.3,33.6,C2,T10,NH063,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.7,,,2.8,7.7,C2,T10,NH063,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,14.4,,,12.8,16.2,C2,T10,NH063,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.2,,,20,24.7,C2,T10,NH063,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,18.4,,,16.7,20.3,C2,T10,NH063,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.9,,,18.3,21.5,C2,T10,NH063,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,17.1,,,14.4,20.2,C2,T10,NH063,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16.4,,,14.9,17.9,C2,T10,NH063,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,17.1,,,15.1,19.4,C2,T10,NH063,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.9,,,15.8,18.2,C2,T10,NH063,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.5,,,16.1,18.9,C2,T10,NH063,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13.7,,,11.1,16.8,C2,T10,NH063,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.2,,,13.5,17,C2,T10,NH063,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.8,,,10.6,20.4,C2,T10,NH063,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.1,,,2.4,6.8,C2,T10,NH063,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.5,,,11,16.5,C2,T10,NH063,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.9,,,18.2,23.9,C2,T10,NH063,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.1,,,12.2,18.5,C2,T10,NH063,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18,,,16,20.1,C2,T10,NH063,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.8,,,8.7,18.5,C2,T10,NH063,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.8,,,12,15.9,C2,T10,NH063,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.8,,,15.4,18.3,C2,T10,NH063,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.5,,,14.2,16.9,C2,T10,NH063,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.2,,,14.3,18.3,C2,T10,NH063,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.6,,,9.4,12,C2,T10,NH063,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.5,,,12.7,18.8,C2,T10,NH063,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.1,,,11.5,27.4,C2,T10,NH063,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5,,,2.7,9.1,C2,T10,NH063,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,11.1,,,9.2,13.3,C2,T10,NH063,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.7,,,16.8,23,C2,T10,NH063,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.5,,,13.3,18,C2,T10,NH063,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,17.2,,,15.5,19,C2,T10,NH063,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,16.9,,,13.7,20.8,C2,T10,NH063,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.3,,,11.3,15.5,C2,T10,NH063,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.2,,,13.2,17.3,C2,T10,NH063,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,14.4,,,12.9,16.1,C2,T10,NH063,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,14.7,,,12.8,16.9,C2,T10,NH063,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13,,,10.4,16.1,C2,T10,NH063,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.1,,,12.2,18.5,C2,T10,NH063,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,13.8,,,9.8,18.9,C2,T10,NH063,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.7,,,1.4,5.3,C2,T10,NH063,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,10.3,,,9,11.9,C2,T10,NH063,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.3,,,16.9,21.9,C2,T10,NH063,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.7,,,11.3,16.5,C2,T10,NH063,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,16.4,,,14.6,18.2,C2,T10,NH063,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.1,,,9.3,15.7,C2,T10,NH063,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,12.2,,,10.6,14.1,C2,T10,NH063,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.8,15.8,C2,T10,NH063,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,13.4,,,12,14.8,C2,T10,NH063,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.6,,,12,15.3,C2,T10,NH063,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.4,,,8.1,13.2,C2,T10,NH063,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH063,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.9,,,12.4,15.6,C2,T10,NH063,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,12.5,,,7.3,20.7,C2,T10,NH063,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.5,,,3.1,9.7,C2,T10,NH063,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.3,,,6.8,10.1,C2,T10,NH063,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.5,,,16.4,23,C2,T10,NH063,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.5,,,10.6,14.7,C2,T10,NH063,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.8,,,13.8,18,C2,T10,NH063,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.3,,,8.1,15.7,C2,T10,NH063,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,11.1,,,9.6,12.8,C2,T10,NH063,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.4,16.3,C2,T10,NH063,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,12.8,,,11.4,14.4,C2,T10,NH063,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.4,,,11.5,15.6,C2,T10,NH063,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10,,,8.5,11.6,C2,T10,NH063,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.2,,,7.9,13.2,C2,T10,NH063,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,12.2,,,9.2,16.2,C2,T10,NH063,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,10,,,7.2,13.7,C2,T10,NH063,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.5,6.6,C2,T10,NH063,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,9.9,,,8.4,11.7,C2,T10,NH063,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,14.3,,,12.3,16.6,C2,T10,NH063,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.6,,,8.9,12.7,C2,T10,NH063,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,13.1,,,11.9,14.5,C2,T10,NH063,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.4,,,7.7,13.8,C2,T10,NH063,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,10.1,,,9,11.3,C2,T10,NH063,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,11.5,,,10.1,13,C2,T10,NH063,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,10.9,,,10.1,11.9,C2,T10,NH063,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,11.2,,,9.9,12.6,C2,T10,NH063,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,7.7,,,6.7,8.9,C2,T10,NH063,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12,,,9.5,15.2,C2,T10,NH063,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,11,,,8.9,13.6,C2,T10,NH063,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.1,,,9.1,13.5,C2,T10,NH063,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,32.5,,,24.6,41.5,C2,T10,NH064,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.3,,,24.7,32.2,C2,T10,NH064,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.4,,,21.2,30.1,C2,T10,NH064,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,19.2,,,15,24.2,C2,T10,NH064,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.9,,,22.6,29.6,C2,T10,NH064,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.1,,,13.2,29.3,C2,T10,NH064,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,36.9,,,32.3,41.7,C2,T10,NH064,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.4,,,12.2,19.2,C2,T10,NH064,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.9,,,23,29.1,C2,T10,NH064,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,25.9,,,22.1,30.2,C2,T10,NH064,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,17.3,,,12.5,23.5,C2,T10,NH064,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.4,,,25,32,C2,T10,NH064,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,23.5,,,14.1,36.6,C2,T10,NH064,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,22.1,,,15.6,30.3,C2,T10,NH064,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,24.9,,,21.5,28.7,C2,T10,NH064,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.2,,,16.9,24.1,C2,T10,NH064,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,17.4,,,14,21.3,C2,T10,NH064,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,21.4,,,20.1,22.7,C2,T10,NH064,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.6,,,10.8,19.4,C2,T10,NH064,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.1,,,29.2,35.2,C2,T10,NH064,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,11.6,,,9.6,14,C2,T10,NH064,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,21.7,,,20.3,23.1,C2,T10,NH064,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,22.3,,,20.5,24.1,C2,T10,NH064,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,16.5,,,12.4,21.5,C2,T10,NH064,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.7,,,22.5,27.2,C2,T10,NH064,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,17.8,,,13,24,C2,T10,NH064,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,22.9,,,14.9,33.5,C2,T10,NH064,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,16.8,,,12.6,21.9,C2,T10,NH064,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,15.2,,,11.9,19.2,C2,T10,NH064,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12,,,8.7,16.1,C2,T10,NH064,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.2,,,12.1,18.8,C2,T10,NH064,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.8,,,6.9,16.5,C2,T10,NH064,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,22.4,,,17.8,27.8,C2,T10,NH064,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,9.9,,,7.2,13.6,C2,T10,NH064,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,197.1,,,194.6,199.6,C2,T10,NH067,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16,,,12.8,19.7,C2,T10,NH064,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.4,,,13.2,22.5,C2,T10,NH064,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,9.3,,,6.4,13.4,C2,T10,NH064,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.7,,,13.8,24.9,C2,T10,NH064,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,10.9,,,6.9,16.9,C2,T10,NH064,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,9.4,,,5,16.9,C2,T10,NH064,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,16.3,,,13.4,19.6,C2,T10,NH064,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,13.6,,,10.8,17,C2,T10,NH064,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.9,,,7.4,10.7,C2,T10,NH064,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,13,,,11.4,14.8,C2,T10,NH064,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,7.9,,,5.3,11.7,C2,T10,NH064,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,20.9,,,17.9,24.1,C2,T10,NH064,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,5.7,,,4.3,7.6,C2,T10,NH064,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,13.2,,,11.6,15,C2,T10,NH064,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.1,,,11.5,15,C2,T10,NH064,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,8.9,,,6.4,12.1,C2,T10,NH064,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.4,,,15.5,21.6,C2,T10,NH064,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,13.1,,,7.8,21.2,C2,T10,NH064,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,20,,,12.4,30.5,C2,T10,NH064,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,23.1,,,18.5,28.5,C2,T10,NH064,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,15.3,,,11.6,19.8,C2,T10,NH064,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.6,,,9,14.7,C2,T10,NH064,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.7,,,13.3,18.4,C2,T10,NH064,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.5,,,8,16.4,C2,T10,NH064,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,25.9,,,22.7,29.5,C2,T10,NH064,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,10,,,8.1,12.3,C2,T10,NH064,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17.9,,,15.5,20.4,C2,T10,NH064,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19.6,,,16.4,23.1,C2,T10,NH064,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,8.9,,,5.6,14,C2,T10,NH064,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20.1,,,15.9,25.1,C2,T10,NH064,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,10.4,,,4.9,20.8,C2,T10,NH064,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,21.4,,,14.6,30.3,C2,T10,NH064,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,21,,,17.7,24.6,C2,T10,NH064,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,17.9,,,15.8,20.2,C2,T10,NH064,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.2,,,9.4,15.8,C2,T10,NH064,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,16.8,,,15.4,18.3,C2,T10,NH064,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.8,,,8.1,16.8,C2,T10,NH064,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.8,,,24.4,31.4,C2,T10,NH064,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,9.2,,,7.3,11.4,C2,T10,NH064,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.3,,,16.2,20.6,C2,T10,NH064,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.9,,,15.5,20.7,C2,T10,NH064,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,14.9,,,11.1,19.7,C2,T10,NH064,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH064,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.3,,,21.2,27.8,C2,T10,NH064,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,17.4,,,11,26.2,C2,T10,NH064,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,15.6,,,10.2,23,C2,T10,NH064,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,16.9,,,13.4,21.1,C2,T10,NH064,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,15.8,,,11.1,21.9,C2,T10,NH064,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.9,,,8.5,21.9,C2,T10,NH064,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.5,,,12.3,19.3,C2,T10,NH064,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,15.4,,,10.3,22.4,C2,T10,NH064,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,23.4,,,20.1,27.1,C2,T10,NH064,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,8.8,,,6.1,12.4,C2,T10,NH064,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.9,,,12.9,19.3,C2,T10,NH064,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.1,,,12.9,20,C2,T10,NH064,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,11.1,,,8.8,14,C2,T10,NH064,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12.4,,,8.3,18.1,C2,T10,NH064,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,19.7,,,14.6,25.9,C2,T10,NH064,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.7,,,7.3,27.2,C2,T10,NH064,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,14.1,,,8.7,22.3,C2,T10,NH064,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,20.5,,,16.6,25.1,C2,T10,NH064,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,16.4,,,14.3,18.7,C2,T10,NH064,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.1,,,11.1,15.5,C2,T10,NH064,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,16,,,14,18.2,C2,T10,NH064,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.2,,,8.3,20.3,C2,T10,NH064,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,26.6,,,22.5,31,C2,T10,NH064,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,8.2,,,6,11,C2,T10,NH064,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17.2,,,14.9,19.7,C2,T10,NH064,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,18.8,,,15.7,22.4,C2,T10,NH064,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.4,,,9.1,11.9,C2,T10,NH064,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,11.3,,,7.7,16.5,C2,T10,NH064,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,16.3,,,14.3,18.5,C2,T10,NH064,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of low HDL (high-density lipoprotein) cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14,,,9.4,20.4,C2,T10,NH064,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,7.6,,,3.7,15,C2,T10,NH065,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,12.8,,,9.5,17,C2,T10,NH065,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21,,,16.6,26.3,C2,T10,NH065,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,22.9,,,17.7,29.2,C2,T10,NH065,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.6,,,16.5,23,C2,T10,NH065,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.4,,,12.7,31.1,C2,T10,NH065,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,19.7,,,15,25.4,C2,T10,NH065,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.5,,,12.5,16.8,C2,T10,NH065,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17.2,,,14.8,19.8,C2,T10,NH065,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,18.6,,,15.8,21.7,C2,T10,NH065,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,7.3,,,5.1,10.3,C2,T10,NH065,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.4,,,22.4,30.8,C2,T10,NH065,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.5,,,5.9,31.4,C2,T10,NH065,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,6,,,2.5,13.7,C2,T10,NH065,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,18.1,,,14.5,22.5,C2,T10,NH065,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.9,,,16.8,25.8,C2,T10,NH065,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,21.4,,,17.2,26.4,C2,T10,NH065,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.7,,,17.8,24.1,C2,T10,NH065,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,18.5,,,14.2,23.9,C2,T10,NH065,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,23.8,,,20.8,27,C2,T10,NH065,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,13.5,,,11.2,16.2,C2,T10,NH065,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.7,,,16.4,21.2,C2,T10,NH065,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19.4,,,16.7,22.4,C2,T10,NH065,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.8,,,5.7,19.4,C2,T10,NH065,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,22,,,17.7,26.9,C2,T10,NH065,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,22.7,,,11.9,39,C2,T10,NH065,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,10.7,,,6,18.4,C2,T10,NH065,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,15.4,,,12.3,19.1,C2,T10,NH065,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.3,,,18.7,26.4,C2,T10,NH065,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,22,,,18.3,26.1,C2,T10,NH065,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.8,,,18.5,23.4,C2,T10,NH065,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,17,,,11.6,24.2,C2,T10,NH065,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21.9,,,18.8,25.4,C2,T10,NH065,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.4,,,13,18.2,C2,T10,NH065,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.6,,,16.9,20.4,C2,T10,NH065,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19.8,,,17.4,22.4,C2,T10,NH065,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,8.2,,,6.3,10.7,C2,T10,NH065,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25,,,19.7,31.2,C2,T10,NH065,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.5,,,12.2,29.7,C2,T10,NH065,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.9,,,3.6,9.7,C2,T10,NH065,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,18.8,,,15.4,22.8,C2,T10,NH065,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,17.6,,,14.7,20.9,C2,T10,NH065,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,18.1,,,13.6,23.7,C2,T10,NH065,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.6,,,16.7,20.7,C2,T10,NH065,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,16.3,,,10.6,24.2,C2,T10,NH065,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,20.9,,,18.6,23.4,C2,T10,NH065,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,12.8,,,10.4,15.7,C2,T10,NH065,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17,,,15.4,18.9,C2,T10,NH065,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.8,,,15.3,20.5,C2,T10,NH065,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,8.2,,,6.2,10.7,C2,T10,NH065,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.4,,,19.6,27.7,C2,T10,NH065,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,12.4,,,7.3,20.3,C2,T10,NH065,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.4,,,2.9,9.9,C2,T10,NH065,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13,,,10.3,16.2,C2,T10,NH065,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,15.6,,,11.9,20.2,C2,T10,NH065,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,16.5,,,11.9,22.5,C2,T10,NH065,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.8,,,13.2,18.9,C2,T10,NH065,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,16.5,,,11.8,22.6,C2,T10,NH065,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.1,,,14.1,20.5,C2,T10,NH065,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,10.6,,,8.8,12.7,C2,T10,NH065,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,13.9,,,11.9,16.1,C2,T10,NH065,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,14.6,,,12.1,17.5,C2,T10,NH065,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,5.4,,,3.2,8.8,C2,T10,NH065,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.9,,,15.3,23.1,C2,T10,NH065,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.1,,,6.7,27.3,C2,T10,NH065,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,6.8,,,3.5,12.9,C2,T10,NH065,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,10.6,,,8.4,13.2,C2,T10,NH065,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,14.1,,,11.9,16.7,C2,T10,NH065,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.7,,,8.7,15.5,C2,T10,NH065,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,12.8,,,11.8,13.9,C2,T10,NH065,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.1,,,7.5,13.5,C2,T10,NH065,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.9,,,11.8,16.4,C2,T10,NH065,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,9.2,,,7.5,11.1,C2,T10,NH065,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.7,,,10.4,13,C2,T10,NH065,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,11.4,,,9.8,13.1,C2,T10,NH065,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,5.3,,,3.6,7.7,C2,T10,NH065,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH065,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,17.8,,,14.2,22,C2,T10,NH065,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,8.7,,,4.4,16.5,C2,T10,NH065,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,6.5,,,3.3,12.3,C2,T10,NH065,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,12,,,8.1,17.6,C2,T10,NH065,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,12.3,,,8.9,16.8,C2,T10,NH065,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.2,,,9.2,18.7,C2,T10,NH065,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,13.3,,,10.5,16.8,C2,T10,NH065,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.6,,,7.2,18.2,C2,T10,NH065,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,15.8,,,12.5,19.7,C2,T10,NH065,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,8,,,5.7,11,C2,T10,NH065,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.8,,,9.2,15,C2,T10,NH065,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,12.2,,,8.9,16.5,C2,T10,NH065,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,6.1,,,4.1,9,C2,T10,NH065,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,11,,,8.6,14,C2,T10,NH065,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,12.7,,,8.6,18.4,C2,T10,NH065,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of high serum triglycerides among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,12.9,,,7.2,21.9,C2,T10,NH065,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,27.7,,,22.8,33.2,C2,T10,NH066,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,51.7,,,46.5,56.8,C2,T10,NH066,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,77.6,,,74.4,80.5,C2,T10,NH066,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.6,,,85.6,91,C2,T10,NH066,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,74.2,,,71.4,76.8,C2,T10,NH066,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,87.9,,,84.7,90.5,C2,T10,NH066,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,63.9,,,61,66.8,C2,T10,NH066,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,67.1,,,62.9,71.1,C2,T10,NH066,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,62.7,68.2,C2,T10,NH066,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,68.4,,,64.5,72,C2,T10,NH066,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.1,,,55.2,62.9,C2,T10,NH066,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,50.7,,,46.7,54.7,C2,T10,NH066,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,54.2,,,48.2,59.9,C2,T10,NH066,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,21.9,,,17.5,27.2,C2,T10,NH066,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,53.9,,,51.2,56.6,C2,T10,NH066,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,77.4,,,73.8,80.7,C2,T10,NH066,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.3,,,84.5,91.2,C2,T10,NH066,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,75.3,,,72.4,78,C2,T10,NH066,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,86.5,,,82.2,89.8,C2,T10,NH066,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,63.5,,,61.1,65.8,C2,T10,NH066,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,67.8,,,64.9,70.5,C2,T10,NH066,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,63.2,67.8,C2,T10,NH066,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,67.9,,,65.1,70.6,C2,T10,NH066,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,62,,,56.8,66.9,C2,T10,NH066,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,51.5,,,46.8,56.2,C2,T10,NH066,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,65.1,,,58,71.5,C2,T10,NH066,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.2,,,20.6,32.6,C2,T10,NH066,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,53.4,,,48.6,58.1,C2,T10,NH066,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.1,,,76.9,82.9,C2,T10,NH066,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,92.2,,,91.1,93.2,C2,T10,NH066,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,77.4,,,75,79.7,C2,T10,NH066,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,92.4,,,90.7,93.7,C2,T10,NH066,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,64.6,,,61.9,67.2,C2,T10,NH066,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,70,,,67.1,72.8,C2,T10,NH066,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,67.3,,,64.8,69.8,C2,T10,NH066,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,69.4,,,65.7,72.9,C2,T10,NH066,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65.4,,,62.9,67.8,C2,T10,NH066,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,52.4,,,46.7,58,C2,T10,NH066,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,65.5,,,57.8,72.4,C2,T10,NH066,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.9,,,25.1,35,C2,T10,NH066,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.2,,,53,61.4,C2,T10,NH066,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.9,,,77.8,83.7,C2,T10,NH066,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,89.8,,,87.1,92,C2,T10,NH066,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.1,,,76.4,81.5,C2,T10,NH066,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,90.1,,,85.5,93.3,C2,T10,NH066,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,65.9,,,63.1,68.6,C2,T10,NH066,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.2,,,69.8,74.5,C2,T10,NH066,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,68.9,,,66.6,71.2,C2,T10,NH066,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,71.4,,,68.8,73.9,C2,T10,NH066,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67.2,,,64.1,70.1,C2,T10,NH066,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,49.6,,,45.1,54.1,C2,T10,NH066,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,69,,,59.3,77.3,C2,T10,NH066,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.3,,,24.2,35,C2,T10,NH066,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,55.5,,,51.1,59.8,C2,T10,NH066,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.4,,,77.6,82.9,C2,T10,NH066,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,93.3,,,91.6,94.7,C2,T10,NH066,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,78.9,,,77,80.7,C2,T10,NH066,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,93.4,,,90.8,95.3,C2,T10,NH066,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,65.3,,,62.7,67.9,C2,T10,NH066,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.4,,,70,74.7,C2,T10,NH066,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,68.9,,,66.8,70.9,C2,T10,NH066,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,70.8,,,67.8,73.6,C2,T10,NH066,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,70.3,,,67.5,72.9,C2,T10,NH066,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,55.6,,,52.9,58.3,C2,T10,NH066,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,66.2,,,58.9,72.8,C2,T10,NH066,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.5,,,24.5,35.2,C2,T10,NH066,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.8,,,53.4,60.2,C2,T10,NH066,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,81,,,77.6,84,C2,T10,NH066,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,91.2,,,89.4,92.8,C2,T10,NH066,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.7,,,77,82.1,C2,T10,NH066,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,90.1,,,86.7,92.7,C2,T10,NH066,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,66.9,,,64.7,69,C2,T10,NH066,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,71.1,,,68.7,73.3,C2,T10,NH066,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,69,,,67.1,70.8,C2,T10,NH066,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,71.7,,,69.9,73.4,C2,T10,NH066,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67,,,63.1,70.7,C2,T10,NH066,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH066,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,53.6,,,49.9,57.3,C2,T10,NH066,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,69.8,,,64.2,74.9,C2,T10,NH066,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,34,,,26.6,42.2,C2,T10,NH066,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,58.8,,,55.1,62.4,C2,T10,NH066,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,81.6,,,78.4,84.5,C2,T10,NH066,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,92.7,,,90.6,94.4,C2,T10,NH066,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,80.9,,,78.5,83,C2,T10,NH066,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,91.8,,,89.8,93.5,C2,T10,NH066,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,68.1,,,66.2,69.9,C2,T10,NH066,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.7,,,70,75.3,C2,T10,NH066,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,70.5,,,68.5,72.4,C2,T10,NH066,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,72.9,,,70.2,75.4,C2,T10,NH066,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,72.8,,,67.8,77.3,C2,T10,NH066,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,71.5,,,68,74.8,C2,T10,NH066,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,57,,,52,61.8,C2,T10,NH066,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,67.5,,,62.7,72,C2,T10,NH066,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,37.2,,,30.8,44,C2,T10,NH066,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,63.5,,,61.2,65.8,C2,T10,NH066,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,85.3,,,83.6,86.9,C2,T10,NH066,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,93.3,,,91.3,94.9,C2,T10,NH066,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,83.7,,,82.9,84.6,C2,T10,NH066,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,95.5,,,92.5,97.4,C2,T10,NH066,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,71.1,,,68.4,73.7,C2,T10,NH066,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,76.8,,,75.4,78.3,C2,T10,NH066,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,74,,,72.6,75.3,C2,T10,NH066,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76,,,73.9,77.9,C2,T10,NH066,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,73.9,,,70.5,77,C2,T10,NH066,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,75.6,,,71.3,79.4,C2,T10,NH066,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,64.9,,,62.2,67.6,C2,T10,NH066,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,74.5,,,70.7,78.1,C2,T10,NH066,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,176.4,,,170.6,182.2,C2,T10,NH067,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,196.1,,,192.5,199.7,C2,T10,NH067,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,214.6,,,211.7,217.4,C2,T10,NH067,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,215.5,,,213.5,217.5,C2,T10,NH067,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,210.3,,,207,213.6,C2,T10,NH067,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,209.1,,,207.1,211.1,C2,T10,NH067,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,203.6,,,200.9,206.3,C2,T10,NH067,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,204.6,,,202,207.2,C2,T10,NH067,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,204.3,,,202,206.7,C2,T10,NH067,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,205.6,,,202.6,208.6,C2,T10,NH067,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,203,,,200.4,205.7,C2,T10,NH067,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,205,,,197.3,212.8,C2,T10,NH067,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,172.8,,,167.3,178.3,C2,T10,NH067,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,197.2,,,194.3,200.1,C2,T10,NH067,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,213.6,,,209.8,217.5,C2,T10,NH067,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,208.1,,,204.5,211.6,C2,T10,NH067,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,209.2,,,206.3,212,C2,T10,NH067,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,208.2,,,203.2,213.2,C2,T10,NH067,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,201.4,,,197.6,205.3,C2,T10,NH067,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,202.6,,,200.8,204.4,C2,T10,NH067,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,202.4,,,200.1,204.7,C2,T10,NH067,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,202.3,,,199.7,204.9,C2,T10,NH067,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,199.8,,,194.8,204.8,C2,T10,NH067,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,200.2,,,195.9,204.5,C2,T10,NH067,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,213.7,,,206.3,221.2,C2,T10,NH067,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,172.9,,,169,176.9,C2,T10,NH067,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,199,,,196.9,201.2,C2,T10,NH067,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,210.2,,,207.1,213.3,C2,T10,NH067,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,205.7,,,203.8,207.5,C2,T10,NH067,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,207.5,,,205.3,209.8,C2,T10,NH067,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,203.8,,,200,207.5,C2,T10,NH067,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,200.5,,,199.1,201.9,C2,T10,NH067,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,202.2,,,199.9,204.5,C2,T10,NH067,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,201.7,,,200.3,203,C2,T10,NH067,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,202.5,,,200.9,204.2,C2,T10,NH067,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,197,,,194,200.1,C2,T10,NH067,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,201,,,198.9,203,C2,T10,NH067,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,196.1,,,189.6,202.6,C2,T10,NH067,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,173.6,,,169.7,177.4,C2,T10,NH067,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,196.2,,,193.3,199,C2,T10,NH067,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,208.4,,,205.8,210.9,C2,T10,NH067,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,196.7,,,193.6,199.9,C2,T10,NH067,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,203.3,,,201.7,205,C2,T10,NH067,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,192.4,,,187.1,197.7,C2,T10,NH067,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,195.5,,,193.6,197.4,C2,T10,NH067,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,200.6,,,199,202.2,C2,T10,NH067,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,198.4,,,197,199.7,C2,T10,NH067,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,198.9,,,197.2,200.6,C2,T10,NH067,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,190.6,,,188.1,193.1,C2,T10,NH067,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,201.4,,,197.4,205.4,C2,T10,NH067,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,200.9,,,195.5,206.2,C2,T10,NH067,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,176,,,170,182.1,C2,T10,NH067,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,194.4,,,191.9,197,C2,T10,NH067,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,206.2,,,202.9,209.4,C2,T10,NH067,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,194.5,,,191.8,197.2,C2,T10,NH067,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,201.7,,,199.9,203.5,C2,T10,NH067,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,194.2,,,191.5,196.9,C2,T10,NH067,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,194,,,191.6,196.4,C2,T10,NH067,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,199.2,,,197,201.3,C2,T10,NH067,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,197,,,195.3,198.6,C2,T10,NH067,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,197.3,,,195.2,199.3,C2,T10,NH067,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,193.3,,,190.2,196.4,C2,T10,NH067,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,199.9,,,196.5,203.2,C2,T10,NH067,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,196.4,,,190.6,202.2,C2,T10,NH067,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,172.2,,,168.4,176,C2,T10,NH067,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,192.9,,,191.4,194.3,C2,T10,NH067,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,206.8,,,203,210.5,C2,T10,NH067,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,193.1,,,189.3,196.9,C2,T10,NH067,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,201.5,,,198.9,204.2,C2,T10,NH067,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,189.2,,,185.5,192.9,C2,T10,NH067,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,193.8,,,191.5,196.2,C2,T10,NH067,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,197.3,,,194.9,199.6,C2,T10,NH067,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,195.8,,,193.9,197.8,C2,T10,NH067,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,196.2,,,193.7,198.6,C2,T10,NH067,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,190.6,,,188.5,192.8,C2,T10,NH067,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T10,NH067,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,197.6,,,195.6,199.6,C2,T10,NH067,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,194.3,,,186.1,202.5,C2,T10,NH067,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,174.1,,,170.6,177.7,C2,T10,NH067,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,190.5,,,188.6,192.5,C2,T10,NH067,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,206.1,,,203.4,208.8,C2,T10,NH067,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,192.9,,,188.7,197.2,C2,T10,NH067,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,200.9,,,198.5,203.4,C2,T10,NH067,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,189.8,,,185.4,194.3,C2,T10,NH067,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,190.8,,,188.6,193.1,C2,T10,NH067,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,198.5,,,196.6,200.4,C2,T10,NH067,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,194.9,,,193.2,196.7,C2,T10,NH067,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,195.9,,,193.4,198.3,C2,T10,NH067,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,189.8,,,187.7,192,C2,T10,NH067,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,191.6,,,188.4,194.8,C2,T10,NH067,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,194.7,,,191.5,197.9,C2,T10,NH067,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,190.7,,,187.1,194.2,C2,T10,NH067,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,mean,169.9,,,166.1,173.7,C2,T10,NH067,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,mean,187.4,,,184.6,190.3,C2,T10,NH067,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,mean,198.6,,,196.5,200.7,C2,T10,NH067,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,mean,184.8,,,181.4,188.2,C2,T10,NH067,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,mean,194,,,193,195,C2,T10,NH067,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,mean,181.9,,,177.1,186.7,C2,T10,NH067,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,mean,186.1,,,183.6,188.5,C2,T10,NH067,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,mean,191.9,,,190.4,193.3,C2,T10,NH067,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,mean,189.2,,,187.8,190.7,C2,T10,NH067,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,mean,189.6,,,187.8,191.4,C2,T10,NH067,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,mean,183.2,,,180.3,186.1,C2,T10,NH067,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,mean,191,,,187.6,194.3,C2,T10,NH067,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,mean,191.2,,,187.3,195.2,C2,T10,NH067,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Cholesterol Abnormalities,Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,mean,188.3,,,185.8,190.8,C2,T10,NH067,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,0,,,0,0.2,C2,T11,NH070,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,3.1,,,2,4.7,C2,T11,NH070,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,12.9,,,10.6,15.6,C2,T11,NH070,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,20,,,16.9,23.5,C2,T11,NH070,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,11.6,,,9.8,13.6,C2,T11,NH070,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,18,,,13.2,23.9,C2,T11,NH070,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,10,,,8.3,12.1,C2,T11,NH070,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,7.9,,,6.6,9.5,C2,T11,NH070,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,8.9,,,7.6,10.4,C2,T11,NH070,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,7.3,,,5.9,8.9,C2,T11,NH070,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,16.1,,,14,18.4,C2,T11,NH070,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,12.9,,,11.1,15.1,C2,T11,NH070,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,16.7,,,9.2,28.3,C2,T11,NH070,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,0.9,,,0.3,2.2,C2,T11,NH070,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,4.1,,,2.9,5.8,C2,T11,NH070,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,11.9,,,9.5,14.8,C2,T11,NH070,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,20.8,,,19.2,22.4,C2,T11,NH070,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,11.8,,,10.5,13.2,C2,T11,NH070,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,20,,,16.5,24,C2,T11,NH070,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,10.7,,,9,12.5,C2,T11,NH070,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,8.1,,,7.1,9.3,C2,T11,NH070,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,9.3,,,8.2,10.6,C2,T11,NH070,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,7.6,,,6.6,8.6,C2,T11,NH070,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,15.6,,,13.4,17.9,C2,T11,NH070,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,14.7,,,13.1,16.5,C2,T11,NH070,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,17.5,,,9.9,29.1,C2,T11,NH070,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,1.1,,,0.5,2.2,C2,T11,NH070,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,3.9,,,2.9,5.1,C2,T11,NH070,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,13.8,,,11.8,16.2,C2,T11,NH070,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,22.3,,,19.3,25.5,C2,T11,NH070,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,13.4,,,11.9,15,C2,T11,NH070,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,17.8,,,15,21.1,C2,T11,NH070,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,11.2,,,9.9,12.7,C2,T11,NH070,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,9.2,,,8.1,10.5,C2,T11,NH070,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,10.1,,,9.1,11.3,C2,T11,NH070,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,8.6,,,7.4,9.8,C2,T11,NH070,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,14.4,,,12.1,17,C2,T11,NH070,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,16.4,,,14.4,18.5,C2,T11,NH070,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,16,,,11.3,22.3,C2,T11,NH070,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,0.3,,,0.1,1.5,C2,T11,NH070,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,4.7,,,3.6,6,C2,T11,NH070,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,12.2,,,10,14.8,C2,T11,NH070,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,21.6,,,19.3,24.2,C2,T11,NH070,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,12.8,,,11.3,14.6,C2,T11,NH070,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,20.1,,,17.2,23.3,C2,T11,NH070,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,10,,,8.6,11.6,C2,T11,NH070,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,9.5,,,8.3,10.9,C2,T11,NH070,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,9.7,,,8.8,10.8,C2,T11,NH070,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,7.8,,,6.7,9,C2,T11,NH070,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,17.6,,,15.2,20.3,C2,T11,NH070,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,17.5,,,15,20.3,C2,T11,NH070,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,12.6,,,8.5,18.2,C2,T11,NH070,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,0.8,,,0.4,1.6,C2,T11,NH070,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,4,,,3.3,4.9,C2,T11,NH070,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,15.7,,,13.3,18.6,C2,T11,NH070,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,27.4,,,23,32.2,C2,T11,NH070,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,15.6,,,13.6,17.9,C2,T11,NH070,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,26,,,21.8,30.8,C2,T11,NH070,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,13,,,11.4,14.8,C2,T11,NH070,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,10.8,,,9.1,12.8,C2,T11,NH070,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.8,,,10.3,13.5,C2,T11,NH070,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,10,,,8,12.3,C2,T11,NH070,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,21,,,19,23.2,C2,T11,NH070,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,16.2,,,13.9,18.7,C2,T11,NH070,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,14.1,,,10.3,19,C2,T11,NH070,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,1,,,0.4,2.8,C2,T11,NH070,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,4.1,,,3.2,5.3,C2,T11,NH070,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,15.2,,,13.1,17.6,C2,T11,NH070,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,26.9,,,23.8,30.2,C2,T11,NH070,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,15.5,,,13.9,17.2,C2,T11,NH070,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,26.4,,,22.6,30.6,C2,T11,NH070,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,12.9,,,11.2,14.7,C2,T11,NH070,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,10.2,,,9,11.4,C2,T11,NH070,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.4,,,10.3,12.7,C2,T11,NH070,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,9.4,,,8,10.9,C2,T11,NH070,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,18.2,,,16.7,19.8,C2,T11,NH070,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH070,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.6,,,16.5,20.9,C2,T11,NH070,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,16.7,,,12.7,21.6,C2,T11,NH070,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,0.8,,,0.4,1.6,C2,T11,NH070,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,5.4,,,4.2,6.9,C2,T11,NH070,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,15.3,,,13.1,17.7,C2,T11,NH070,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,24.5,,,21.9,27.3,C2,T11,NH070,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,15.7,,,13.9,17.8,C2,T11,NH070,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,25.8,,,22,29.9,C2,T11,NH070,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,12.7,,,10.7,14.8,C2,T11,NH070,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,10.3,,,8.9,11.9,C2,T11,NH070,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.4,,,10.1,12.8,C2,T11,NH070,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,8.7,,,7.6,10,C2,T11,NH070,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,19.9,,,16.7,23.4,C2,T11,NH070,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,15.4,,,12.8,18.6,C2,T11,NH070,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.3,,,16.7,26.9,C2,T11,NH070,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,17.2,,,12.9,22.5,C2,T11,NH070,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,1.4,,,0.5,4,C2,T11,NH070,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,4.8,,,4.1,5.7,C2,T11,NH070,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,16.4,,,14.1,19,C2,T11,NH070,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,25,,,22.3,28,C2,T11,NH070,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,16.5,,,15.2,17.8,C2,T11,NH070,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,24.9,,,20.6,29.8,C2,T11,NH070,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,13,,,11.8,14.3,C2,T11,NH070,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,10.7,,,9.5,12.1,C2,T11,NH070,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,11.8,,,10.8,12.8,C2,T11,NH070,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,10.1,,,8.8,11.6,C2,T11,NH070,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,17.2,,,15,19.6,C2,T11,NH070,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,16.3,,,13.8,19.1,C2,T11,NH070,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,17.5,,,15.6,19.5,C2,T11,NH070,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Diabetes,Prevalence of diabetes among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,14.8,,,12,18.1,C2,T11,NH070,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,18.6,,,14.1,24.2,C2,T13,NH071,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.2,,,24.9,31.8,C2,T13,NH071,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.6,,,30.7,40.9,C2,T13,NH071,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.8,,,27,34.9,C2,T13,NH071,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.5,,,28.7,36.4,C2,T13,NH071,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.2,,,18.9,28.1,C2,T13,NH071,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.2,,,24.2,30.3,C2,T13,NH071,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.5,,,30,37.1,C2,T13,NH071,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.4,,,27.4,33.6,C2,T13,NH071,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.6,,,25,32.6,C2,T13,NH071,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.6,,,36.3,43,C2,T13,NH071,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,34.2,,,29.4,39.3,C2,T13,NH071,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,27.8,,,18.9,39,C2,T13,NH071,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24,,,17.9,31.3,C2,T13,NH071,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,27.9,,,25.3,30.7,C2,T13,NH071,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.2,,,31.8,38.8,C2,T13,NH071,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,28.1,,,25.6,30.7,C2,T13,NH071,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,29.5,35.2,C2,T13,NH071,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,18.9,,,14.7,24,C2,T13,NH071,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.4,,,25.4,29.5,C2,T13,NH071,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,32.9,,,30.1,35.8,C2,T13,NH071,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28,32.4,C2,T13,NH071,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.8,,,27.4,32.3,C2,T13,NH071,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.7,,,35.2,42.3,C2,T13,NH071,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,30.9,,,27.3,34.8,C2,T13,NH071,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.2,,,5.3,22.1,C2,T13,NH071,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.4,,,21.2,30,C2,T13,NH071,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.5,,,28.6,34.5,C2,T13,NH071,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.7,,,31.6,39.9,C2,T13,NH071,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.7,,,26.5,33.2,C2,T13,NH071,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,34.3,,,31.9,36.7,C2,T13,NH071,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.5,,,19.5,28.1,C2,T13,NH071,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30.9,,,28.5,33.4,C2,T13,NH071,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33,,,29.8,36.5,C2,T13,NH071,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,32,,,29.7,34.4,C2,T13,NH071,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.6,,,28.1,33.1,C2,T13,NH071,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44.7,,,40.6,48.8,C2,T13,NH071,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,36.6,,,33,40.4,C2,T13,NH071,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.5,,,12.2,27.2,C2,T13,NH071,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24.1,,,16.9,33,C2,T13,NH071,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,28.7,37.4,C2,T13,NH071,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,40.3,,,35.8,44.8,C2,T13,NH071,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.4,,,27.5,33.5,C2,T13,NH071,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,36.6,,,33.7,39.5,C2,T13,NH071,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,24.7,,,20.5,29.5,C2,T13,NH071,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.9,,,29,37,C2,T13,NH071,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.2,,,32.6,38,C2,T13,NH071,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,34.1,,,31.5,36.8,C2,T13,NH071,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.7,,,29.7,36,C2,T13,NH071,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.9,,,42.5,49.3,C2,T13,NH071,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,33.9,,,32,35.9,C2,T13,NH071,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,25.4,,,18.2,34.2,C2,T13,NH071,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.2,,,19.6,34.1,C2,T13,NH071,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.8,,,29.3,36.6,C2,T13,NH071,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,37.3,,,34.2,40.6,C2,T13,NH071,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.9,,,28.9,34.9,C2,T13,NH071,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.6,,,33.3,38.1,C2,T13,NH071,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,26.2,,,22.5,30.3,C2,T13,NH071,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.3,,,29.7,35,C2,T13,NH071,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.3,,,33.1,37.5,C2,T13,NH071,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33.7,,,31.6,35.8,C2,T13,NH071,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.3,,,29,35.9,C2,T13,NH071,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44,,,40.1,48,C2,T13,NH071,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.2,,,34.4,46.4,C2,T13,NH071,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,11.5,31.3,C2,T13,NH071,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,23.2,,,17.3,30.4,C2,T13,NH071,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.9,,,32.6,37.4,C2,T13,NH071,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39,,,36.2,41.9,C2,T13,NH071,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,37.4,,,34.3,40.7,C2,T13,NH071,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.4,,,36.6,40.2,C2,T13,NH071,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.8,,,24.9,33.1,C2,T13,NH071,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.3,,,32,38.8,C2,T13,NH071,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.1,,,34.3,37.8,C2,T13,NH071,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.8,,,34,37.6,C2,T13,NH071,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,34.4,,,32.1,36.7,C2,T13,NH071,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,49.5,,,45.2,53.8,C2,T13,NH071,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH071,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.4,,,37,44,C2,T13,NH071,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,15.5,24.3,C2,T13,NH071,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.2,,,20.5,30.6,C2,T13,NH071,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.4,,,31.4,37.4,C2,T13,NH071,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39.4,,,34.8,44.2,C2,T13,NH071,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.4,,,29.5,37.6,C2,T13,NH071,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.1,,,34.1,40.1,C2,T13,NH071,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.7,,,24.4,33.4,C2,T13,NH071,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.7,,,31.1,36.3,C2,T13,NH071,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.3,,,32.9,39.9,C2,T13,NH071,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.1,,,32.4,37.9,C2,T13,NH071,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.9,,,29.5,36.5,C2,T13,NH071,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,47.9,,,44.7,51.1,C2,T13,NH071,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.8,,,8.3,13.9,C2,T13,NH071,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.8,,,42.5,51.2,C2,T13,NH071,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.4,,,14.8,25,C2,T13,NH071,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.3,,,20.9,30.3,C2,T13,NH071,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,39.1,,,36.7,41.6,C2,T13,NH071,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,41.1,,,37,45.4,C2,T13,NH071,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,35.9,,,32,40,C2,T13,NH071,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,40.2,,,37.9,42.6,C2,T13,NH071,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,29.3,,,25.1,33.9,C2,T13,NH071,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.2,,,33.1,37.4,C2,T13,NH071,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,40.5,,,37.8,43.2,C2,T13,NH071,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,37.9,,,36.1,39.7,C2,T13,NH071,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,36.6,,,34.5,38.9,C2,T13,NH071,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,48.5,,,44.5,52.5,C2,T13,NH071,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12.4,,,10,15.2,C2,T13,NH071,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.5,,,42.4,50.6,C2,T13,NH071,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Obesity,Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.5,,,16.5,25.2,C2,T13,NH071,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,50.7,,,45,56.4,C2,T13,NH072,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,35,,,30.9,39.3,C2,T13,NH072,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,29.9,,,25.6,34.4,C2,T13,NH072,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.5,,,25.8,33.6,C2,T13,NH072,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,30.7,,,27.2,34.5,C2,T13,NH072,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,35.9,,,32.6,39.4,C2,T13,NH072,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,31.5,,,28.5,34.6,C2,T13,NH072,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.5,,,31.3,40,C2,T13,NH072,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33.5,,,30.6,36.7,C2,T13,NH072,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,35.1,,,31,39.5,C2,T13,NH072,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,28.8,,,27,30.7,C2,T13,NH072,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.5,,,22.1,29.2,C2,T13,NH072,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,47.3,,,39.6,55.2,C2,T13,NH072,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,47.7,,,41.2,54.3,C2,T13,NH072,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,35.4,,,32.4,38.5,C2,T13,NH072,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.7,,,24.4,29.2,C2,T13,NH072,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29,,,25.4,32.8,C2,T13,NH072,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,29.3,,,27.6,31.1,C2,T13,NH072,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,34.6,,,27,43,C2,T13,NH072,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,29.1,,,27.4,30.9,C2,T13,NH072,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.6,,,33.3,37.9,C2,T13,NH072,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,32.4,,,31.1,33.6,C2,T13,NH072,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33.9,,,32.4,35.4,C2,T13,NH072,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,25.7,,,22.9,28.7,C2,T13,NH072,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,24.2,32.4,C2,T13,NH072,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,42.7,,,34.7,51.1,C2,T13,NH072,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,45.9,,,40.3,51.6,C2,T13,NH072,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,35.1,,,32.5,37.7,C2,T13,NH072,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.2,,,23.1,29.7,C2,T13,NH072,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.3,,,25.7,33.1,C2,T13,NH072,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,28.5,,,26.2,30.9,C2,T13,NH072,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,33.8,,,30.1,37.8,C2,T13,NH072,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.8,,,25.4,30.5,C2,T13,NH072,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36,,,32.2,40.1,C2,T13,NH072,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,32,,,29.8,34.3,C2,T13,NH072,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33.6,,,30.7,36.7,C2,T13,NH072,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.5,,,19.8,25.5,C2,T13,NH072,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.1,,,19.6,29.3,C2,T13,NH072,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,45.8,,,39.4,52.4,C2,T13,NH072,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,45.8,,,39.4,52.3,C2,T13,NH072,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,33.5,,,29.4,37.9,C2,T13,NH072,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.1,,,22.5,27.9,C2,T13,NH072,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30,,,27.3,32.8,C2,T13,NH072,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,27.9,,,25.8,30.2,C2,T13,NH072,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,36.7,,,32.1,41.5,C2,T13,NH072,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,25.4,,,22.9,28.1,C2,T13,NH072,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.6,,,33.7,39.6,C2,T13,NH072,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.1,,,28.9,33.5,C2,T13,NH072,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.6,,,29.4,35.9,C2,T13,NH072,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.7,,,19.7,25.9,C2,T13,NH072,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.8,,,22.5,27.2,C2,T13,NH072,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,48.2,,,40.7,55.9,C2,T13,NH072,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,42.8,,,37.5,48.3,C2,T13,NH072,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.7,,,28.8,34.7,C2,T13,NH072,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.8,,,23.7,30.1,C2,T13,NH072,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,27.8,,,24.4,31.6,C2,T13,NH072,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,27,,,24.7,29.4,C2,T13,NH072,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,30.3,,,27.8,32.8,C2,T13,NH072,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,26.7,,,24.7,28.7,C2,T13,NH072,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.5,,,30.7,36.3,C2,T13,NH072,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28.4,32.1,C2,T13,NH072,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,31.4,,,28.7,34.1,C2,T13,NH072,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.4,,,22,26.9,C2,T13,NH072,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20.5,,,17,24.6,C2,T13,NH072,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50.7,,,43.3,58.1,C2,T13,NH072,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,47.1,,,37.8,56.6,C2,T13,NH072,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.9,,,29.2,34.6,C2,T13,NH072,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.4,,,20.4,26.7,C2,T13,NH072,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,25.9,,,23.8,28.1,C2,T13,NH072,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.2,,,23.4,27.1,C2,T13,NH072,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,32.3,,,28.7,36.2,C2,T13,NH072,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,24.9,,,21.6,28.5,C2,T13,NH072,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.4,,,31.2,35.8,C2,T13,NH072,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.2,,,26.9,31.6,C2,T13,NH072,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.9,,,28,33.9,C2,T13,NH072,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,21.6,,,19.4,23.9,C2,T13,NH072,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH072,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.2,,,15.6,21.2,C2,T13,NH072,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,44.4,,,37.7,51.3,C2,T13,NH072,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,46.8,,,38.9,54.8,C2,T13,NH072,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31,,,26.7,35.7,C2,T13,NH072,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.5,,,20.7,26.6,C2,T13,NH072,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,28.2,,,24.6,32,C2,T13,NH072,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.8,,,24,27.7,C2,T13,NH072,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,32.4,,,28.8,36.1,C2,T13,NH072,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.5,,,25,30.3,C2,T13,NH072,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,31.2,,,28.1,34.4,C2,T13,NH072,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.4,,,26.9,32.1,C2,T13,NH072,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.7,,,27.4,34.1,C2,T13,NH072,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,21.7,,,19.2,24.4,C2,T13,NH072,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,57.3,,,53.6,60.9,C2,T13,NH072,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,19,,,14.7,24.2,C2,T13,NH072,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,48.4,,,46.1,50.7,C2,T13,NH072,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,45.5,,,40.2,50.9,C2,T13,NH072,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.4,,,26.3,30.7,C2,T13,NH072,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.4,,,21.2,25.8,C2,T13,NH072,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,26,,,23.5,28.7,C2,T13,NH072,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.4,,,22.9,26.1,C2,T13,NH072,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.9,,,24.4,33.9,C2,T13,NH072,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,24.6,,,22.4,26.8,C2,T13,NH072,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,31.1,,,28.8,33.6,C2,T13,NH072,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,27.9,,,26.3,29.6,C2,T13,NH072,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.9,,,27.3,30.5,C2,T13,NH072,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,21.8,,,18.9,25,C2,T13,NH072,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,53.5,,,49.9,57,C2,T13,NH072,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.9,,,13.4,18.8,C2,T13,NH072,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 8: Prevalence of  healthy weight among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,46.1,,,41.5,50.8,C2,T13,NH072,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,3863.4,,,3698.9,4027.8,C2,T12,NH073,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,3923.5,,,3804.4,4042.5,C2,T12,NH073,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3533.7,,,3424.2,3643.2,C2,T12,NH073,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,2980.8,,,2879.6,3082.1,C2,T12,NH073,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3461.8,,,3381.6,3542,C2,T12,NH073,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2734.5,,,2631,2837.9,C2,T12,NH073,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4240.3,,,4138.6,4342,C2,T12,NH073,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,3025.9,,,2958.6,3093.1,C2,T12,NH073,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3615.9,,,3553.9,3677.9,C2,T12,NH073,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3691.3,,,3613.7,3769,C2,T12,NH073,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3258.3,,,3077.9,3438.6,C2,T12,NH073,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T12,NH073,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3462.3,,,3295.5,3629,C2,T12,NH073,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3756.1,,,3472,4040.2,C2,T12,NH073,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,3781.7,,,3618.8,3944.6,C2,T12,NH073,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,4052.6,,,3940,4165.2,C2,T12,NH073,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3604.8,,,3457.3,3752.3,C2,T12,NH073,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,3057.9,,,2904.3,3211.6,C2,T12,NH073,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3597.2,,,3485.7,3708.8,C2,T12,NH073,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2809.9,,,2708.8,2911.1,C2,T12,NH073,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4345.3,,,4222.9,4467.7,C2,T12,NH073,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,3070,,,2977.2,3162.9,C2,T12,NH073,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3687.5,,,3594.7,3780.3,C2,T12,NH073,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3789.3,,,3681,3897.6,C2,T12,NH073,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3427.8,,,3287.1,3568.4,C2,T12,NH073,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T12,NH073,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3285.8,,,3099.9,3471.8,C2,T12,NH073,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3611.6,,,3325.2,3898,C2,T12,NH073,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,3788.5,,,3495,4081.9,C2,T12,NH073,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,3838.3,,,3707.9,3968.8,C2,T12,NH073,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3584.3,,,3414.1,3754.5,C2,T12,NH073,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,2912.8,,,2802.3,3023.3,C2,T12,NH073,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3515.7,,,3382.3,3649.1,C2,T12,NH073,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2733.7,,,2568.2,2899.2,C2,T12,NH073,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4207.8,,,4028.3,4387.3,C2,T12,NH073,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,3015.5,,,2928.6,3102.5,C2,T12,NH073,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3582.6,,,3460.4,3704.8,C2,T12,NH073,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3662.6,,,3520.2,3805.1,C2,T12,NH073,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3344.1,,,3194.6,3493.5,C2,T12,NH073,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T12,NH073,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3268.3,,,3121.6,3414.9,C2,T12,NH073,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3683.8,,,3272.4,4095.2,C2,T12,NH073,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,3749.1,,,3561.1,3937.1,C2,T12,NH073,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,3777.1,,,3688.9,3865.3,C2,T12,NH073,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3640.3,,,3542.9,3737.6,C2,T12,NH073,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,2992.4,,,2880.1,3104.8,C2,T12,NH073,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3506.8,,,3437.8,3575.8,C2,T12,NH073,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2741,,,2592.9,2889,C2,T12,NH073,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4234.3,,,4147.5,4321.2,C2,T12,NH073,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,2981,,,2926.8,3035.3,C2,T12,NH073,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3591.1,,,3536.5,3645.7,C2,T12,NH073,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3656.9,,,3595.1,3718.6,C2,T12,NH073,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3321.2,,,3199.6,3442.8,C2,T12,NH073,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,,-,Data not available,,,C2,T12,NH073,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3297.3,,,3150.9,3443.7,C2,T12,NH073,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3849.3,,,3580.5,4118.2,C2,T12,NH073,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,4081.1,,,3815.4,4346.8,C2,T12,NH073,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,3832.9,,,3700.8,3965,C2,T12,NH073,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3506.8,,,3367.1,3646.6,C2,T12,NH073,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,3048,,,2948.6,3147.3,C2,T12,NH073,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3473.7,,,3389.1,3558.3,C2,T12,NH073,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2860.7,,,2725.5,2995.9,C2,T12,NH073,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4240.5,,,4137.8,4343.2,C2,T12,NH073,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,3014.6,,,2950.1,3079,C2,T12,NH073,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3620.6,,,3571.8,3669.5,C2,T12,NH073,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3647.7,,,3577.4,3718.1,C2,T12,NH073,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3489.2,,,3386.6,3591.7,C2,T12,NH073,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,3807.6,,,3573,4042.1,C2,T12,NH073,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3704,,,3563.8,3844.3,C2,T12,NH073,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3692,,,3496.1,3887.9,C2,T12,NH073,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,mean,3796.2,,,3574.8,4017.7,C2,T12,NH073,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,mean,3769.7,,,3709,3830.3,C2,T12,NH073,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,mean,3469.3,,,3331.6,3607,C2,T12,NH073,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,mean,3014.4,,,2925.1,3103.7,C2,T12,NH073,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,mean,3400.9,,,3322.8,3479,C2,T12,NH073,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,mean,2934.5,,,2766,3103,C2,T12,NH073,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,mean,4093.9,,,3986.2,4201.6,C2,T12,NH073,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,mean,3013.6,,,2964.1,3063.1,C2,T12,NH073,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,mean,3540.7,,,3475.6,3605.8,C2,T12,NH073,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,mean,3545.3,,,3474.1,3616.5,C2,T12,NH073,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,mean,3492.1,,,3353.7,3630.6,C2,T12,NH073,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,mean,3650.8,,,3407.7,3893.9,C2,T12,NH073,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,mean,3647.3,,,3411.2,3883.3,C2,T12,NH073,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Nutrition,Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,mean,3585.3,,,3390.4,3780.3,C2,T12,NH073,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,34.9,,,28.1,42.4,C2,T15,NH074,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.7,,,30.6,39.1,C2,T15,NH074,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.7,,,22.9,33.2,C2,T15,NH074,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.1,,,11.9,19,C2,T15,NH074,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,26.9,,,23.6,30.4,C2,T15,NH074,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.7,,,7,15.9,C2,T15,NH074,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.5,,,30.1,39.2,C2,T15,NH074,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,23.4,,,20.2,26.9,C2,T15,NH074,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.7,,,25.4,32.2,C2,T15,NH074,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.8,,,25.3,34.7,C2,T15,NH074,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.8,,,28.3,37.8,C2,T15,NH074,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.2,,,16.9,26.4,C2,T15,NH074,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,24.3,,,20,29.2,C2,T15,NH074,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.7,,,35.1,48.7,C2,T15,NH074,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.2,,,29.2,35.4,C2,T15,NH074,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,29,,,25.7,32.5,C2,T15,NH074,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.7,,,10.4,15.4,C2,T15,NH074,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,26.3,,,24.1,28.7,C2,T15,NH074,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.8,,,6.3,12,C2,T15,NH074,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.7,,,29.8,35.7,C2,T15,NH074,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,24.2,,,21.8,26.7,C2,T15,NH074,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.3,,,26,30.6,C2,T15,NH074,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.2,,,25,31.7,C2,T15,NH074,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,33.7,,,29.3,38.3,C2,T15,NH074,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.5,,,21.8,29.5,C2,T15,NH074,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,25.3,,,15.9,37.7,C2,T15,NH074,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.1,,,35.7,46.7,C2,T15,NH074,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,36.4,,,32,40.9,C2,T15,NH074,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,32.3,,,29.1,35.7,C2,T15,NH074,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.5,,,10.8,14.3,C2,T15,NH074,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,28.5,,,25.8,31.3,C2,T15,NH074,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.5,,,7,10.3,C2,T15,NH074,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,38.1,,,34.2,42.2,C2,T15,NH074,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,24,,,21.5,26.7,C2,T15,NH074,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.8,,,28.2,33.6,C2,T15,NH074,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,31.8,,,28.9,34.9,C2,T15,NH074,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,34.4,,,29,40.2,C2,T15,NH074,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.4,,,21.3,25.7,C2,T15,NH074,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,28,,,20.9,36.5,C2,T15,NH074,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.3,,,34.6,48.3,C2,T15,NH074,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,29.2,36.8,C2,T15,NH074,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.3,,,24.5,32.5,C2,T15,NH074,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,14.3,,,11.7,17.4,C2,T15,NH074,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,27.1,,,24.6,29.7,C2,T15,NH074,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.7,,,7.4,12.6,C2,T15,NH074,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.6,,,31.6,37.8,C2,T15,NH074,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.9,,,20.7,25.3,C2,T15,NH074,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.6,,,26.4,31,C2,T15,NH074,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.7,,,27.3,34.3,C2,T15,NH074,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.7,,,24.6,35.4,C2,T15,NH074,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.6,,,19.4,24.1,C2,T15,NH074,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,26.3,,,18.2,36.4,C2,T15,NH074,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,35,,,28.9,41.6,C2,T15,NH074,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,33.7,,,30.3,37.2,C2,T15,NH074,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.9,,,23.4,32.8,C2,T15,NH074,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.1,,,10.7,13.6,C2,T15,NH074,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.8,,,21.9,28.1,C2,T15,NH074,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.5,,,7.6,11.9,C2,T15,NH074,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,29.6,37.2,C2,T15,NH074,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.4,,,19.8,25.3,C2,T15,NH074,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,27.8,,,24.7,31,C2,T15,NH074,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.4,,,25.1,34.1,C2,T15,NH074,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.9,,,29.9,36,C2,T15,NH074,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.9,,,15.8,22.3,C2,T15,NH074,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20,,,14.2,27.5,C2,T15,NH074,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,36.1,,,29.4,43.4,C2,T15,NH074,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,30.1,,,27.4,33,C2,T15,NH074,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.3,,,23.4,27.3,C2,T15,NH074,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.1,,,9.4,12.9,C2,T15,NH074,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,22.6,,,21.2,24.1,C2,T15,NH074,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8,,,6.3,10.2,C2,T15,NH074,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30,,,27.7,32.3,C2,T15,NH074,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,21.4,,,19.7,23.2,C2,T15,NH074,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.5,,,24,27.1,C2,T15,NH074,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.4,,,24.5,28.4,C2,T15,NH074,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,33.5,,,27.8,39.8,C2,T15,NH074,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH074,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,19.9,,,16.4,23.8,C2,T15,NH074,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.8,,,13.2,28.6,C2,T15,NH074,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.1,,,19.2,32.1,C2,T15,NH074,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,29.8,,,26.9,33,C2,T15,NH074,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.8,,,22.3,29.7,C2,T15,NH074,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12,,,9.1,15.6,C2,T15,NH074,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,23.3,,,20.8,26,C2,T15,NH074,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,6.1,,,4.1,9,C2,T15,NH074,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,31.1,,,27.3,35.3,C2,T15,NH074,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.9,,,16.1,22.1,C2,T15,NH074,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,24.8,,,22.1,27.7,C2,T15,NH074,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26,,,22.5,29.8,C2,T15,NH074,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.5,,,24.5,35.1,C2,T15,NH074,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,11.1,,,9.1,13.6,C2,T15,NH074,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20.5,,,17.3,24.1,C2,T15,NH074,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.9,,,14.3,29.4,C2,T15,NH074,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.9,,,22.1,32.2,C2,T15,NH074,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,22.7,,,20.3,25.3,C2,T15,NH074,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.4,,,17.5,25.8,C2,T15,NH074,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.2,,,6.8,9.9,C2,T15,NH074,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.3,,,16.1,20.8,C2,T15,NH074,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,4.7,,,3.2,6.8,C2,T15,NH074,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21,,,18.9,23.4,C2,T15,NH074,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,19.2,,,16.5,22.3,C2,T15,NH074,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,20.1,,,18,22.4,C2,T15,NH074,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,21.7,,,18.5,25.2,C2,T15,NH074,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26,,,23.1,29.1,C2,T15,NH074,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,8.2,,,6.3,10.6,C2,T15,NH074,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.2,,,10.5,16.6,C2,T15,NH074,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Risk Factors,Smoking,Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,16.1,,,12.7,20.2,C2,T15,NH074,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.2,,,0.1,0.5,C2,T1,NH101,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.1,,,1,4.4,C2,T1,NH101,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,0.3,,,0.1,0.7,C2,T1,NH101,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,1.3,,,0.7,2.4,C2,T1,NH101,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,0.3,,,0,2.3,C2,T1,NH101,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,1.2,,,0.5,3.1,C2,T1,NH101,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.6,,,0.3,1.2,C2,T1,NH101,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.9,,,0.5,1.7,C2,T1,NH101,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.8,,,0.3,2,C2,T1,NH101,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,1.1,,,0.6,2.2,C2,T1,NH101,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T1,NH101,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.2,,,0.7,1.9,C2,T1,NH101,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.7,,,0.2,11.7,C2,T1,NH101,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.9,,,0.5,1.6,C2,T1,NH101,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1,,,0.5,1.9,C2,T1,NH101,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,0.3,,,0.1,0.8,C2,T1,NH101,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.9,,,0.6,1.3,C2,T1,NH101,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,0.2,,,0,1.2,C2,T1,NH101,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.8,,,0.4,1.5,C2,T1,NH101,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.7,,,0.4,1.3,C2,T1,NH101,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.7,,,0.5,1.1,C2,T1,NH101,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.4,,,0.2,0.8,C2,T1,NH101,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2,,,0.9,4.2,C2,T1,NH101,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T1,NH101,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1,,,0.5,1.9,C2,T1,NH101,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.4,,,0.3,6.8,C2,T1,NH101,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1.1,C2,T1,NH101,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1.2,,,0.5,3,C2,T1,NH101,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,0.2,,,0.1,0.5,C2,T1,NH101,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.9,,,0.4,1.8,C2,T1,NH101,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.8,,,0.3,1.9,C2,T1,NH101,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.5,,,0.2,1.1,C2,T1,NH101,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.6,,,0.3,1.3,C2,T1,NH101,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.4,,,0.1,1.4,C2,T1,NH101,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,1.8,,,0.8,3.8,C2,T1,NH101,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1,,,0.3,2.9,C2,T1,NH101,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) poor CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH101,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,14.4,,,8.3,23.7,C2,T1,NH103,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,4.7,,,3,7.4,C2,T1,NH103,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1.7,,,0.7,4.3,C2,T1,NH103,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.4,,,1.9,2.9,C1,T5,NH600,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,1.8,,,0.9,3.5,C2,T1,NH103,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2,,,1.2,3.5,C2,T1,NH103,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,5.3,,,3.5,7.9,C2,T1,NH103,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.6,,,2.5,5.2,C2,T1,NH103,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.8,,,3.1,7.3,C2,T1,NH103,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,1.6,,,0.8,3,C2,T1,NH103,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T1,NH103,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1,,,0.4,2.6,C2,T1,NH103,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3,,,1.2,7.3,C2,T1,NH103,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,7.8,,,4,14.6,C2,T1,NH103,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.3,,,4.4,9.1,C2,T1,NH103,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1.3,,,0.7,2.5,C2,T1,NH103,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,2.2,,,1.6,3.1,C2,T1,NH103,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,1.5,,,0.8,2.7,C2,T1,NH103,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,5.5,,,4.1,7.3,C2,T1,NH103,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.6,,,2.7,4.6,C2,T1,NH103,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.4,,,3.2,6.2,C2,T1,NH103,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.8,,,0.3,2.4,C2,T1,NH103,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T1,NH103,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.9,,,1.1,3.4,C2,T1,NH103,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.5,,,1.1,10.1,C2,T1,NH103,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,12.1,,,7,20.2,C2,T1,NH103,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.4,,,4.6,8.9,C2,T1,NH103,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.9,,,0.3,2.8,C2,T1,NH103,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,1.9,,,1.1,3.1,C2,T1,NH103,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T1,NH103,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.7,,,1.8,4.1,C2,T1,NH103,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,5,,,3.4,7.3,C2,T1,NH103,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.8,,,2.8,5.3,C2,T1,NH103,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.4,,,2.9,6.6,C2,T1,NH103,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,1.1,,,0.4,3,C2,T1,NH103,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,8.1,,,6.4,10.4,C2,T1,NH103,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.1,,,1.1,4,C2,T1,NH103,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Major Cardiovascular Disease,Prevalence of 6-7 (out of 7) ideal CV Health metrics among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,6.7,,,5,8.9,C2,T1,NH103,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.1,9.1,C2,T9,NH201,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.7,,,6.5,11.6,C2,T9,NH201,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.9,,,19.5,26.7,C2,T9,NH201,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,53.2,,,48.7,57.6,C2,T9,NH201,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.9,,,23,29.1,C2,T9,NH201,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,65.2,,,59.6,70.3,C2,T9,NH201,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,20,,,16.8,23.6,C2,T9,NH201,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22,,,19.7,24.5,C2,T9,NH201,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,21.2,,,18.8,23.9,C2,T9,NH201,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19.3,,,16.7,22.2,C2,T9,NH201,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.3,,,26.1,32.8,C2,T9,NH201,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.3,,,21.8,26.9,C2,T9,NH201,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,26.5,,,15.5,41.5,C2,T9,NH201,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.3,,,1,5.1,C2,T9,NH201,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7.4,,,6.5,8.5,C2,T9,NH201,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23,,,20.1,26.1,C2,T9,NH201,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,47.8,,,44.4,51.2,C2,T9,NH201,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.2,,,8.6,12,C1,T5,NH600,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.4,,,22.1,26.8,C2,T9,NH201,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,52.6,,,47.1,58,C2,T9,NH201,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,18.7,,,17,20.6,C2,T9,NH201,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,20.4,,,18.9,22,C2,T9,NH201,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,19.9,,,18.5,21.4,C2,T9,NH201,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,18.7,,,17,20.4,C2,T9,NH201,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.8,,,27.5,32.1,C2,T9,NH201,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.8,,,16.5,21.4,C2,T9,NH201,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,21,,,14.7,29,C2,T9,NH201,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.7,,,0.3,1.8,C2,T9,NH201,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7.2,,,5.6,9.3,C2,T9,NH201,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26,,,21.7,30.8,C2,T9,NH201,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,43.1,,,39,47.3,C2,T9,NH201,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.9,,,21.9,28.2,C2,T9,NH201,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,53,,,48.2,57.6,C2,T9,NH201,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,19.1,,,15.9,22.8,C2,T9,NH201,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,20,,,18.1,21.9,C2,T9,NH201,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,19.7,,,17.4,22.2,C2,T9,NH201,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,18.6,,,16.1,21.5,C2,T9,NH201,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.8,,,23.1,30.8,C2,T9,NH201,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20,,,17,23.3,C2,T9,NH201,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,22.6,,,17.6,28.5,C2,T9,NH201,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4,,,2.3,6.9,C2,T9,NH201,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.1,,,6.3,10.4,C2,T9,NH201,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.6,,,17.8,23.8,C2,T9,NH201,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,38.6,,,36.1,41.3,C2,T9,NH201,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,22.1,,,20.1,24.1,C2,T9,NH201,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,43.7,,,40.1,47.4,C2,T9,NH201,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,18.6,,,16.3,21.1,C2,T9,NH201,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.8,,,15.5,18,C2,T9,NH201,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17.9,,,16.3,19.6,C2,T9,NH201,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.9,,,15,18.9,C2,T9,NH201,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,25.5,,,23.4,27.6,C2,T9,NH201,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.7,,,13.4,18.3,C2,T9,NH201,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,17.6,,,13.2,23,C2,T9,NH201,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.8,,,1.7,4.5,C2,T9,NH201,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.9,,,5.8,8.2,C2,T9,NH201,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20,,,18.2,22,C2,T9,NH201,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,36.5,,,32.5,40.7,C2,T9,NH201,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.8,,,19.5,22.2,C2,T9,NH201,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,43.4,,,39.7,47.2,C2,T9,NH201,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.4,,,15.9,19,C2,T9,NH201,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.7,,,14.7,16.9,C2,T9,NH201,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.6,,,15.5,17.8,C2,T9,NH201,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,15.6,,,14.2,17,C2,T9,NH201,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.2,,,21.5,27.2,C2,T9,NH201,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,17.3,,,14,21.3,C2,T9,NH201,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.7,,,12.4,19.7,C2,T9,NH201,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,1.7,,,0.6,4.7,C2,T9,NH201,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.9,,,5.7,8.2,C2,T9,NH201,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,17,,,14.9,19.2,C2,T9,NH201,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,32,,,28.4,35.9,C2,T9,NH201,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.6,,,16.8,20.6,C2,T9,NH201,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,38.3,,,33.4,43.4,C2,T9,NH201,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16,,,14.8,17.3,C2,T9,NH201,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,12.9,,,11.4,14.6,C2,T9,NH201,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,14.5,,,13.4,15.8,C2,T9,NH201,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.1,,,11.7,14.7,C2,T9,NH201,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.9,,,20.1,26,C2,T9,NH201,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH201,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.3,,,16.5,20.3,C2,T9,NH201,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.4,,,11.2,20.9,C2,T9,NH201,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.9,,,1.3,6.6,C2,T9,NH201,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.8,,,5.1,9,C2,T9,NH201,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,17.7,,,15.1,20.7,C2,T9,NH201,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.6,,,30.4,36.9,C2,T9,NH201,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.6,,,17.4,22.1,C2,T9,NH201,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,44.9,,,37.9,52,C2,T9,NH201,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16.1,,,14.4,18.1,C2,T9,NH201,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,13.8,,,11.9,16,C2,T9,NH201,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15,,,13.4,16.9,C2,T9,NH201,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.8,,,11.8,16.1,C2,T9,NH201,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23,,,20.3,26,C2,T9,NH201,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,14,,,12.3,16,C2,T9,NH201,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.3,,,11,21,C2,T9,NH201,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.2,,,11.7,17.2,C2,T9,NH201,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.6,,,1.3,5.3,C2,T9,NH201,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,6.9,,,5.7,8.5,C2,T9,NH201,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,17.7,,,14.7,21.2,C2,T9,NH201,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,32,,,28.3,35.9,C2,T9,NH201,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.3,,,17,21.9,C2,T9,NH201,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,39.6,,,32,47.7,C2,T9,NH201,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16.3,,,13.7,19.3,C2,T9,NH201,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,13.2,,,11.7,14.8,C2,T9,NH201,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,14.8,,,13,16.7,C2,T9,NH201,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.3,,,10.8,16.1,C2,T9,NH201,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.4,,,21.1,25.9,C2,T9,NH201,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,16.5,,,14.6,18.6,C2,T9,NH201,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.2,,,12.4,18.5,C2,T9,NH201,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of poor blood pressure level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,17.4,,,14.5,20.8,C2,T9,NH201,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,67.4,,,59.3,74.5,C2,T9,NH203,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,54.1,,,49.1,59,C2,T9,NH203,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.9,,,23.6,32.6,C2,T9,NH203,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.2,,,6.2,10.9,C2,T9,NH203,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,30.3,,,26.5,34.4,C2,T9,NH203,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,5.2,,,3.9,6.9,C2,T9,NH203,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30.4,,,26.2,35,C2,T9,NH203,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45.8,,,42.8,48.8,C2,T9,NH203,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,37.8,,,34.8,41,C2,T9,NH203,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,39.1,,,34.9,43.4,C2,T9,NH203,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.6,,,3,4.4,C1,T5,NH600,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.2,,,26.6,31.9,C2,T9,NH203,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,38.6,,,35,42.4,C2,T9,NH203,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,36,,,25.3,48.3,C2,T9,NH203,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,66.1,,,60.4,71.3,C2,T9,NH203,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.7,,,53.3,60,C2,T9,NH203,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,29.4,,,25.7,33.5,C2,T9,NH203,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.7,,,8,14.3,C2,T9,NH203,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,31.9,,,28.6,35.3,C2,T9,NH203,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.2,,,5.8,11.5,C2,T9,NH203,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.2,,,29,37.6,C2,T9,NH203,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,46.4,,,43.8,49,C2,T9,NH203,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,39.6,,,37.1,42.1,C2,T9,NH203,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,40.8,,,37.9,43.8,C2,T9,NH203,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,28.5,,,25.7,31.5,C2,T9,NH203,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,45.4,,,42.4,48.4,C2,T9,NH203,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,27.8,,,20,37.2,C2,T9,NH203,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,72.9,,,68.2,77.1,C2,T9,NH203,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.9,,,52,61.7,C2,T9,NH203,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24.9,,,21.4,28.8,C2,T9,NH203,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.8,,,9.2,15,C2,T9,NH203,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,29.4,,,26.2,32.8,C2,T9,NH203,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9,,,5.9,13.5,C2,T9,NH203,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.4,,,29.6,37.5,C2,T9,NH203,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45.2,,,43,47.5,C2,T9,NH203,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,39.1,,,36.4,41.9,C2,T9,NH203,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,40.1,,,36.9,43.4,C2,T9,NH203,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30.6,,,26.6,34.9,C2,T9,NH203,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,43,,,38.2,48,C2,T9,NH203,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,33.6,,,25.6,42.8,C2,T9,NH203,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,67.4,,,58.9,74.9,C2,T9,NH203,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.7,,,52.2,61,C2,T9,NH203,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,30.3,,,26.8,34,C2,T9,NH203,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.7,,,11,16.9,C2,T9,NH203,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.5,,,30,35.2,C2,T9,NH203,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.2,,,8.7,11.9,C2,T9,NH203,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.2,,,31.4,37.1,C2,T9,NH203,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,47.4,,,44.1,50.7,C2,T9,NH203,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.3,,,10.1,14.9,C1,T5,NH600,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,40.5,,,37.7,43.3,C2,T9,NH203,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,40.7,,,37.2,44.3,C2,T9,NH203,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.8,,,27.5,32.1,C2,T9,NH203,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,44.5,,,40.9,48,C2,T9,NH203,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50.5,,,44,56.9,C2,T9,NH203,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,69.9,,,62.7,76.1,C2,T9,NH203,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.9,,,53.6,62,C2,T9,NH203,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,30.5,,,27.4,33.8,C2,T9,NH203,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.3,,,9.1,14,C2,T9,NH203,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,31.6,,,29.1,34.2,C2,T9,NH203,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,7.8,,,5.6,10.8,C2,T9,NH203,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34,,,31.3,36.8,C2,T9,NH203,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,47.6,,,45,50.2,C2,T9,NH203,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,40.7,,,38.5,42.9,C2,T9,NH203,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,41.2,,,38.2,44.2,C2,T9,NH203,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,33.3,,,29.8,36.9,C2,T9,NH203,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,41.9,,,35,49.2,C2,T9,NH203,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,46.3,,,39.9,52.7,C2,T9,NH203,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,74.4,,,69,79.1,C2,T9,NH203,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,59.6,,,56.7,62.4,C2,T9,NH203,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,32.4,,,27.9,37.3,C2,T9,NH203,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.2,,,10.5,16.3,C2,T9,NH203,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,33.5,,,30,37.1,C2,T9,NH203,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.4,,,7.3,11.9,C2,T9,NH203,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.9,,,32.9,39.1,C2,T9,NH203,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,50.3,,,47.8,52.8,C2,T9,NH203,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,42.9,,,40.5,45.4,C2,T9,NH203,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,44.3,,,41.6,47.1,C2,T9,NH203,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30.7,,,27,34.7,C2,T9,NH203,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NH203,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,43.6,,,40,47.3,C2,T9,NH203,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,42.3,,,36.6,48.3,C2,T9,NH203,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,71,,,64.7,76.5,C2,T9,NH203,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.1,,,52.3,61.7,C2,T9,NH203,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.4,,,25.7,31.2,C2,T9,NH203,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.9,,,10.8,17.6,C2,T9,NH203,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,30,,,27.5,32.7,C2,T9,NH203,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.7,,,7,13.4,C2,T9,NH203,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,3.2,,,2.4,4.2,C1,T5,NH600,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.6,,,31.9,37.5,C2,T9,NH203,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,46.8,,,43.7,49.9,C2,T9,NH203,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,40.6,,,38.2,42.9,C2,T9,NH203,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,40.5,,,37.5,43.6,C2,T9,NH203,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30.3,,,26,35.1,C2,T9,NH203,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48,,,44.9,51.1,C2,T9,NH203,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,47.4,,,43.3,51.4,C2,T9,NH203,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,43.7,,,39.2,48.3,C2,T9,NH203,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,70.8,,,66.9,74.4,C2,T9,NH203,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,62.5,,,59.3,65.7,C2,T9,NH203,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,32.6,,,29.1,36.3,C2,T9,NH203,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.1,,,10.4,14.1,C2,T9,NH203,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,33.1,,,30.7,35.5,C2,T9,NH203,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.3,,,8.7,14.5,C2,T9,NH203,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,37.3,,,34.9,39.8,C2,T9,NH203,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,50.4,,,48.3,52.4,C2,T9,NH203,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,43.8,,,42,45.5,C2,T9,NH203,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.5,,,43,48,C2,T9,NH203,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.7,,,29.4,34.1,C2,T9,NH203,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,49.8,,,46.8,52.7,C2,T9,NH203,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,43.7,,,39.7,47.6,C2,T9,NH203,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Hypertension,Prevalence of ideal blood pressure level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,46.4,,,41.8,51.1,C2,T9,NH203,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.2,,,3.1,8.8,C2,T10,NH301,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.6,,,10.9,16.8,C2,T10,NH301,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.3,,,19.7,25.1,C2,T10,NH301,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,25.6,,,23.6,27.7,C2,T10,NH301,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,21.2,,,18.5,24.2,C2,T10,NH301,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.7,,,18,23.7,C2,T10,NH301,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.4,,,15.2,19.8,C2,T10,NH301,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.5,,,16.1,21.2,C2,T10,NH301,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.2,,,16.2,20.3,C2,T10,NH301,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19,,,16.9,21.4,C2,T10,NH301,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,14.2,,,11.7,17,C2,T10,NH301,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.7,,,13.8,17.9,C2,T10,NH301,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.9,,,11.2,22,C2,T10,NH301,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.7,6,C2,T10,NH301,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,12.8,,,10.8,15.2,C2,T10,NH301,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.7,,,19.7,26.2,C2,T10,NH301,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,19.4,,,16.1,23.2,C2,T10,NH301,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.6,,,17.5,21.8,C2,T10,NH301,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,19.7,,,16.4,23.5,C2,T10,NH301,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,15.8,,,13.4,18.5,C2,T10,NH301,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.6,,,15.1,18.2,C2,T10,NH301,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.5,,,14.9,18.2,C2,T10,NH301,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.3,,,14.2,18.6,C2,T10,NH301,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,16.2,,,12.7,20.3,C2,T10,NH301,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,14.8,,,11.9,18.2,C2,T10,NH301,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,23.9,,,16.3,33.6,C2,T10,NH301,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.7,,,2.8,7.7,C2,T10,NH301,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,14.4,,,12.8,16.2,C2,T10,NH301,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.2,,,20,24.7,C2,T10,NH301,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,18.4,,,16.7,20.3,C2,T10,NH301,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.9,,,18.3,21.5,C2,T10,NH301,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,17.1,,,14.4,20.2,C2,T10,NH301,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16.4,,,14.9,17.9,C2,T10,NH301,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,17.1,,,15.1,19.4,C2,T10,NH301,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.9,,,15.8,18.2,C2,T10,NH301,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.6,,,2,3.3,C1,T5,NH600,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.5,,,16.1,18.9,C2,T10,NH301,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13.7,,,11.1,16.8,C2,T10,NH301,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.2,,,13.5,17,C2,T10,NH301,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.8,,,10.6,20.4,C2,T10,NH301,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.1,,,2.4,6.8,C2,T10,NH301,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.5,,,11,16.5,C2,T10,NH301,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.9,,,18.2,23.9,C2,T10,NH301,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.1,,,12.2,18.5,C2,T10,NH301,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18,,,16,20.1,C2,T10,NH301,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.8,,,8.7,18.5,C2,T10,NH301,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.8,,,12,15.9,C2,T10,NH301,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.8,,,15.4,18.3,C2,T10,NH301,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.5,,,14.2,16.9,C2,T10,NH301,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.2,,,14.3,18.3,C2,T10,NH301,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.6,,,9.4,12,C2,T10,NH301,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.5,,,12.7,18.8,C2,T10,NH301,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.1,,,11.5,27.4,C2,T10,NH301,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5,,,2.7,9.1,C2,T10,NH301,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,11.1,,,9.2,13.3,C2,T10,NH301,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.7,,,16.8,23,C2,T10,NH301,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.5,,,13.3,18,C2,T10,NH301,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,17.2,,,15.5,19,C2,T10,NH301,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,16.9,,,13.7,20.8,C2,T10,NH301,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.3,,,11.3,15.5,C2,T10,NH301,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.2,,,13.2,17.3,C2,T10,NH301,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,14.4,,,12.9,16.1,C2,T10,NH301,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,14.7,,,12.8,16.9,C2,T10,NH301,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13,,,10.4,16.1,C2,T10,NH301,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.1,,,12.2,18.5,C2,T10,NH301,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,13.8,,,9.8,18.9,C2,T10,NH301,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.7,,,1.4,5.3,C2,T10,NH301,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,10.3,,,9,11.9,C2,T10,NH301,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.3,,,16.9,21.9,C2,T10,NH301,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.7,,,11.3,16.5,C2,T10,NH301,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,16.4,,,14.6,18.2,C2,T10,NH301,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.8,,,2.4,3.4,C1,T5,NH600,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.1,,,9.3,15.7,C2,T10,NH301,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,12.2,,,10.6,14.1,C2,T10,NH301,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.8,15.8,C2,T10,NH301,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,13.4,,,12,14.8,C2,T10,NH301,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.6,,,12,15.3,C2,T10,NH301,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.4,,,8.1,13.2,C2,T10,NH301,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH301,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.9,,,12.4,15.6,C2,T10,NH301,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,12.5,,,7.3,20.7,C2,T10,NH301,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.5,,,3.1,9.7,C2,T10,NH301,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.3,,,6.8,10.1,C2,T10,NH301,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.5,,,16.4,23,C2,T10,NH301,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.5,,,10.6,14.7,C2,T10,NH301,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.8,,,13.8,18,C2,T10,NH301,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.3,,,8.1,15.7,C2,T10,NH301,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,11.1,,,9.6,12.8,C2,T10,NH301,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.4,16.3,C2,T10,NH301,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,12.8,,,11.4,14.4,C2,T10,NH301,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.4,,,11.5,15.6,C2,T10,NH301,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10,,,8.5,11.6,C2,T10,NH301,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.2,,,7.9,13.2,C2,T10,NH301,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,12.2,,,9.2,16.2,C2,T10,NH301,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,10,,,7.2,13.7,C2,T10,NH301,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.5,6.6,C2,T10,NH301,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,9.9,,,8.4,11.7,C2,T10,NH301,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,14.3,,,12.3,16.6,C2,T10,NH301,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.6,,,8.9,12.7,C2,T10,NH301,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,13.1,,,11.9,14.5,C2,T10,NH301,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.4,,,7.7,13.8,C2,T10,NH301,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,10.1,,,9,11.3,C2,T10,NH301,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,11.5,,,10.1,13,C2,T10,NH301,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,10.9,,,10.1,11.9,C2,T10,NH301,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,11.2,,,9.9,12.6,C2,T10,NH301,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,7.7,,,6.7,8.9,C2,T10,NH301,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12,,,9.5,15.2,C2,T10,NH301,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,11,,,8.9,13.6,C2,T10,NH301,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of poor serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.1,,,9.1,13.5,C2,T10,NH301,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,81.2,,,75.7,85.7,C2,T10,NH303,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.3,,,53.9,60.6,C2,T10,NH303,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.3,,,25.3,31.6,C2,T10,NH303,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,26.3,,,23.8,29.1,C2,T10,NH303,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.8,,,32.3,39.5,C2,T10,NH303,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,34.5,,,30.9,38.4,C2,T10,NH303,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,42.7,,,39.9,45.5,C2,T10,NH303,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45,,,42.8,47.3,C2,T10,NH303,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,43.7,,,41.6,45.8,C2,T10,NH303,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,41.7,,,39,44.5,C2,T10,NH303,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,53.4,,,50.1,56.6,C2,T10,NH303,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,47.9,,,44.9,51,C2,T10,NH303,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,44.4,,,36.8,52.4,C2,T10,NH303,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,78.7,,,75.3,81.8,C2,T10,NH303,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.6,,,53,60.3,C2,T10,NH303,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.4,,,32.4,38.4,C2,T10,NH303,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.6,,,25.7,33.8,C2,T10,NH303,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.6,,,36.1,41.2,C2,T10,NH303,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,31.3,,,26.7,36.2,C2,T10,NH303,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9,,,7,11.4,C1,T5,NH600,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,46,,,43.6,48.5,C2,T10,NH303,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,47.6,,,44.4,50.8,C2,T10,NH303,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,46.5,,,44.2,48.7,C2,T10,NH303,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.9,,,43.3,48.4,C2,T10,NH303,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,50.6,,,46.1,55.1,C2,T10,NH303,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,48.5,,,43.5,53.5,C2,T10,NH303,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,34.9,,,28.7,41.7,C2,T10,NH303,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,80.2,,,75.7,84.1,C2,T10,NH303,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,53.8,,,51.4,56.1,C2,T10,NH303,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,32.8,,,28.7,37.1,C2,T10,NH303,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,26.9,,,24.4,29.5,C2,T10,NH303,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.3,,,32.5,38.2,C2,T10,NH303,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,32.4,,,28,37.2,C2,T10,NH303,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,42.8,,,40.2,45.4,C2,T10,NH303,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45.4,,,42.8,48.1,C2,T10,NH303,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,44,,,42,46,C2,T10,NH303,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,43.1,,,40.7,45.4,C2,T10,NH303,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,51.3,,,49.3,53.3,C2,T10,NH303,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,44.5,,,41.1,47.9,C2,T10,NH303,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50,,,40.4,59.5,C2,T10,NH303,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,82.4,,,78.2,86,C2,T10,NH303,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.4,,,54,60.8,C2,T10,NH303,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,31.6,,,27.8,35.6,C2,T10,NH303,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.4,,,26.8,34.2,C2,T10,NH303,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.2,,,34.6,39.9,C2,T10,NH303,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,34,,,29.6,38.6,C2,T10,NH303,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,46.6,,,43.9,49.2,C2,T10,NH303,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45.4,,,42.8,48.1,C2,T10,NH303,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,45.7,,,43.5,48,C2,T10,NH303,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.3,,,42.8,47.8,C2,T10,NH303,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,52.5,,,48.4,56.6,C2,T10,NH303,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,44.7,,,42.1,47.2,C2,T10,NH303,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,43.2,,,37.6,48.9,C2,T10,NH303,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,78.2,,,70.7,84.1,C2,T10,NH303,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.3,,,53.5,59.1,C2,T10,NH303,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,33,,,29.2,37,C2,T10,NH303,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.1,,,27.3,33.1,C2,T10,NH303,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,36.7,,,34.1,39.3,C2,T10,NH303,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,35.5,,,29.7,41.7,C2,T10,NH303,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,45.8,,,43.2,48.5,C2,T10,NH303,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,44.8,,,42.4,47.3,C2,T10,NH303,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,45.1,,,43.3,47,C2,T10,NH303,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,44.8,,,42.5,47.2,C2,T10,NH303,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,50,,,47,53,C2,T10,NH303,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,44.2,,,40.2,48.3,C2,T10,NH303,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,39.3,,,30.8,48.6,C2,T10,NH303,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,79.5,,,74.5,83.8,C2,T10,NH303,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,59.1,,,57,61.1,C2,T10,NH303,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,31.2,,,28,34.6,C2,T10,NH303,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.2,,,26.3,36.6,C2,T10,NH303,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,36.5,,,34,39.1,C2,T10,NH303,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,33.7,,,29.1,38.7,C2,T10,NH303,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,45.7,,,43.8,47.7,C2,T10,NH303,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,78.3,,,75.6,80.8,C2,T12,NH501,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,47,,,43.9,50,C2,T10,NH303,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,46.2,,,44.3,48.1,C2,T10,NH303,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.7,,,43.3,48.1,C2,T10,NH303,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,49.2,,,45.8,52.7,C2,T10,NH303,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NH303,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,44.3,,,41.5,47.2,C2,T10,NH303,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,54,,,45.9,61.9,C2,T10,NH303,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,80.3,,,73.2,85.9,C2,T10,NH303,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,61.6,,,59.3,63.8,C2,T10,NH303,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.3,,,25.5,31.4,C2,T10,NH303,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,24.1,,,21.7,26.6,C2,T10,NH303,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,33.5,,,31.6,35.4,C2,T10,NH303,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,27.9,,,25.1,30.9,C2,T10,NH303,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,45.7,,,43.9,47.5,C2,T10,NH303,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,44.3,,,42.1,46.5,C2,T10,NH303,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,44.9,,,43.4,46.4,C2,T10,NH303,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,44.1,,,42.2,46.1,C2,T10,NH303,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,48.9,,,46.4,51.3,C2,T10,NH303,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,46.9,,,41.3,52.6,C2,T10,NH303,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.3,,,41.9,50.7,C2,T10,NH303,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,47.4,,,42.5,52.3,C2,T10,NH303,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,85.7,,,81.2,89.2,C2,T10,NH303,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,63.1,,,58.5,67.5,C2,T10,NH303,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.2,,,31.7,38.8,C2,T10,NH303,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,26.9,,,22.1,32.3,C2,T10,NH303,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.9,,,35.1,40.8,C2,T10,NH303,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,27.5,,,23.6,31.7,C2,T10,NH303,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,48.6,,,44.6,52.6,C2,T10,NH303,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,49.6,,,45.9,53.2,C2,T10,NH303,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,49,,,45.7,52.2,C2,T10,NH303,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,47.3,,,43.1,51.5,C2,T10,NH303,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,55.8,,,52.9,58.6,C2,T10,NH303,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48,,,43.8,52.2,C2,T10,NH303,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,52.2,,,48,56.3,C2,T10,NH303,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Cholesterol Abnormalities,Prevalence of ideal serum total cholesterol level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,51,,,46.9,55.1,C2,T10,NH303,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T11,NH401,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,5.8,,,3.7,8.9,C2,T11,NH401,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.8,,,17.7,26.5,C2,T11,NH401,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.3,,,25.5,35.6,C2,T11,NH401,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.4,,,16.4,23,C2,T11,NH401,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,29.2,,,21.4,38.4,C2,T11,NH401,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.4,,,14.4,20.9,C2,T11,NH401,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,13.4,,,10.8,16.4,C2,T11,NH401,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.2,,,12.8,18.1,C2,T11,NH401,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,12.8,,,10.3,15.7,C2,T11,NH401,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.9,,,20.6,27.6,C2,T11,NH401,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.1,,,18.2,24.3,C2,T11,NH401,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,27.4,,,14,46.6,C2,T11,NH401,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,1.5,,,0.4,5.8,C2,T11,NH401,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7.5,,,5.1,11,C2,T11,NH401,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,18.6,,,14.9,22.9,C2,T11,NH401,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,32.7,,,30.6,35,C2,T11,NH401,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19,,,17.1,21,C2,T11,NH401,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,30.4,,,26,35.2,C2,T11,NH401,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.8,,,15.2,20.7,C2,T11,NH401,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,13.3,,,11.4,15.4,C2,T11,NH401,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.5,,,13.6,17.6,C2,T11,NH401,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,12.8,,,11.1,14.7,C2,T11,NH401,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.4,,,20.2,26.9,C2,T11,NH401,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,22.5,,,19.9,25.4,C2,T11,NH401,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,30.4,,,19.3,44.3,C2,T11,NH401,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.1,,,0.6,7.4,C2,T11,NH401,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7,,,4.9,9.9,C2,T11,NH401,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.8,,,18.4,25.7,C2,T11,NH401,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.6,,,26.7,36.9,C2,T11,NH401,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.9,,,18.5,23.5,C2,T11,NH401,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,27.3,,,22.1,33.1,C2,T11,NH401,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,18.1,,,15.1,21.5,C2,T11,NH401,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.5,,,12.7,16.5,C2,T11,NH401,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.2,,,14.3,18.4,C2,T11,NH401,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.3,,,11,15.9,C2,T11,NH401,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.2,,,20.1,26.5,C2,T11,NH401,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.1,,,22.1,30.5,C2,T11,NH401,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,24,,,16.4,33.6,C2,T11,NH401,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T11,NH401,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.8,,,6.6,11.7,C2,T11,NH401,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,18.6,,,14.7,23.3,C2,T11,NH401,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,32.4,,,28.5,36.6,C2,T11,NH401,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.3,,,17.4,23.7,C2,T11,NH401,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,31.8,,,25.7,38.7,C2,T11,NH401,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,15.7,,,13.2,18.5,C2,T11,NH401,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.9,,,13.5,18.7,C2,T11,NH401,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.9,,,14,18,C2,T11,NH401,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.1,,,11,15.5,C2,T11,NH401,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26,,,22.1,30.2,C2,T11,NH401,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,27.7,,,23.4,32.5,C2,T11,NH401,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.2,,,8.6,25.5,C2,T11,NH401,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.5,,,0.1,2.3,C2,T11,NH401,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7.5,,,5.7,9.9,C2,T11,NH401,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.3,,,19.7,27.4,C2,T11,NH401,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,38.6,,,32.4,45.2,C2,T11,NH401,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.1,,,20.8,27.7,C2,T11,NH401,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,36.5,,,30.4,43.1,C2,T11,NH401,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21.1,,,18.5,23.9,C2,T11,NH401,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.1,,,13.7,18.9,C2,T11,NH401,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.4,,,16.2,20.9,C2,T11,NH401,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,15.7,,,12.7,19.1,C2,T11,NH401,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.4,,,26.5,36.7,C2,T11,NH401,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.9,,,23.3,28.6,C2,T11,NH401,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,21.3,,,12,35,C2,T11,NH401,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.9,,,0.2,3.7,C2,T11,NH401,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,7,,,5.2,9.3,C2,T11,NH401,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.6,,,19.7,28,C2,T11,NH401,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,36.2,,,32.2,40.4,C2,T11,NH401,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,23.7,,,21.1,26.6,C2,T11,NH401,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,35.8,,,29.1,43.3,C2,T11,NH401,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,20.8,,,17.8,24.2,C2,T11,NH401,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.7,,,12.9,16.6,C2,T11,NH401,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,17.6,,,15.5,19.8,C2,T11,NH401,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,14.6,,,12.3,17.2,C2,T11,NH401,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.4,,,22.6,26.3,C2,T11,NH401,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH401,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,23.8,32.9,C2,T11,NH401,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,24,,,18.4,30.7,C2,T11,NH401,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,1.8,,,0.8,4.2,C2,T11,NH401,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,9.1,,,6.9,11.9,C2,T11,NH401,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.9,,,20,28.4,C2,T11,NH401,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.9,,,30.6,37.3,C2,T11,NH401,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,23.5,,,20.3,27.1,C2,T11,NH401,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,39.3,,,34,44.9,C2,T11,NH401,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,19.5,,,16.4,23.1,C2,T11,NH401,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.5,,,14.2,18.9,C2,T11,NH401,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18,,,15.6,20.6,C2,T11,NH401,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.6,,,11.3,16.4,C2,T11,NH401,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.1,,,25.4,37.4,C2,T11,NH401,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,23.7,,,19.7,28.2,C2,T11,NH401,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,29.7,,,23.7,36.5,C2,T11,NH401,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,26.3,,,21.7,31.6,C2,T11,NH401,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.7,,,0.9,7.8,C2,T11,NH401,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.1,,,6.5,10.1,C2,T11,NH401,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.7,,,23.3,30.5,C2,T11,NH401,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,34.8,,,30.6,39.2,C2,T11,NH401,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.6,,,23.6,27.7,C2,T11,NH401,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,36.8,,,31.1,42.9,C2,T11,NH401,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21.5,,,19.3,23.9,C2,T11,NH401,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.3,,,14.9,17.7,C2,T11,NH401,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.8,,,17.4,20.4,C2,T11,NH401,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.7,,,14.3,19.3,C2,T11,NH401,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.8,,,22.1,27.7,C2,T11,NH401,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,23.4,,,19.2,28,C2,T11,NH401,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.4,,,21.3,30,C2,T11,NH401,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of poor HbA1c or serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,21.8,,,16.9,27.5,C2,T11,NH401,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,85.7,,,77.6,91.2,C2,T11,NH403,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,67,,,60.6,72.8,C2,T11,NH403,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,40.4,,,35,46.1,C2,T11,NH403,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,23.6,,,19.4,28.5,C2,T11,NH403,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,42.7,,,37.5,48.2,C2,T11,NH403,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,24.9,,,18.2,33.2,C2,T11,NH403,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,42.3,,,36.3,48.6,C2,T11,NH403,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,60.5,,,56.8,64,C2,T11,NH403,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,51.6,,,47.4,55.7,C2,T11,NH403,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,52.9,,,47.6,58.1,C2,T11,NH403,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,49.9,,,44.1,55.7,C2,T11,NH403,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,43.7,,,41.1,46.4,C2,T11,NH403,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,52,,,34.3,69.1,C2,T11,NH403,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,77.3,,,67.3,84.9,C2,T11,NH403,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,59.9,,,55.7,63.9,C2,T11,NH403,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,33.5,,,30.1,37.2,C2,T11,NH403,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,22.5,,,18.9,26.6,C2,T11,NH403,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.5,,,34.3,40.8,C2,T11,NH403,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,24.7,,,20.4,29.5,C2,T11,NH403,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,36.2,,,32.8,39.8,C2,T11,NH403,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,54.8,,,51.1,58.4,C2,T11,NH403,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,45.4,,,42.7,48.3,C2,T11,NH403,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,47.4,,,44.3,50.5,C2,T11,NH403,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,47.7,,,42.6,53,C2,T11,NH403,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,34.1,,,29.2,39.5,C2,T11,NH403,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,33.4,,,22.8,46,C2,T11,NH403,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,74.6,,,65.5,81.9,C2,T11,NH403,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,61,,,55.7,66.1,C2,T11,NH403,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,37.4,,,31.7,43.5,C2,T11,NH403,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,23.6,,,17.6,30.8,C2,T11,NH403,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,39.6,,,33.4,46.2,C2,T11,NH403,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,25.3,,,19.9,31.7,C2,T11,NH403,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,39.4,,,34.5,44.4,C2,T11,NH403,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,54.8,,,48.7,60.8,C2,T11,NH403,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,47.2,,,42.1,52.2,C2,T11,NH403,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.2,,,43,55.5,C2,T11,NH403,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.2,,,39.5,51.1,C2,T11,NH403,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,38.6,,,33.6,43.9,C2,T11,NH403,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,37.5,,,29.6,46.1,C2,T11,NH403,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,76.6,,,68.3,83.3,C2,T11,NH403,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,59.4,,,54.2,64.5,C2,T11,NH403,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.8,,,27.1,45.5,C2,T11,NH403,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,19.7,,,15.9,24.2,C2,T11,NH403,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.9,,,30.2,42.1,C2,T11,NH403,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.6,,,15.3,27.1,C2,T11,NH403,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,38.9,,,34.4,43.6,C2,T11,NH403,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,51.8,,,47.4,56.1,C2,T11,NH403,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,45.2,,,41,49.4,C2,T11,NH403,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49,,,43.1,54.9,C2,T11,NH403,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,36.8,,,32,41.8,C2,T11,NH403,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,32.9,,,27.6,38.7,C2,T11,NH403,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,40.7,,,31.9,50.1,C2,T11,NH403,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,69.3,,,61.6,76.1,C2,T11,NH403,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,54.2,,,49.3,59,C2,T11,NH403,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24.9,,,21.7,28.3,C2,T11,NH403,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.6,,,9.7,18.9,C2,T11,NH403,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,28,,,23.9,32.4,C2,T11,NH403,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13,,,8.8,18.8,C2,T11,NH403,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,29.5,,,26,33.2,C2,T11,NH403,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,45,,,40.9,49.2,C2,T11,NH403,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,37.3,,,34.1,40.6,C2,T11,NH403,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,39.4,,,34.3,44.8,C2,T11,NH403,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30.1,,,23.7,37.4,C2,T11,NH403,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,30.6,,,28.2,33,C2,T11,NH403,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,38.3,,,27.3,50.8,C2,T11,NH403,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,71.5,,,62.2,79.3,C2,T11,NH403,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.6,,,53.6,61.4,C2,T11,NH403,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,29.2,,,26.3,32.3,C2,T11,NH403,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,17.5,,,15.3,20.1,C2,T11,NH403,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,31.3,,,29.2,33.5,C2,T11,NH403,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,17.1,,,13.4,21.7,C2,T11,NH403,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.8,,,29.5,36.2,C2,T11,NH403,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,50,,,47.4,52.6,C2,T11,NH403,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,41.6,,,39.1,44.2,C2,T11,NH403,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.4,,,42.5,48.3,C2,T11,NH403,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.8,,,29.3,36.5,C2,T11,NH403,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T11,NH403,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31,,,27,35.3,C2,T11,NH403,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,39.6,,,29.9,50.2,C2,T11,NH403,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,73.7,,,65.6,80.5,C2,T11,NH403,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,55.7,,,51.6,59.8,C2,T11,NH403,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,30.5,,,26.1,35.3,C2,T11,NH403,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,14.8,,,11.1,19.6,C2,T11,NH403,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,31.6,,,28.6,34.7,C2,T11,NH403,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.9,,,10,19,C2,T11,NH403,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35,,,31.3,38.8,C2,T11,NH403,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,47.8,,,45.1,50.5,C2,T11,NH403,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,41.4,,,38.8,44,C2,T11,NH403,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.1,,,42,48.2,C2,T11,NH403,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.2,,,26.9,35.8,C2,T11,NH403,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,40,,,34,46.4,C2,T11,NH403,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,32.8,,,28.2,37.7,C2,T11,NH403,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,38.3,,,33.7,43.1,C2,T11,NH403,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,73,,,63,81.1,C2,T11,NH403,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,58.5,,,54.3,62.6,C2,T11,NH403,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,31.9,,,28,36.2,C2,T11,NH403,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,23.7,,,18.5,29.7,C2,T11,NH403,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,34.9,,,31.3,38.8,C2,T11,NH403,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,19.8,,,15,25.6,C2,T11,NH403,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,38.8,,,33.1,44.8,C2,T11,NH403,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,49.8,,,47.3,52.4,C2,T11,NH403,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,44.3,,,41,47.7,C2,T11,NH403,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,47.9,,,43.6,52.1,C2,T11,NH403,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,36.3,,,32.8,39.9,C2,T11,NH403,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,38.6,,,33.9,43.6,C2,T11,NH403,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31.5,,,27.4,35.9,C2,T11,NH403,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Diabetes,Prevalence of ideal HbA1c and serum fasting glucose level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,38.7,,,33,44.6,C2,T11,NH403,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,89,,,84,92.6,C2,T12,NH501,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,82.1,,,78.9,84.9,C2,T12,NH501,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,72.3,,,67.6,76.6,C2,T12,NH501,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,61.5,,,56.4,66.2,C2,T12,NH501,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,72.1,,,69.1,74.9,C2,T12,NH501,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,57.6,,,52.3,62.7,C2,T12,NH501,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,79,,,75.9,81.9,C2,T12,NH501,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.2,,,69.2,75,C2,T12,NH501,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,75.6,,,73.2,77.8,C2,T12,NH501,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76.5,,,73.7,79.2,C2,T12,NH501,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,77.6,,,72.7,81.9,C2,T12,NH501,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH501,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,78.5,,,72.1,83.8,C2,T12,NH501,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,58.6,,,51,65.7,C2,T12,NH501,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,83.8,,,78.3,88.1,C2,T12,NH501,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,80.4,,,76.8,83.6,C2,T12,NH501,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,68.7,,,65.7,71.5,C2,T12,NH501,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,62.2,,,57.5,66.7,C2,T12,NH501,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,69.6,,,66.6,72.4,C2,T12,NH501,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,59.1,,,52.3,65.5,C2,T12,NH501,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,68.6,,,65.3,71.7,C2,T12,NH501,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,73.2,,,70.7,75.6,C2,T12,NH501,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,73.5,,,70.3,76.4,C2,T12,NH501,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,76,,,71.4,80,C2,T12,NH501,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH501,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,76.9,,,70.9,82,C2,T12,NH501,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,57.6,,,47.8,66.8,C2,T12,NH501,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,81.4,,,73.3,87.5,C2,T12,NH501,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,81.6,,,77.1,85.4,C2,T12,NH501,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,68.3,,,64.9,71.5,C2,T12,NH501,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,61.3,,,58.3,64.3,C2,T12,NH501,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,70.1,,,67.6,72.5,C2,T12,NH501,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,60,,,55.3,64.5,C2,T12,NH501,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,75.1,,,71.6,78.3,C2,T12,NH501,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,71.3,,,68.7,73.9,C2,T12,NH501,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,73.2,,,70.6,75.5,C2,T12,NH501,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,73.8,,,70.6,76.7,C2,T12,NH501,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,77.9,,,74.7,80.7,C2,T12,NH501,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH501,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,76.4,,,73,79.4,C2,T12,NH501,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,52.3,,,40.9,63.5,C2,T12,NH501,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,81.2,,,73.7,87,C2,T12,NH501,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,76.2,,,72.6,79.4,C2,T12,NH501,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,66.9,,,63.7,69.9,C2,T12,NH501,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,58.4,,,54,62.6,C2,T12,NH501,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,67.2,,,64.5,69.8,C2,T12,NH501,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,59,,,54.9,63,C2,T12,NH501,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,74.4,,,70.6,77.9,C2,T12,NH501,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,66.2,,,62.9,69.4,C2,T12,NH501,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,70.2,,,67.3,72.9,C2,T12,NH501,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,70.6,,,67.2,73.7,C2,T12,NH501,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,74.4,,,69.7,78.5,C2,T12,NH501,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH501,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,74.8,,,71.1,78.2,C2,T12,NH501,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,52.6,,,42.3,62.7,C2,T12,NH501,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,85.3,,,81.1,88.6,C2,T12,NH501,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,78.5,,,74.4,82.1,C2,T12,NH501,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,69.1,,,65.2,72.7,C2,T12,NH501,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,57.4,,,52.2,62.5,C2,T12,NH501,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,68.6,,,64.5,72.4,C2,T12,NH501,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,56.7,,,50.9,62.3,C2,T12,NH501,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,74.8,,,72.3,77.1,C2,T12,NH501,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,69.4,,,64.6,73.9,C2,T12,NH501,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,72.1,,,68.7,75.2,C2,T12,NH501,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,73.5,,,69.3,77.4,C2,T12,NH501,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,73,,,68,77.4,C2,T12,NH501,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48.3,,,43.6,53,C2,T12,NH501,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,77.7,,,72,82.6,C2,T12,NH501,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of poor diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,56.5,,,50.4,62.5,C2,T12,NH501,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.7,,,0.2,2,C2,T12,NH503,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,1.5,,,0.7,3.1,C2,T12,NH503,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.7,,,0.3,1.6,C2,T12,NH503,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,1.8,,,0.8,4.2,C2,T12,NH503,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.5,,,0.2,1.3,C2,T12,NH503,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.5,,,0.2,1.1,C2,T12,NH503,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.5,,,0.2,1.1,C2,T12,NH503,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.5,,,0.3,1.1,C2,T12,NH503,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.2,,,0,1.1,C2,T12,NH503,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH503,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,0.1,,,0,0.7,C2,T12,NH503,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.4,,,0.2,0.9,C2,T12,NH503,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.8,,,0.1,5.4,C2,T12,NH503,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.4,,,0.1,1.1,C2,T12,NH503,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,1,,,0.4,2.5,C2,T12,NH503,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.4,,,0.2,0.9,C2,T12,NH503,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,0.6,,,0.2,2.5,C2,T12,NH503,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.3,,,0.2,0.5,C2,T12,NH503,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.4,,,0.2,1,C2,T12,NH503,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.4,,,0.2,0.7,C2,T12,NH503,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.3,,,0.2,0.6,C2,T12,NH503,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.2,,,0,1.4,C2,T12,NH503,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH503,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,0.1,,,0,0.7,C2,T12,NH503,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.3,,,1.2,8.7,C2,T12,NH503,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,1.4,,,0.3,5.7,C2,T12,NH503,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0,,,0,0.2,C2,T12,NH503,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.8,,,0.3,2,C2,T12,NH503,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,0.9,,,0.5,1.5,C2,T12,NH503,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.6,,,0.3,1.1,C2,T12,NH503,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,1,,,0.5,2.3,C2,T12,NH503,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.8,,,0.4,1.6,C2,T12,NH503,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.6,,,0.3,1,C2,T12,NH503,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.5,,,0.2,1.1,C2,T12,NH503,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.1,,,0.1,0.4,C2,T12,NH503,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH503,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,0.6,,,0.2,1.5,C2,T12,NH503,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.6,,,1.3,10.1,C2,T12,NH503,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.7,,,0.3,1.6,C2,T12,NH503,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.4,,,0.2,0.8,C2,T12,NH503,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,0.8,,,0.4,1.6,C2,T12,NH503,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.7,,,0.4,1.2,C2,T12,NH503,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,1.1,,,0.5,2.5,C2,T12,NH503,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.5,,,0.2,1,C2,T12,NH503,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.6,,,0.3,1.1,C2,T12,NH503,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.5,,,0.3,0.9,C2,T12,NH503,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.6,,,0.3,1,C2,T12,NH503,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.8,,,0.3,1.8,C2,T12,NH503,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T12,NH503,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,0.6,,,0.2,1.9,C2,T12,NH503,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,0.2,,,0,0.6,C2,T12,NH503,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T12,NH503,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.2,,,0.1,0.5,C2,T12,NH503,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,0.8,,,0.4,1.7,C2,T12,NH503,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,1.2,,,0.7,2.1,C2,T12,NH503,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,0.8,,,0.4,1.3,C2,T12,NH503,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,2,,,0.9,4.3,C2,T12,NH503,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,0.6,,,0.3,1.3,C2,T12,NH503,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,0.5,,,0.3,0.9,C2,T12,NH503,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,0.6,,,0.3,1,C2,T12,NH503,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,0.6,,,0.3,1.2,C2,T12,NH503,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,0.4,,,0.2,0.7,C2,T12,NH503,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,1.6,,,0.8,3.4,C2,T12,NH503,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,0.1,,,0,0.7,C2,T12,NH503,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Nutrition,Prevalence of ideal diet score among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.6,,,0.8,3.4,C2,T12,NH503,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.7,,,0.2,2.5,C1,T5,NH600,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.3,,,0.1,0.8,C1,T5,NH600,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.9,,,2,4.1,C1,T5,NH600,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,6.7,,,5.3,8.4,C1,T5,NH600,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,2.8,,,2.3,3.5,C1,T5,NH600,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.3,,,8,13.2,C1,T5,NH600,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.7,,,2.1,3.6,C1,T5,NH600,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2,,,1.4,2.9,C1,T5,NH600,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.3,,,1.7,3,C1,T5,NH600,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.9,,,1.7,5,C1,T5,NH600,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.3,,,1.6,3.4,C1,T5,NH600,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,0.7,,,0.1,4.5,C1,T5,NH600,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.1,,,0,1,C1,T5,NH600,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1.1,C1,T5,NH600,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.2,,,1.2,4,C1,T5,NH600,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.5,,,6.8,10.5,C1,T5,NH600,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.1,,,2.4,4.1,C1,T5,NH600,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.9,,,7.7,15.1,C1,T5,NH600,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.7,,,2.1,3.6,C1,T5,NH600,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.4,,,1.8,3.2,C1,T5,NH600,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.6,,,2,3.2,C1,T5,NH600,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.4,,,1.8,3.2,C1,T5,NH600,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.9,,,2.8,5.3,C1,T5,NH600,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.3,,,1.6,3.3,C1,T5,NH600,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.7,,,0.6,5.2,C1,T5,NH600,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1.2,C1,T5,NH600,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.2,,,1.4,3.3,C1,T5,NH600,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3,,,2.6,3.5,C1,T5,NH600,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.7,,,1.8,3.9,C1,T5,NH600,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.8,,,1.2,2.6,C1,T5,NH600,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.2,,,0.7,6.2,C1,T5,NH600,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,0.8,C1,T5,NH600,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.4,,,1.6,3.4,C1,T5,NH600,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.5,,,7.8,11.6,C1,T5,NH600,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.6,,,3.1,4.2,C1,T5,NH600,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.9,,,8.3,14,C1,T5,NH600,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,3.4,,,2.9,4,C1,T5,NH600,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.2,,,1.8,2.8,C1,T5,NH600,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.8,,,2.4,3.2,C1,T5,NH600,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.6,,,2.2,3.1,C1,T5,NH600,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.4,,,3.4,5.7,C1,T5,NH600,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.1,,,1.3,3.3,C1,T5,NH600,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.2,,,0.7,6.6,C1,T5,NH600,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.5,,,0.2,1,C1,T5,NH600,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1.9,,,1.5,2.6,C1,T5,NH600,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.2,,,2.5,4.1,C1,T5,NH600,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.1,,,8.3,14.8,C1,T5,NH600,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.9,,,2.4,3.5,C1,T5,NH600,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.1,,,1.4,3.1,C1,T5,NH600,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.5,,,2,3.1,C1,T5,NH600,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.1,,,1.5,3,C1,T5,NH600,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.4,,,3.4,5.7,C1,T5,NH600,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.9,,,1.5,2.3,C1,T5,NH600,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,5.5,,,3.4,8.8,C1,T5,NH600,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,0.8,C1,T5,NH600,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2,,,1.4,3,C1,T5,NH600,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,6.3,,,4.9,8.1,C1,T5,NH600,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,2.7,,,2.1,3.4,C1,T5,NH600,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.4,,,6.3,11.2,C1,T5,NH600,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.4,,,1.9,3.1,C1,T5,NH600,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,1.7,,,1.3,2.2,C1,T5,NH600,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2,,,1.6,2.5,C1,T5,NH600,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2,,,1.5,2.6,C1,T5,NH600,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.3,,,2.4,4.5,C1,T5,NH600,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T5,NH600,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.4,,,1,1.8,C1,T5,NH600,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,0.8,,,0.2,2.5,C1,T5,NH600,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,1,,,0.5,1.9,C1,T5,NH600,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,1.5,,,1,2.2,C1,T5,NH600,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.5,,,7.5,14.4,C1,T5,NH600,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.6,,,2.8,4.8,C1,T5,NH600,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.9,,,9.5,17.4,C1,T5,NH600,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.5,,,1.7,3.7,C1,T5,NH600,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.9,,,2.3,3.6,C1,T5,NH600,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.7,,,2.1,3.5,C1,T5,NH600,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.6,,,2,3.4,C1,T5,NH600,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.4,,,2.4,4.8,C1,T5,NH600,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,1.1,,,0.7,1.7,C1,T5,NH600,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3,,,1.5,6,C1,T5,NH600,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.1,,,1.1,8.2,C1,T5,NH600,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T5,NH600,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.2,C1,T5,NH600,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.3,,,1.7,3,C1,T5,NH600,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.4,,,7,10.1,C1,T5,NH600,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.5,,,3,4.1,C1,T5,NH600,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.1,,,9.2,13.3,C1,T5,NH600,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.5,,,1.8,3.6,C1,T5,NH600,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.5,,,2.1,3,C1,T5,NH600,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.5,,,2.2,2.9,C1,T5,NH600,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.5,,,2.1,3,C1,T5,NH600,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.7,,,2.7,5.1,C1,T5,NH600,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,0.8,,,0.3,1.9,C1,T5,NH600,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.4,,,1.2,4.7,C1,T5,NH600,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Heart Failure,Prevalence of heart failure among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.3,,,0.6,2.8,C1,T5,NH600,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,18.6,,,14.1,24.2,C2,T13,NH601,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.2,,,24.9,31.8,C2,T13,NH601,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.6,,,30.7,40.9,C2,T13,NH601,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.8,,,27,34.9,C2,T13,NH601,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.5,,,28.7,36.4,C2,T13,NH601,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.2,,,18.9,28.1,C2,T13,NH601,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.2,,,24.2,30.3,C2,T13,NH601,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.5,,,30,37.1,C2,T13,NH601,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.4,,,27.4,33.6,C2,T13,NH601,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.6,,,25,32.6,C2,T13,NH601,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.6,,,36.3,43,C2,T13,NH601,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,34.2,,,29.4,39.3,C2,T13,NH601,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,27.8,,,18.9,39,C2,T13,NH601,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24,,,17.9,31.3,C2,T13,NH601,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,27.9,,,25.3,30.7,C2,T13,NH601,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.2,,,31.8,38.8,C2,T13,NH601,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,28.1,,,25.6,30.7,C2,T13,NH601,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,29.5,35.2,C2,T13,NH601,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,18.9,,,14.7,24,C2,T13,NH601,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.4,,,25.4,29.5,C2,T13,NH601,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,32.9,,,30.1,35.8,C2,T13,NH601,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28,32.4,C2,T13,NH601,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.8,,,27.4,32.3,C2,T13,NH601,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.7,,,35.2,42.3,C2,T13,NH601,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,30.9,,,27.3,34.8,C2,T13,NH601,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.2,,,5.3,22.1,C2,T13,NH601,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.4,,,21.2,30,C2,T13,NH601,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.5,,,28.6,34.5,C2,T13,NH601,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.7,,,31.6,39.9,C2,T13,NH601,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.7,,,26.5,33.2,C2,T13,NH601,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,34.3,,,31.9,36.7,C2,T13,NH601,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.5,,,19.5,28.1,C2,T13,NH601,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30.9,,,28.5,33.4,C2,T13,NH601,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33,,,29.8,36.5,C2,T13,NH601,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,32,,,29.7,34.4,C2,T13,NH601,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.6,,,28.1,33.1,C2,T13,NH601,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44.7,,,40.6,48.8,C2,T13,NH601,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,36.6,,,33,40.4,C2,T13,NH601,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.5,,,12.2,27.2,C2,T13,NH601,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24.1,,,16.9,33,C2,T13,NH601,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,28.7,37.4,C2,T13,NH601,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,40.3,,,35.8,44.8,C2,T13,NH601,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.4,,,27.5,33.5,C2,T13,NH601,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,36.6,,,33.7,39.5,C2,T13,NH601,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,24.7,,,20.5,29.5,C2,T13,NH601,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.9,,,29,37,C2,T13,NH601,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.2,,,32.6,38,C2,T13,NH601,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,34.1,,,31.5,36.8,C2,T13,NH601,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.7,,,29.7,36,C2,T13,NH601,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.9,,,42.5,49.3,C2,T13,NH601,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,33.9,,,32,35.9,C2,T13,NH601,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,25.4,,,18.2,34.2,C2,T13,NH601,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.2,,,19.6,34.1,C2,T13,NH601,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.8,,,29.3,36.6,C2,T13,NH601,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,37.3,,,34.2,40.6,C2,T13,NH601,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.9,,,28.9,34.9,C2,T13,NH601,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.6,,,33.3,38.1,C2,T13,NH601,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,26.2,,,22.5,30.3,C2,T13,NH601,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.3,,,29.7,35,C2,T13,NH601,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.3,,,33.1,37.5,C2,T13,NH601,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33.7,,,31.6,35.8,C2,T13,NH601,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.3,,,29,35.9,C2,T13,NH601,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44,,,40.1,48,C2,T13,NH601,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.2,,,34.4,46.4,C2,T13,NH601,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,11.5,31.3,C2,T13,NH601,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,23.2,,,17.3,30.4,C2,T13,NH601,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.9,,,32.6,37.4,C2,T13,NH601,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39,,,36.2,41.9,C2,T13,NH601,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,37.4,,,34.3,40.7,C2,T13,NH601,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.4,,,36.6,40.2,C2,T13,NH601,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.8,,,24.9,33.1,C2,T13,NH601,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.3,,,32,38.8,C2,T13,NH601,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.1,,,34.3,37.8,C2,T13,NH601,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.8,,,34,37.6,C2,T13,NH601,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,34.4,,,32.1,36.7,C2,T13,NH601,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,49.5,,,45.2,53.8,C2,T13,NH601,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH601,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.4,,,37,44,C2,T13,NH601,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,15.5,24.3,C2,T13,NH601,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.2,,,20.5,30.6,C2,T13,NH601,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.4,,,31.4,37.4,C2,T13,NH601,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39.4,,,34.8,44.2,C2,T13,NH601,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.4,,,29.5,37.6,C2,T13,NH601,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.1,,,34.1,40.1,C2,T13,NH601,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.7,,,24.4,33.4,C2,T13,NH601,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.7,,,31.1,36.3,C2,T13,NH601,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.3,,,32.9,39.9,C2,T13,NH601,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.1,,,32.4,37.9,C2,T13,NH601,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.9,,,29.5,36.5,C2,T13,NH601,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,47.9,,,44.7,51.1,C2,T13,NH601,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.8,,,8.3,13.9,C2,T13,NH601,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.8,,,42.5,51.2,C2,T13,NH601,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.4,,,14.8,25,C2,T13,NH601,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.3,,,20.9,30.3,C2,T13,NH601,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,39.1,,,36.7,41.6,C2,T13,NH601,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,41.1,,,37,45.4,C2,T13,NH601,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,35.9,,,32,40,C2,T13,NH601,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,40.2,,,37.9,42.6,C2,T13,NH601,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,29.3,,,25.1,33.9,C2,T13,NH601,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.2,,,33.1,37.4,C2,T13,NH601,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,40.5,,,37.8,43.2,C2,T13,NH601,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,37.9,,,36.1,39.7,C2,T13,NH601,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,36.6,,,34.5,38.9,C2,T13,NH601,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,48.5,,,44.5,52.5,C2,T13,NH601,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12.4,,,10,15.2,C2,T13,NH601,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.5,,,42.4,50.6,C2,T13,NH601,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of poor BMI level aomg US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.5,,,16.5,25.2,C2,T13,NH601,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,54.7,,,49.1,60.2,C2,T13,NH603,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,37.7,,,32.9,42.8,C2,T13,NH603,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,30.7,,,26.3,35.6,C2,T13,NH603,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.5,,,28.3,34.9,C2,T13,NH603,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.4,,,28.6,36.5,C2,T13,NH603,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,38.3,,,35.1,41.6,C2,T13,NH603,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.7,,,29.5,36.1,C2,T13,NH603,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,38.3,,,33.8,43,C2,T13,NH603,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.6,,,32.4,39,C2,T13,NH603,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.9,,,1.5,5.4,C1,T6,NH900,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,37.8,,,33.2,42.6,C2,T13,NH603,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30,,,28.2,31.9,C2,T13,NH603,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.6,,,23.1,30.3,C2,T13,NH603,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,47.8,,,40,55.7,C2,T13,NH603,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,51.3,,,43.3,59.3,C2,T13,NH603,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,37.7,,,34.5,41.1,C2,T13,NH603,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.6,,,25,30.3,C2,T13,NH603,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.1,,,27.5,35,C2,T13,NH603,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,30.5,,,28.8,32.3,C2,T13,NH603,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,36.8,,,29.1,45.2,C2,T13,NH603,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30.1,,,28.6,31.6,C2,T13,NH603,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,38.4,,,36.2,40.6,C2,T13,NH603,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,34.3,,,33.1,35.5,C2,T13,NH603,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,35.7,,,34.1,37.4,C2,T13,NH603,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,28.1,,,25.1,31.3,C2,T13,NH603,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.5,,,24.6,32.7,C2,T13,NH603,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,45.6,,,38.6,52.7,C2,T13,NH603,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,51,,,44.7,57.3,C2,T13,NH603,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,37,,,34.3,39.9,C2,T13,NH603,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.1,,,24.2,30.3,C2,T13,NH603,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30,,,26.4,33.9,C2,T13,NH603,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,29.5,,,27.5,31.6,C2,T13,NH603,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,34.9,,,31.2,38.9,C2,T13,NH603,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,29.2,,,26.6,31.9,C2,T13,NH603,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,38.1,,,34.4,41.9,C2,T13,NH603,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33.7,,,31.5,35.9,C2,T13,NH603,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,35.5,,,32.6,38.6,C2,T13,NH603,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.7,,,20.8,26.8,C2,T13,NH603,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.3,,,19.9,29.3,C2,T13,NH603,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,49.6,,,42.2,57,C2,T13,NH603,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,50.8,,,44.2,57.4,C2,T13,NH603,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,35,,,30.7,39.6,C2,T13,NH603,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.5,,,24.1,29.1,C2,T13,NH603,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.8,,,29,34.8,C2,T13,NH603,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,29.4,,,27.4,31.6,C2,T13,NH603,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,39.2,,,34.5,44,C2,T13,NH603,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,26.7,,,24.2,29.5,C2,T13,NH603,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,39.1,,,35.9,42.4,C2,T13,NH603,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33,,,30.6,35.5,C2,T13,NH603,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,34.6,,,31.4,38,C2,T13,NH603,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24,,,20.9,27.4,C2,T13,NH603,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.8,,,23.1,28.7,C2,T13,NH603,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50.5,,,42.5,58.4,C2,T13,NH603,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,46.6,,,40.4,53,C2,T13,NH603,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,30,36,C2,T13,NH603,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.5,,,25.4,31.7,C2,T13,NH603,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.2,,,25.7,32.8,C2,T13,NH603,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,28.4,,,26.1,30.7,C2,T13,NH603,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,32,,,29.7,34.4,C2,T13,NH603,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.6,,,25.7,29.6,C2,T13,NH603,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.8,,,33.1,38.6,C2,T13,NH603,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.9,,,30.1,33.7,C2,T13,NH603,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33.2,,,30.6,35.9,C2,T13,NH603,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.5,,,24.1,29.1,C2,T13,NH603,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21,,,17.7,24.7,C2,T13,NH603,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,52.4,,,45.3,59.5,C2,T13,NH603,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,50.8,,,41.4,60.1,C2,T13,NH603,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,33.3,,,30.4,36.4,C2,T13,NH603,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.3,,,22,28.9,C2,T13,NH603,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,27.5,,,25.3,29.9,C2,T13,NH603,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,26.8,,,25,28.8,C2,T13,NH603,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,33.8,,,30.5,37.2,C2,T13,NH603,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,25.9,,,22.6,29.5,C2,T13,NH603,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.1,,,33.6,38.7,C2,T13,NH603,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,31,,,28.6,33.6,C2,T13,NH603,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.9,,,29.8,36.2,C2,T13,NH603,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.3,,,20.7,26.1,C2,T13,NH603,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NH603,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.6,,,16,21.6,C2,T13,NH603,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,47.5,,,40.7,54.4,C2,T13,NH603,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,52.2,,,44.8,59.5,C2,T13,NH603,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.6,,,27.9,37.7,C2,T13,NH603,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24.2,,,21.4,27.2,C2,T13,NH603,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.3,,,26.4,34.5,C2,T13,NH603,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,27,,,25,29.1,C2,T13,NH603,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,35,,,31.6,38.5,C2,T13,NH603,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,28.3,,,25.6,31.1,C2,T13,NH603,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.8,,,30.5,37.3,C2,T13,NH603,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.1,,,28.4,34.1,C2,T13,NH603,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.3,,,28.9,35.9,C2,T13,NH603,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.7,,,20.7,26.9,C2,T13,NH603,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,61,,,57.6,64.3,C2,T13,NH603,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20,,,15.3,25.8,C2,T13,NH603,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,51.5,,,48.7,54.3,C2,T13,NH603,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,50.4,,,43.7,57.1,C2,T13,NH603,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,29.3,,,27,31.7,C2,T13,NH603,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24.5,,,22.3,26.8,C2,T13,NH603,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,27.9,,,25.3,30.7,C2,T13,NH603,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,25.6,,,24.1,27.2,C2,T13,NH603,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,30.5,,,26.1,35.4,C2,T13,NH603,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,25.9,,,23.9,28.1,C2,T13,NH603,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,32.8,,,30.5,35.2,C2,T13,NH603,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.5,,,27.9,31,C2,T13,NH603,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.3,,,28.7,31.9,C2,T13,NH603,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.6,,,20.8,26.6,C2,T13,NH603,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,58.1,,,54,62,C2,T13,NH603,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,16.3,,,13.5,19.5,C2,T13,NH603,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Obesity,Prevalence of ideal BMI level among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50.2,,,45,55.5,C2,T13,NH603,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0,,,0,0.3,C1,T4,NH700,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.3,,,0.1,0.9,C1,T4,NH700,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,4.6,,,3.7,5.7,C1,T4,NH700,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.6,,,8.2,11.4,C1,T4,NH700,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.3,,,3.7,5,C1,T4,NH700,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.8,,,8.2,14.2,C1,T4,NH700,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.1,,,4.1,6.2,C1,T4,NH700,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.1,,,1.6,2.9,C1,T4,NH700,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.5,,,3.1,3.9,C1,T4,NH700,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.7,,,3.2,4.3,C1,T4,NH700,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.4,,,1.7,3.3,C1,T4,NH700,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.4,,,1.7,3.4,C1,T4,NH700,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,4.8,,,2.1,10.6,C1,T4,NH700,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T4,NH700,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.7,,,0.4,1.3,C1,T4,NH700,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.9,,,2.7,5.6,C1,T4,NH700,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.8,,,9,15.3,C1,T4,NH700,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.8,,,3.8,5.9,C1,T4,NH700,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.8,,,10.1,21.2,C1,T4,NH700,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.1,,,3.9,6.5,C1,T4,NH700,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.8,,,2.1,3.8,C1,T4,NH700,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.9,,,3.2,4.7,C1,T4,NH700,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.2,,,3.4,5.2,C1,T4,NH700,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.1,,,2.2,4.4,C1,T4,NH700,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.2,,,1.3,3.8,C1,T4,NH700,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.4,,,1,5.4,C1,T4,NH700,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T4,NH700,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,0.9,C1,T4,NH700,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,4.1,,,2.9,5.8,C1,T4,NH700,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,14,,,11.6,16.9,C1,T4,NH700,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,5.5,,,4.4,6.7,C1,T4,NH700,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.5,,,11,18.8,C1,T4,NH700,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.9,,,4.8,7.3,C1,T4,NH700,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.8,,,2.1,3.8,C1,T4,NH700,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,4.2,,,3.4,5.2,C1,T4,NH700,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.5,,,3.6,5.7,C1,T4,NH700,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.4,,,1.6,3.5,C1,T4,NH700,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.5,,,2,3.2,C1,T4,NH700,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,5.3,,,2.6,10.5,C1,T4,NH700,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.8,,,0.2,2.7,C1,T4,NH700,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.2,,,0.1,0.6,C1,T4,NH700,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3,,,2.2,4.2,C1,T4,NH700,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.6,,,11.1,14.4,C1,T4,NH700,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.5,,,3.8,5.4,C1,T4,NH700,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.3,,,10.6,16.6,C1,T4,NH700,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.4,,,4.7,6.2,C1,T4,NH700,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.2,,,1.6,3,C1,T4,NH700,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.6,,,3.2,4.1,C1,T4,NH700,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.8,,,3.3,4.5,C1,T4,NH700,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.6,,,1.8,3.7,C1,T4,NH700,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.8,,,2.2,3.6,C1,T4,NH700,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.6,,,0.9,7.4,C1,T4,NH700,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T4,NH700,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1,C1,T4,NH700,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.5,,,2.8,4.5,C1,T4,NH700,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.4,,,9.3,13.9,C1,T4,NH700,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.5,,,3.9,5.2,C1,T4,NH700,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.8,,,9.2,15,C1,T4,NH700,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.3,,,4.4,6.4,C1,T4,NH700,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2,,,1.7,2.4,C1,T4,NH700,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.5,,,3,4,C1,T4,NH700,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.6,,,3.1,4.2,C1,T4,NH700,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,1.5,,,1.1,2.2,C1,T4,NH700,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3.6,,,2.7,4.9,C1,T4,NH700,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,6.1,,,3.2,11.4,C1,T4,NH700,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T4,NH700,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.5,,,0.2,1.1,C1,T4,NH700,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.1,,,2.1,4.5,C1,T4,NH700,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.6,,,9.3,12.1,C1,T4,NH700,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.3,,,3.6,5.2,C1,T4,NH700,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.5,,,10.5,17.2,C1,T4,NH700,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.9,,,4.1,5.8,C1,T4,NH700,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,1.8,,,1.3,2.4,C1,T4,NH700,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.2,,,2.7,3.7,C1,T4,NH700,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.4,,,2.8,4.1,C1,T4,NH700,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.3,,,1.9,2.9,C1,T4,NH700,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T4,NH700,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.6,,,1.9,3.5,C1,T4,NH700,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3,,,1.4,6.1,C1,T4,NH700,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T4,NH700,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1.1,C1,T4,NH700,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.2,,,1.3,3.6,C1,T4,NH700,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.2,,,8.6,14.4,C1,T4,NH700,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4,,,3.1,5.2,C1,T4,NH700,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.1,,,10.6,18.5,C1,T4,NH700,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4,,,3,5.3,C1,T4,NH700,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2,,,1.4,2.8,C1,T4,NH700,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.9,,,2.2,3.8,C1,T4,NH700,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3,,,2.2,4.1,C1,T4,NH700,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2,,,1.6,2.6,C1,T4,NH700,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,2.2,,,1.3,3.7,C1,T4,NH700,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.7,,,1,7.2,C1,T4,NH700,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.1,,,2,4.7,C1,T4,NH700,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.2,,,0,1.5,C1,T4,NH700,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.1,1.2,C1,T4,NH700,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.1,,,2.1,4.5,C1,T4,NH700,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13,,,10.4,16.2,C1,T4,NH700,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.9,,,3.9,6.2,C1,T4,NH700,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,15.7,,,12.1,20.2,C1,T4,NH700,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.6,,,3.7,5.7,C1,T4,NH700,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.7,,,1.8,3.9,C1,T4,NH700,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.5,,,2.8,4.5,C1,T4,NH700,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.9,,,2.9,5.2,C1,T4,NH700,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.9,,,2.1,3.8,C1,T4,NH700,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,2,,,1.2,3.4,C1,T4,NH700,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.9,,,1.1,3.1,C1,T4,NH700,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,None,Cardiovascular Diseases,Coronary Heart Disease,Prevalence of coronary heart disease among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.7,,,1.4,5.2,C1,T4,NH700,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,33.8,,,29.8,38.1,C2,T14,NH701,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,41.3,,,36.6,46.2,C2,T14,NH701,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,54.7,,,46.7,62.4,C2,T14,NH701,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,64.4,,,58,70.3,C2,T14,NH701,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,54,,,47.8,60,C2,T14,NH701,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,71.7,,,65.5,77.3,C2,T14,NH701,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,46.2,,,40.2,52.3,C2,T14,NH701,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,52.6,,,48,57.3,C2,T14,NH701,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,49.6,,,44.4,54.8,C2,T14,NH701,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.3,,,37.2,53.6,C2,T14,NH701,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.1,,,56.3,61.8,C2,T14,NH701,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T14,NH701,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,63,,,57.9,67.9,C2,T14,NH701,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,50.8,,,43.6,57.9,C2,T14,NH701,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,35.8,,,30.7,41.2,C2,T14,NH701,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,43.4,,,40.6,46.2,C2,T14,NH701,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,49.8,,,46.4,53.2,C2,T14,NH701,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,61.8,,,58.3,65.3,C2,T14,NH701,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,51.7,,,49.5,53.8,C2,T14,NH701,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,69,,,64,73.6,C2,T14,NH701,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,44.6,,,42.1,47,C2,T14,NH701,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,51.9,,,49.2,54.6,C2,T14,NH701,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,48.3,,,46.1,50.5,C2,T14,NH701,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,43.6,,,40,47.3,C2,T14,NH701,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.8,,,56.6,62.9,C2,T14,NH701,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T14,NH701,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,63.6,,,58,68.8,C2,T14,NH701,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,48.2,,,42.2,54.2,C2,T14,NH701,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.7,,,22.6,37.9,C2,T14,NH701,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,37.3,,,32.9,42.1,C2,T14,NH701,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,49.2,,,43.5,55,C2,T14,NH701,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,60.6,,,56,65.1,C2,T14,NH701,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,49.9,,,45.2,54.6,C2,T14,NH701,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,68.4,,,62.1,74,C2,T14,NH701,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,43.2,,,38.9,47.6,C2,T14,NH701,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,46.6,,,41.9,51.3,C2,T14,NH701,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,44.9,,,41,48.9,C2,T14,NH701,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,40.7,,,36,45.6,C2,T14,NH701,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,52.8,,,48.1,57.5,C2,T14,NH701,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,42.7,,,37.8,47.8,C2,T14,NH701,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,57.9,,,53.5,62.1,C2,T14,NH701,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,43.7,,,38,49.6,C2,T14,NH701,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,39.6,,,32,47.8,C2,T14,NH701,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,41.3,,,38.5,44.1,C2,T14,NH701,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,50.7,,,47.8,53.7,C2,T14,NH701,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,58,,,53.7,62.3,C2,T14,NH701,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,51,,,48,53.9,C2,T14,NH701,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,62.7,,,56.9,68.1,C2,T14,NH701,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,46.2,,,44,48.3,C2,T14,NH701,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,48.7,,,44.8,52.7,C2,T14,NH701,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,47.5,,,44.8,50.1,C2,T14,NH701,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.9,,,42.5,49.4,C2,T14,NH701,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,51.4,,,46.2,56.5,C2,T14,NH701,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,39.7,,,34,45.7,C2,T14,NH701,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,56.3,,,52.3,60.2,C2,T14,NH701,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of poor physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,41.8,,,37.7,46.1,C2,T14,NH701,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,48.7,,,42.9,54.6,C2,T14,NH703,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,43.1,,,38,48.4,C2,T14,NH703,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.1,,,28.7,42,C2,T14,NH703,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,28.4,,,22.9,34.6,C2,T14,NH703,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.2,,,30.3,40.5,C2,T14,NH703,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,22,,,16.6,28.5,C2,T14,NH703,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,40.5,,,36,45.2,C2,T14,NH703,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36,,,31.3,41,C2,T14,NH703,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,38.1,,,33.6,42.9,C2,T14,NH703,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,41.7,,,34.6,49.2,C2,T14,NH703,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.2,,,25.9,32.7,C2,T14,NH703,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T14,NH703,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.9,,,23.4,30.8,C2,T14,NH703,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,35,,,28.3,42.4,C2,T14,NH703,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,52.6,,,45,60.2,C2,T14,NH703,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,44.2,,,41.1,47.3,C2,T14,NH703,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39.7,,,36.8,42.7,C2,T14,NH703,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.7,,,27.8,35.8,C2,T14,NH703,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.6,,,36.1,41.1,C2,T14,NH703,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,25.2,,,20.8,30.1,C2,T14,NH703,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,44.5,,,41.4,47.6,C2,T14,NH703,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,37.8,,,35,40.7,C2,T14,NH703,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,41.1,,,38.5,43.8,C2,T14,NH703,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,45.8,,,41.7,50.1,C2,T14,NH703,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,30.3,,,28,32.7,C2,T14,NH703,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T14,NH703,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,24.2,32.3,C2,T14,NH703,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,35.7,,,30,41.9,C2,T14,NH703,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,57.8,,,50.2,65,C2,T14,NH703,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,48.3,,,44,52.6,C2,T14,NH703,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,40.8,,,36.1,45.7,C2,T14,NH703,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,32.3,,,28.7,36,C2,T14,NH703,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,39.6,,,35.8,43.6,C2,T14,NH703,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,26.1,,,20.7,32.3,C2,T14,NH703,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,45.3,,,41.2,49.6,C2,T14,NH703,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,42.2,,,37.7,46.9,C2,T14,NH703,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,43.8,,,40.3,47.3,C2,T14,NH703,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,47.5,,,43.2,51.8,C2,T14,NH703,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,37.7,,,33.9,41.7,C2,T14,NH703,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,42.3,,,38.5,46.3,C2,T14,NH703,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,32.7,,,29.3,36.3,C2,T14,NH703,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,44.4,,,39.6,49.3,C2,T14,NH703,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,46,,,38.2,54,C2,T14,NH703,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,47.2,,,45,49.5,C2,T14,NH703,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39.1,,,36.7,41.6,C2,T14,NH703,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.6,,,29.4,38,C2,T14,NH703,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.9,,,36.7,41.2,C2,T14,NH703,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,29.1,,,24,34.7,C2,T14,NH703,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,43.8,,,41.6,46.1,C2,T14,NH703,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,39.8,,,37,42.6,C2,T14,NH703,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,41.8,,,39.6,44,C2,T14,NH703,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,43.4,,,40.7,46.1,C2,T14,NH703,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,37.4,,,33.3,41.6,C2,T14,NH703,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,45.1,,,40.7,49.6,C2,T14,NH703,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,33.2,,,28.8,37.8,C2,T14,NH703,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Physical Inactivity,Prevalence of ideal physical activity levels among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,44.9,,,41.7,48.3,C2,T14,NH703,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.5,,,0.1,4.2,C1,T3,NH800,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.3,C1,T3,NH800,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,5,,,3.9,6.2,C1,T3,NH800,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.9,,,8.1,12.1,C1,T3,NH800,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.7,,,3.9,5.7,C1,T3,NH800,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.1,,,9.7,15.1,C1,T3,NH800,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.8,,,4.7,7.3,C1,T3,NH800,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.1,,,1.5,2.8,C1,T3,NH800,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.8,,,3.2,4.5,C1,T3,NH800,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4,,,3.3,4.8,C1,T3,NH800,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.3,,,2,5.2,C1,T3,NH800,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.2,,,1.4,3.5,C1,T3,NH800,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,4.6,,,2.1,9.9,C1,T3,NH800,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.1,,,0,0.9,C1,T3,NH800,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.7,,,0.3,1.5,C1,T3,NH800,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.2,,,1.9,5.3,C1,T3,NH800,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12,,,10,14.4,C1,T3,NH800,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.5,,,3.7,5.5,C1,T3,NH800,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,15.1,,,12.1,18.8,C1,T3,NH800,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.8,,,3.9,5.9,C1,T3,NH800,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.8,,,2.2,3.5,C1,T3,NH800,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.7,,,3.1,4.4,C1,T3,NH800,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.9,,,3.2,4.7,C1,T3,NH800,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.2,,,3.2,5.5,C1,T3,NH800,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3.2,,,2.1,4.7,C1,T3,NH800,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.1,,,0.4,3.2,C1,T3,NH800,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T3,NH800,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,0.8,C1,T3,NH800,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,4.6,,,3.1,6.8,C1,T3,NH800,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.3,,,11,16.1,C1,T3,NH800,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,5.5,,,4.5,6.8,C1,T3,NH800,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.1,,,11,17.9,C1,T3,NH800,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5.6,,,4.4,7.1,C1,T3,NH800,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,3.1,,,2.3,4.2,C1,T3,NH800,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,4.2,,,3.5,5.1,C1,T3,NH800,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4.4,,,3.6,5.3,C1,T3,NH800,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.9,,,2.9,5.2,C1,T3,NH800,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,22.8,,,20.1,25.8,C2,T15,NH801,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.7,,,2.1,3.5,C1,T3,NH800,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,4.3,,,2,9.2,C1,T3,NH800,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.4,,,0.1,2.5,C1,T3,NH800,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.2,C1,T3,NH800,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.6,,,2.5,5.2,C1,T3,NH800,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.9,,,9.3,15.1,C1,T3,NH800,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.7,,,3.7,5.9,C1,T3,NH800,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.9,,,12.4,17.9,C1,T3,NH800,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,5,,,4.1,6.2,C1,T3,NH800,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.7,,,2,3.7,C1,T3,NH800,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.8,,,3,4.6,C1,T3,NH800,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,4,,,3.1,5.1,C1,T3,NH800,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.6,,,2.7,5,C1,T3,NH800,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2,,,1.2,3.3,C1,T3,NH800,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.5,,,1.2,5.3,C1,T3,NH800,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.2,,,0,1.8,C1,T3,NH800,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.1,C1,T3,NH800,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.2,,,2.5,3.9,C1,T3,NH800,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.5,,,10.1,13.1,C1,T3,NH800,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.4,,,3.8,5.2,C1,T3,NH800,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.8,,,11.4,16.5,C1,T3,NH800,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.7,,,3.9,5.6,C1,T3,NH800,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.5,,,2.1,2.9,C1,T3,NH800,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.5,,,3,4,C1,T3,NH800,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.3,,,2.7,4,C1,T3,NH800,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.6,,,2.8,4.7,C1,T3,NH800,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.2,,,1.5,3.3,C1,T3,NH800,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,5.6,,,3.2,9.8,C1,T3,NH800,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.2,,,0,1.2,C1,T3,NH800,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.8,,,0.4,1.6,C1,T3,NH800,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.8,,,2.9,5,C1,T3,NH800,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.4,,,7,10,C1,T3,NH800,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.2,,,3.4,5.1,C1,T3,NH800,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.7,,,8.5,13.3,C1,T3,NH800,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.9,,,4,5.8,C1,T3,NH800,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,1.8,,,1.3,2.4,C1,T3,NH800,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.2,,,2.6,3.9,C1,T3,NH800,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.3,,,2.7,4.1,C1,T3,NH800,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.3,,,2.6,4.3,C1,T3,NH800,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T3,NH800,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3.2,,,2.3,4.4,C1,T3,NH800,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,1.8,,,0.7,4.7,C1,T3,NH800,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.1,,,0,0.4,C1,T3,NH800,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.2,C1,T3,NH800,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.8,,,2.1,3.8,C1,T3,NH800,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.7,,,8.2,13.8,C1,T3,NH800,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.3,,,3.7,5,C1,T3,NH800,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.5,,,8.3,13.3,C1,T3,NH800,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,3.9,,,3.3,4.7,C1,T3,NH800,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.5,,,1.8,3.3,C1,T3,NH800,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.1,,,2.7,3.6,C1,T3,NH800,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.3,,,2.7,3.9,C1,T3,NH800,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,2.6,,,1.9,3.4,C1,T3,NH800,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,1.5,,,1,2.2,C1,T3,NH800,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.6,,,1.3,5.1,C1,T3,NH800,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.8,,,1.5,5,C1,T3,NH800,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T3,NH800,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.4,0.8,C1,T3,NH800,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,3.1,,,2.4,3.8,C1,T3,NH800,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.1,,,8.9,13.7,C1,T3,NH800,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.6,,,3.8,5.5,C1,T3,NH800,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.2,,,10.2,16.9,C1,T3,NH800,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,4.2,,,3.3,5.4,C1,T3,NH800,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.4,,,1.8,3.2,C1,T3,NH800,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.3,,,2.7,3.9,C1,T3,NH800,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.4,,,2.7,4.3,C1,T3,NH800,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3,,,2.5,3.6,C1,T3,NH800,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,1.8,,,1,3.1,C1,T3,NH800,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.8,,,2.2,3.5,C1,T3,NH800,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Acute Myocardial Infarction (Heart Attack),Prevalence of acute myocardial infarction (heart attack) among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.1,,,1.9,5,C1,T3,NH800,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,32.7,,,26.2,39.9,C2,T15,NH801,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,30.2,,,26.8,34,C2,T15,NH801,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24.5,,,20.3,29.2,C2,T15,NH801,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.7,,,8.6,13.2,C2,T15,NH801,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,6.3,,,4.2,9.2,C2,T15,NH801,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.1,,,23.8,30.8,C2,T15,NH801,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.6,,,19.9,25.5,C2,T15,NH801,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,24.8,,,22.2,27.7,C2,T15,NH801,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,25.8,,,22.3,29.6,C2,T15,NH801,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.1,,,23.1,29.3,C2,T15,NH801,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.9,,,15,23.5,C2,T15,NH801,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,24.2,,,18.8,30.5,C2,T15,NH801,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,36.4,,,28.8,44.7,C2,T15,NH801,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.9,,,26.1,31.8,C2,T15,NH801,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.8,,,21.2,26.7,C2,T15,NH801,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.5,,,6.7,10.7,C2,T15,NH801,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,21.9,,,19.9,24,C2,T15,NH801,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,4.9,,,3.4,7,C2,T15,NH801,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,26.1,,,23.6,28.8,C2,T15,NH801,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,21.9,,,19.6,24.4,C2,T15,NH801,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,23.9,,,21.9,26.1,C2,T15,NH801,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,23.9,,,21.3,26.8,C2,T15,NH801,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,27.5,,,23.9,31.3,C2,T15,NH801,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,22.3,,,19.8,25,C2,T15,NH801,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,22.2,,,13.8,33.8,C2,T15,NH801,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,33.9,,,29.2,38.9,C2,T15,NH801,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.2,,,27.8,34.7,C2,T15,NH801,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,26.2,,,24.2,28.4,C2,T15,NH801,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.4,,,7.3,9.5,C2,T15,NH801,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,23.4,,,21.2,25.7,C2,T15,NH801,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,5,,,4.1,6.2,C2,T15,NH801,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,28.3,,,26,30.7,C2,T15,NH801,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.5,,,20.1,25.1,C2,T15,NH801,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.4,,,23.4,27.5,C2,T15,NH801,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.5,,,24.5,28.6,C2,T15,NH801,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,25.1,,,20.3,30.5,C2,T15,NH801,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,22.1,,,20.2,24.1,C2,T15,NH801,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,22.9,,,16.4,31.2,C2,T15,NH801,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,35.6,,,28.8,43.1,C2,T15,NH801,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.2,,,25.2,31.3,C2,T15,NH801,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,24,,,19.8,28.8,C2,T15,NH801,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.8,,,8.9,13.1,C2,T15,NH801,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,22.2,,,19.7,25,C2,T15,NH801,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,6.8,,,5.2,8.7,C2,T15,NH801,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27,,,23.6,30.6,C2,T15,NH801,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,21.2,,,18.6,24.1,C2,T15,NH801,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,24.2,,,21.7,26.8,C2,T15,NH801,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.4,,,22.8,30.3,C2,T15,NH801,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.3,,,19.7,27.4,C2,T15,NH801,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,19,,,16.8,21.4,C2,T15,NH801,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.1,,,16.1,24.8,C2,T15,NH801,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,27.2,,,21.7,33.6,C2,T15,NH801,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.2,,,24.9,31.7,C2,T15,NH801,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,23.6,,,20.3,27.1,C2,T15,NH801,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.2,,,6.8,9.8,C2,T15,NH801,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,20.4,,,18,23.1,C2,T15,NH801,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,5.1,,,3.8,6.9,C2,T15,NH801,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,25.8,,,22.8,28.9,C2,T15,NH801,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,19.8,,,17.2,22.7,C2,T15,NH801,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,22.8,,,20.2,25.6,C2,T15,NH801,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,24,,,20.5,27.8,C2,T15,NH801,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.2,,,22.8,29.9,C2,T15,NH801,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,16.9,,,13.7,20.8,C2,T15,NH801,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,17.2,,,12.1,23.9,C2,T15,NH801,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,27.5,,,21.4,34.5,C2,T15,NH801,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,24.8,,,22.3,27.5,C2,T15,NH801,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.3,,,17.9,22.9,C2,T15,NH801,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,7.7,,,6.5,9.1,C2,T15,NH801,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,17.8,,,16.1,19.6,C2,T15,NH801,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,5.5,,,4.5,6.9,C2,T15,NH801,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,22,,,20.2,23.9,C2,T15,NH801,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.8,,,16.8,21.1,C2,T15,NH801,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,20.3,,,18.8,22,C2,T15,NH801,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,20.5,,,18.6,22.7,C2,T15,NH801,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,27.4,,,22.9,32.4,C2,T15,NH801,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH801,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18,,,14.9,21.6,C2,T15,NH801,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.9,,,9.3,25.9,C2,T15,NH801,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,20.2,,,14.6,27.2,C2,T15,NH801,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,23.9,,,20.8,27.4,C2,T15,NH801,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.3,,,18.7,24.3,C2,T15,NH801,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.2,,,7.2,11.8,C2,T15,NH801,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.9,,,17,20.9,C2,T15,NH801,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,3.9,,,2.7,5.6,C2,T15,NH801,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,23.9,,,20.9,27.1,C2,T15,NH801,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.5,,,14.1,19.2,C2,T15,NH801,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,20,,,17.8,22.5,C2,T15,NH801,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,21.1,,,17.9,24.7,C2,T15,NH801,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22,,,18.2,26.3,C2,T15,NH801,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,9.5,,,7.7,11.5,C2,T15,NH801,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,17.1,,,14,20.6,C2,T15,NH801,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.5,,,12.1,27.2,C2,T15,NH801,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,27.9,,,23.5,32.8,C2,T15,NH801,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,23.3,,,21,25.8,C2,T15,NH801,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.6,,,17.9,25.9,C2,T15,NH801,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.7,,,7.2,10.4,C2,T15,NH801,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.7,,,16.6,21.1,C2,T15,NH801,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,5.4,,,3.8,7.8,C2,T15,NH801,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21.9,,,19.8,24.1,C2,T15,NH801,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,19.4,,,16.8,22.2,C2,T15,NH801,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,20.6,,,18.6,22.8,C2,T15,NH801,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,22.3,,,19.4,25.6,C2,T15,NH801,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.2,,,23.4,29.2,C2,T15,NH801,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,8.2,,,6.5,10.3,C2,T15,NH801,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.9,,,11.1,17.4,C2,T15,NH801,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of poor smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.8,,,12.3,19.9,C2,T15,NH801,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,65,,,56.9,72.3,C2,T15,NH803,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,67.5,,,63.4,71.4,C2,T15,NH803,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,73.1,,,68.5,77.2,C2,T15,NH803,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.9,,,86.2,91.1,C2,T15,NH803,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,75.4,,,72.3,78.2,C2,T15,NH803,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,93.5,,,90.6,95.5,C2,T15,NH803,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,70.8,,,67.2,74.2,C2,T15,NH803,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,75.5,,,72.1,78.6,C2,T15,NH803,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,73.2,,,70.1,76.1,C2,T15,NH803,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,72.2,,,68.2,76,C2,T15,NH803,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,71.4,,,67.2,75.3,C2,T15,NH803,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,79,,,74,83.2,C2,T15,NH803,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,74.7,,,68.7,79.9,C2,T15,NH803,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,58.3,,,48.4,67.5,C2,T15,NH803,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,68.3,,,65,71.6,C2,T15,NH803,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,74.4,,,71.1,77.4,C2,T15,NH803,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,90.3,,,88.1,92.1,C2,T15,NH803,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,76.1,,,73.1,78.8,C2,T15,NH803,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,94.3,,,92.4,95.8,C2,T15,NH803,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,71.1,,,68.3,73.8,C2,T15,NH803,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,76.1,,,72.8,79,C2,T15,NH803,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,73.7,,,71,76.2,C2,T15,NH803,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,73.3,,,69.7,76.6,C2,T15,NH803,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,70.7,,,66.8,74.3,C2,T15,NH803,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,75.4,,,72.4,78.1,C2,T15,NH803,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,76.8,,,65,85.5,C2,T15,NH803,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,61.7,,,57.2,65.9,C2,T15,NH803,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,66.5,,,63,69.8,C2,T15,NH803,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,72,,,69.5,74.4,C2,T15,NH803,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,90.5,,,89.2,91.6,C2,T15,NH803,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,74.8,,,72.3,77.1,C2,T15,NH803,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,94.5,,,93.1,95.6,C2,T15,NH803,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,69.3,,,67.1,71.4,C2,T15,NH803,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,75.7,,,73,78.1,C2,T15,NH803,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,72.5,,,70.5,74.5,C2,T15,NH803,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,71.4,,,69.4,73.4,C2,T15,NH803,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,73.2,,,67.6,78.1,C2,T15,NH803,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,75.5,,,73.2,77.8,C2,T15,NH803,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,74.8,,,66.9,81.4,C2,T15,NH803,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,58.9,,,51.8,65.8,C2,T15,NH803,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,68.8,,,65.3,72.1,C2,T15,NH803,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,74.3,,,70,78.1,C2,T15,NH803,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.1,,,85.5,90.4,C2,T15,NH803,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,76.2,,,73.5,78.7,C2,T15,NH803,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,92.3,,,90.2,94.1,C2,T15,NH803,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,70.3,,,66.7,73.7,C2,T15,NH803,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,76.5,,,73.5,79.2,C2,T15,NH803,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,73.4,,,70.7,75.9,C2,T15,NH803,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,70.7,,,66.8,74.4,C2,T15,NH803,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,75.2,,,71.1,78.9,C2,T15,NH803,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,79,,,76.5,81.3,C2,T15,NH803,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,78.6,,,73,83.4,C2,T15,NH803,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,70,,,63.3,75.9,C2,T15,NH803,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,69.2,,,65.8,72.4,C2,T15,NH803,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,74.9,,,71.4,78.2,C2,T15,NH803,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,91.2,,,89.7,92.5,C2,T15,NH803,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,78.1,,,75.6,80.4,C2,T15,NH803,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,94.2,,,92.2,95.7,C2,T15,NH803,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,72.3,,,69.6,74.9,C2,T15,NH803,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,78.3,,,75.2,81.2,C2,T15,NH803,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,75.3,,,72.6,77.9,C2,T15,NH803,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,74.1,,,70.3,77.6,C2,T15,NH803,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,72.1,,,68.3,75.6,C2,T15,NH803,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,80.7,,,76.4,84.4,C2,T15,NH803,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,81.7,,,74.8,87.1,C2,T15,NH803,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,69.5,,,62.8,75.5,C2,T15,NH803,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,72.3,,,69.2,75.2,C2,T15,NH803,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,78,,,75.7,80.1,C2,T15,NH803,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,90.8,,,89.3,92.1,C2,T15,NH803,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,80.4,,,78.8,81.9,C2,T15,NH803,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,93.6,,,92.3,94.7,C2,T15,NH803,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,75.3,,,73.2,77.2,C2,T15,NH803,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,79.5,,,77.3,81.5,C2,T15,NH803,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,77.4,,,75.7,79,C2,T15,NH803,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76.6,,,74.5,78.6,C2,T15,NH803,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,71.4,,,66.5,75.9,C2,T15,NH803,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NH803,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,80.3,,,76.3,83.8,C2,T15,NH803,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,83.2,,,72.9,90.1,C2,T15,NH803,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,77.9,,,71.2,83.4,C2,T15,NH803,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,73.7,,,70.3,76.9,C2,T15,NH803,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,76.5,,,73.7,79,C2,T15,NH803,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,89.9,,,87.2,92.1,C2,T15,NH803,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.4,,,77.5,81.3,C2,T15,NH803,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,95.5,,,93.7,96.8,C2,T15,NH803,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,73.8,,,70.4,77,C2,T15,NH803,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,81.8,,,78.9,84.4,C2,T15,NH803,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,78,,,75.5,80.3,C2,T15,NH803,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76.6,,,72.9,79.9,C2,T15,NH803,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,76.6,,,71.9,80.6,C2,T15,NH803,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,89.6,,,87.1,91.6,C2,T15,NH803,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,81.2,,,78.2,83.9,C2,T15,NH803,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,80.6,,,72.1,86.9,C2,T15,NH803,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,69.4,,,65.4,73.1,C2,T15,NH803,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,73.9,,,71.3,76.5,C2,T15,NH803,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,76.5,,,72.1,80.5,C2,T15,NH803,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,90.2,,,88.1,92,C2,T15,NH803,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.6,,,76.8,82.1,C2,T15,NH803,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,93.6,,,91,95.5,C2,T15,NH803,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,75.5,,,73,77.8,C2,T15,NH803,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,79,,,76,81.7,C2,T15,NH803,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,77.2,,,74.8,79.5,C2,T15,NH803,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,75.4,,,71.7,78.8,C2,T15,NH803,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,72.5,,,69.6,75.2,C2,T15,NH803,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,90.4,,,88,92.3,C2,T15,NH803,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,83.4,,,79.8,86.4,C2,T15,NH803,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,None,AHA 2020 Goals: Cardiovascular Health,Risk Factors,Smoking,Prevalence of ideal smoking status among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,82.4,,,78.1,85.9,C2,T15,NH803,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.4,,,0.1,2.6,C1,T6,NH900,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.5,,,0.2,1.1,C1,T6,NH900,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.2,,,1.4,3.5,C1,T6,NH900,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.7,,,6.9,10.9,C1,T6,NH900,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.2,,,2.5,4.2,C1,T6,NH900,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.6,,,8,13.9,C1,T6,NH900,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.6,,,2,3.4,C1,T6,NH900,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.7,,,2,3.6,C1,T6,NH900,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.6,,,2.1,3.4,C1,T6,NH900,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.5,,,1.8,3.5,C1,T6,NH900,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.2,,,3.5,5,C1,T6,NH900,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.7,,,2.2,3.2,C1,T6,NH900,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.1,,,0,1,C1,T6,NH900,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.9,,,0.5,1.5,C1,T6,NH900,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.1,,,1.2,3.4,C1,T6,NH900,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9,,,7.9,10.4,C1,T6,NH900,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.3,,,2.8,3.9,C1,T6,NH900,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.8,,,10.5,15.5,C1,T6,NH900,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.8,,,2.3,3.3,C1,T6,NH900,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.9,,,2.2,3.7,C1,T6,NH900,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.8,,,2.4,3.2,C1,T6,NH900,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.6,,,2.2,3.2,C1,T6,NH900,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.2,,,2.9,6,C1,T6,NH900,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.9,,,1.3,2.9,C1,T6,NH900,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.2,,,1,9.7,C1,T6,NH900,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T6,NH900,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,1,,,0.5,1.9,C1,T6,NH900,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.5,,,1.8,3.5,C1,T6,NH900,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.8,,,7.6,10.2,C1,T6,NH900,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.6,,,2.9,4.6,C1,T6,NH900,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.8,,,9,12.9,C1,T6,NH900,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.6,,,2,3.3,C1,T6,NH900,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,3.3,,,2.6,4.1,C1,T6,NH900,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.9,,,2.4,3.6,C1,T6,NH900,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.7,,,2.1,3.5,C1,T6,NH900,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.4,,,3.3,5.9,C1,T6,NH900,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3.1,,,2.3,4,C1,T6,NH900,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,5.1,,,2.3,11,C1,T6,NH900,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.4,,,0.1,2.5,C1,T6,NH900,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.5,,,0.2,1.2,C1,T6,NH900,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.9,,,2.1,3.9,C1,T6,NH900,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.8,,,8.1,12,C1,T6,NH900,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.9,,,3.1,4.9,C1,T6,NH900,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,14.1,,,10.8,18.3,C1,T6,NH900,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.8,,,2.2,3.5,C1,T6,NH900,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,3.4,,,2.6,4.4,C1,T6,NH900,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.1,,,2.5,3.8,C1,T6,NH900,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3,,,2.3,3.8,C1,T6,NH900,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.1,,,3.2,5.3,C1,T6,NH900,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.9,,,1.8,4.9,C1,T6,NH900,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.6,,,1.5,8.3,C1,T6,NH900,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C1,T6,NH900,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.7,,,0.4,1.4,C1,T6,NH900,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.9,,,2,4.2,C1,T6,NH900,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.3,,,8.8,14.6,C1,T6,NH900,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,4.3,,,3.4,5.5,C1,T6,NH900,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,13.9,,,9.9,19.3,C1,T6,NH900,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,3,,,2.6,3.5,C1,T6,NH900,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,3.7,,,2.6,5.1,C1,T6,NH900,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,3.4,,,2.7,4.2,C1,T6,NH900,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,3.3,,,2.5,4.4,C1,T6,NH900,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,5.2,,,3.9,7,C1,T6,NH900,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,1.9,,,1.4,2.7,C1,T6,NH900,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,2.8,,,1.1,6.7,C1,T6,NH900,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.3,,,0.1,1.4,C1,T6,NH900,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.6,,,0.3,1.1,C1,T6,NH900,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.6,,,2.1,3.1,C1,T6,NH900,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.2,,,6.4,10.5,C1,T6,NH900,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.5,,,3,4.1,C1,T6,NH900,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.7,,,9.9,13.8,C1,T6,NH900,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.6,,,2.1,3.3,C1,T6,NH900,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.7,,,2.2,3.3,C1,T6,NH900,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.6,,,2.3,3.1,C1,T6,NH900,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.5,,,2,3,C1,T6,NH900,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,4.3,,,3.5,5.2,C1,T6,NH900,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C1,T6,NH900,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.2,,,1.4,3.5,C1,T6,NH900,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.2,,,2,4.9,C1,T6,NH900,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.8,,,0.2,3.3,C1,T6,NH900,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.5,,,0.3,0.9,C1,T6,NH900,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.7,,,2,3.7,C1,T6,NH900,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.9,,,7.7,10.3,C1,T6,NH900,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.8,,,3,4.7,C1,T6,NH900,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.5,,,9.2,14.3,C1,T6,NH900,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.7,,,2,3.7,C1,T6,NH900,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,2.9,,,2.3,3.6,C1,T6,NH900,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.8,,,2.3,3.4,C1,T6,NH900,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.4,,,1.9,2.9,C1,T6,NH900,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,5,,,3.8,6.6,C1,T6,NH900,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,2.2,,,1.3,3.6,C1,T6,NH900,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,3.7,,,2.9,4.6,C1,T6,NH900,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,4,,,2.6,6.3,C1,T6,NH900,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,0.4,,,0.1,1.9,C1,T6,NH900,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,0.4,,,0.2,1,C1,T6,NH900,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,2.5,,,1.9,3.4,C1,T6,NH900,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,9.5,,,8.2,11,C1,T6,NH900,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,3.9,,,3.4,4.5,C1,T6,NH900,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.2,,,8.3,15.1,C1,T6,NH900,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,2.4,,,1.8,3.3,C1,T6,NH900,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,3.1,,,2.5,3.9,C1,T6,NH900,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,2.8,,,2.5,3.2,C1,T6,NH900,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,2.8,,,2.4,3.3,C1,T6,NH900,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,3.2,,,2.5,4.2,C1,T6,NH900,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,1.9,,,1.1,3.2,C1,T6,NH900,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,2.2,,,1.2,4.1,C1,T6,NH900,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,Million Hearts,None,None,None,Cardiovascular Diseases,Stroke,Prevalence of stroke among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,3.1,,,1.9,4.8,C1,T6,NH900,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,45-64,Percentage,%,72.3,,,55.9,84.3,C2,T8,NHP101,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,65+,Percentage,%,88.3,,,81.4,92.8,C2,T8,NHP101,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Age,75+,Percentage,%,87.8,,,81.2,92.4,C2,T8,NHP101,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Gender,Male,Percentage,%,76.9,,,57.7,89,C2,T8,NHP101,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Gender,Female,Percentage,%,73.8,,,61.2,83.4,C2,T8,NHP101,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Overall,Overall,Percentage,%,75.7,,,62.5,85.3,C2,T8,NHP101,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,78.3,,,56.9,90.8,C2,T8,NHP101,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67.9,,,56.1,77.8,C2,T8,NHP101,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,71.4,,,29.8,93.6,C2,T8,NHP101,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Hispanic,Percentage,%,54.8,,,38.6,70.1,C2,T8,NHP101,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Aspirin use,Aspirin when appropriate: Prevalence of aspirin use for secondary prevention of ischemic vascular disease among US adults (40+) (Percentage); NHANES,Race,Other,Percentage,%,85.7,,,58,96.3,C2,T8,NHP101,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.6,,,20,39.2,C2,T9,NHP102,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.6,,,34,45.4,C2,T9,NHP102,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,24.2,,,19.8,29.3,C2,T9,NHP102,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,27.4,37.6,C2,T9,NHP102,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,16.2,,,12.4,20.9,C2,T9,NHP102,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.4,,,22.5,35,C2,T9,NHP102,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,27,,,20.8,34.2,C2,T9,NHP102,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,27.3,,,22.7,32.3,C2,T9,NHP102,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.5,,,26,35.5,C2,T9,NHP102,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.3,,,16.1,30.1,C2,T9,NHP102,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,15.3,,,9.5,23.9,C2,T9,NHP102,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.8,,,23.5,34.7,C2,T9,NHP102,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,38.9,,,34.3,43.7,C2,T9,NHP102,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,32.1,,,28.8,35.7,C2,T9,NHP102,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,35.3,,,32.2,38.5,C2,T9,NHP102,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,30.6,,,24.8,37,C2,T9,NHP102,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.3,,,24.3,32.6,C2,T9,NHP102,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,42.9,,,36,50,C2,T9,NHP102,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,33.1,,,29.4,37,C2,T9,NHP102,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33,,,28.1,38.3,C2,T9,NHP102,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.5,,,28.5,36.8,C2,T9,NHP102,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,19,,,11.1,30.6,C2,T9,NHP102,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,20.4,,,11.7,33.3,C2,T9,NHP102,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,41.8,,,30.4,54.3,C2,T9,NHP102,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.3,,,33.2,45.7,C2,T9,NHP102,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,38.6,,,34.4,42.9,C2,T9,NHP102,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,40.3,,,36,44.8,C2,T9,NHP102,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,28.6,,,23.5,34.2,C2,T9,NHP102,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,36.8,,,29.9,44.2,C2,T9,NHP102,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,38.5,,,28.4,49.7,C2,T9,NHP102,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,36.2,,,29.5,43.6,C2,T9,NHP102,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,38.1,,,28.2,49,C2,T9,NHP102,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.5,,,27.2,36.2,C2,T9,NHP102,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.2,,,22.8,34.4,C2,T9,NHP102,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,34.4,,,24.4,46.1,C2,T9,NHP102,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,30.9,,,23.9,39,C2,T9,NHP102,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,48.2,,,43.7,52.7,C2,T9,NHP102,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,43.9,,,40.5,47.5,C2,T9,NHP102,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,44.7,,,41.7,47.8,C2,T9,NHP102,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,39.1,,,33.3,45.2,C2,T9,NHP102,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,34.3,,,30.1,38.7,C2,T9,NHP102,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,51.4,,,41.6,61,C2,T9,NHP102,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,37.2,,,33.3,41.2,C2,T9,NHP102,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,37.9,,,31.8,44.3,C2,T9,NHP102,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.1,,,33.2,43.2,C2,T9,NHP102,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,27.7,,,20.1,37,C2,T9,NHP102,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.7,,,29.4,55.1,C2,T9,NHP102,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,47.8,,,39.2,56.5,C2,T9,NHP102,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,49.6,,,44.7,54.6,C2,T9,NHP102,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,48.1,,,44.3,51.9,C2,T9,NHP102,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,49.5,,,46.6,52.4,C2,T9,NHP102,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,43.2,,,38.7,47.7,C2,T9,NHP102,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.9,,,35,47.1,C2,T9,NHP102,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,53.7,,,46,61.2,C2,T9,NHP102,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46,,,40.3,51.8,C2,T9,NHP102,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.1,,,44,56.3,C2,T9,NHP102,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,40,,,33.5,46.9,C2,T9,NHP102,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,37.2,,,32.1,42.5,C2,T9,NHP102,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,21.5,,,14.8,30.1,C2,T9,NHP102,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,36,,,27.9,45,C2,T9,NHP102,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57.1,,,52.5,61.6,C2,T9,NHP102,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,55.1,,,50.6,59.5,C2,T9,NHP102,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.5,,,51.2,57.8,C2,T9,NHP102,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,50.2,,,44.1,56.4,C2,T9,NHP102,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.5,,,34.3,47.1,C2,T9,NHP102,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.7,,,35.1,48.7,C2,T15,NHP104,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.2,,,49.1,63,C2,T9,NHP102,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.5,,,41.3,51.8,C2,T9,NHP102,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.7,,,43.4,56.1,C2,T9,NHP102,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,43.4,,,34.7,52.7,C2,T9,NHP102,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP102,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,21.5,35.8,C2,T9,NHP102,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,44.7,,,32.4,57.6,C2,T9,NHP102,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,45.9,,,35.5,56.7,C2,T9,NHP102,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,56.3,,,49.6,62.8,C2,T9,NHP102,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,50.1,,,45,55.2,C2,T9,NHP102,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,53.2,,,48.4,57.8,C2,T9,NHP102,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,41.7,,,33.5,50.4,C2,T9,NHP102,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,39.6,,,34.3,45.2,C2,T9,NHP102,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,55.6,,,46.9,64,C2,T9,NHP102,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.8,,,40.8,53,C2,T9,NHP102,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.3,,,41.4,59.2,C2,T9,NHP102,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.3,,,38.8,52,C2,T9,NHP102,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,35.6,,,26,46.5,C2,T9,NHP102,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,39.4,,,25.3,55.4,C2,T9,NHP102,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,33.7,,,25.9,42.4,C2,T9,NHP102,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP102,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,46.3,,,39.9,52.9,C2,T9,NHP102,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57,,,49.7,64,C2,T9,NHP102,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,54.1,,,49.2,58.9,C2,T9,NHP102,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.8,,,49.6,59.9,C2,T9,NHP102,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,47.4,,,39.1,55.8,C2,T9,NHP102,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,45,,,38.4,51.7,C2,T9,NHP102,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.7,,,50.3,62.8,C2,T9,NHP102,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,49.6,,,44.4,54.9,C2,T9,NHP102,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,55.7,,,47.4,63.8,C2,T9,NHP102,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.9,,,34.4,45.6,C2,T9,NHP102,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,34.5,,,26.4,43.6,C2,T9,NHP102,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,40.6,,,33.1,48.5,C2,T9,NHP102,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Hypertension,Blood pressure control: Prevalence of blood pressure control among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.3,,,28.9,54.9,C2,T9,NHP102,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,21-24,Percentage,%,60.8,,,12.1,94.6,C2,T10,NHP103,BOC03,AGE03,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,25-44,Percentage,%,51.9,,,40.6,63,C2,T10,NHP103,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,45-64,Percentage,%,58.7,,,54.9,62.3,C2,T10,NHP103,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,65+,Percentage,%,67.8,,,64.2,71.2,C2,T10,NHP103,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,35+,Percentage,%,62.5,,,59.9,65,C2,T10,NHP103,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,75+,Percentage,%,75.7,,,72.7,78.4,C2,T10,NHP103,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Male,Percentage,%,56.2,,,47.1,64.9,C2,T10,NHP103,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Female,Percentage,%,53.1,,,44.8,61.3,C2,T10,NHP103,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Overall,Overall,Percentage,%,54.8,,,48.5,60.9,C2,T10,NHP103,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,61.5,,,52.6,69.6,C2,T10,NHP103,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44.1,,,40.2,48.1,C2,T10,NHP103,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP103,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Hispanic,Percentage,%,42.9,,,34.7,51.4,C2,T10,NHP103,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Other,Percentage,%,34.9,,,24.4,47.2,C2,T10,NHP103,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,21-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T10,NHP103,BOC03,AGE03,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,25-44,Percentage,%,46.7,,,33.7,60.1,C2,T10,NHP103,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,45-64,Percentage,%,61.5,,,55.4,67.1,C2,T10,NHP103,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,65+,Percentage,%,70.4,,,66.5,74.1,C2,T10,NHP103,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,35+,Percentage,%,64.3,,,60.7,67.8,C2,T10,NHP103,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Age,75+,Percentage,%,77.6,,,69.4,84.1,C2,T10,NHP103,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Male,Percentage,%,57.8,,,49.4,65.7,C2,T10,NHP103,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Gender,Female,Percentage,%,57.5,,,51.1,63.7,C2,T10,NHP103,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Overall,Overall,Percentage,%,56.9,,,51.9,61.7,C2,T10,NHP103,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,59.3,,,51.7,66.5,C2,T10,NHP103,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.9,,,48.5,70.2,C2,T10,NHP103,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,58.1,,,45.9,69.4,C2,T10,NHP103,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Hispanic,Percentage,%,38.8,,,21.9,58.9,C2,T10,NHP103,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Cholesterol Abnormalities,Cholesterol management: Prevalence of statin use among US adults (21+) for whom statin therapy is recommended (Percentage); NHANES,Race,Other,Percentage,%,56.5,,,42.9,69.2,C2,T10,NHP103,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,34.9,,,28.1,42.4,C2,T15,NHP104,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.7,,,30.6,39.1,C2,T15,NHP104,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.7,,,22.9,33.2,C2,T15,NHP104,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.1,,,11.9,19,C2,T15,NHP104,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,26.9,,,23.6,30.4,C2,T15,NHP104,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.7,,,7,15.9,C2,T15,NHP104,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.5,,,30.1,39.2,C2,T15,NHP104,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,23.4,,,20.2,26.9,C2,T15,NHP104,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.7,,,25.4,32.2,C2,T15,NHP104,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.8,,,25.3,34.7,C2,T15,NHP104,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.8,,,28.3,37.8,C2,T15,NHP104,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.2,,,16.9,26.4,C2,T15,NHP104,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,24.3,,,20,29.2,C2,T15,NHP104,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.2,,,29.2,35.4,C2,T15,NHP104,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,29,,,25.7,32.5,C2,T15,NHP104,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.7,,,10.4,15.4,C2,T15,NHP104,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,26.3,,,24.1,28.7,C2,T15,NHP104,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.8,,,6.3,12,C2,T15,NHP104,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.7,,,29.8,35.7,C2,T15,NHP104,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,24.2,,,21.8,26.7,C2,T15,NHP104,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.3,,,26,30.6,C2,T15,NHP104,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.2,,,25,31.7,C2,T15,NHP104,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,33.7,,,29.3,38.3,C2,T15,NHP104,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,25.5,,,21.8,29.5,C2,T15,NHP104,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,25.3,,,15.9,37.7,C2,T15,NHP104,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.1,,,35.7,46.7,C2,T15,NHP104,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,36.4,,,32,40.9,C2,T15,NHP104,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,32.3,,,29.1,35.7,C2,T15,NHP104,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.5,,,10.8,14.3,C2,T15,NHP104,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,28.5,,,25.8,31.3,C2,T15,NHP104,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8.5,,,7,10.3,C2,T15,NHP104,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,38.1,,,34.2,42.2,C2,T15,NHP104,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,24,,,21.5,26.7,C2,T15,NHP104,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.8,,,28.2,33.6,C2,T15,NHP104,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,31.8,,,28.9,34.9,C2,T15,NHP104,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,34.4,,,29,40.2,C2,T15,NHP104,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.4,,,21.3,25.7,C2,T15,NHP104,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,28,,,20.9,36.5,C2,T15,NHP104,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,41.3,,,34.6,48.3,C2,T15,NHP104,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,29.2,36.8,C2,T15,NHP104,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,28.3,,,24.5,32.5,C2,T15,NHP104,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,14.3,,,11.7,17.4,C2,T15,NHP104,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,27.1,,,24.6,29.7,C2,T15,NHP104,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.7,,,7.4,12.6,C2,T15,NHP104,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,34.6,,,31.6,37.8,C2,T15,NHP104,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.9,,,20.7,25.3,C2,T15,NHP104,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,28.6,,,26.4,31,C2,T15,NHP104,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.7,,,27.3,34.3,C2,T15,NHP104,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.7,,,24.6,35.4,C2,T15,NHP104,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,21.6,,,19.4,24.1,C2,T15,NHP104,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,26.3,,,18.2,36.4,C2,T15,NHP104,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,35,,,28.9,41.6,C2,T15,NHP104,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,33.7,,,30.3,37.2,C2,T15,NHP104,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,27.9,,,23.4,32.8,C2,T15,NHP104,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.1,,,10.7,13.6,C2,T15,NHP104,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,24.8,,,21.9,28.1,C2,T15,NHP104,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,9.5,,,7.6,11.9,C2,T15,NHP104,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,29.6,37.2,C2,T15,NHP104,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,22.4,,,19.8,25.3,C2,T15,NHP104,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,27.8,,,24.7,31,C2,T15,NHP104,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.4,,,25.1,34.1,C2,T15,NHP104,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.9,,,29.9,36,C2,T15,NHP104,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,18.9,,,15.8,22.3,C2,T15,NHP104,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20,,,14.2,27.5,C2,T15,NHP104,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,36.1,,,29.4,43.4,C2,T15,NHP104,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,30.1,,,27.4,33,C2,T15,NHP104,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.3,,,23.4,27.3,C2,T15,NHP104,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,11.1,,,9.4,12.9,C2,T15,NHP104,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,22.6,,,21.2,24.1,C2,T15,NHP104,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,8,,,6.3,10.2,C2,T15,NHP104,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30,,,27.7,32.3,C2,T15,NHP104,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,21.4,,,19.7,23.2,C2,T15,NHP104,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.5,,,24,27.1,C2,T15,NHP104,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.4,,,24.5,28.4,C2,T15,NHP104,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,33.5,,,27.8,39.8,C2,T15,NHP104,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T15,NHP104,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,19.9,,,16.4,23.8,C2,T15,NHP104,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.8,,,13.2,28.6,C2,T15,NHP104,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.1,,,19.2,32.1,C2,T15,NHP104,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,29.8,,,26.9,33,C2,T15,NHP104,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,25.8,,,22.3,29.7,C2,T15,NHP104,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12,,,9.1,15.6,C2,T15,NHP104,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,23.3,,,20.8,26,C2,T15,NHP104,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,6.1,,,4.1,9,C2,T15,NHP104,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,31.1,,,27.3,35.3,C2,T15,NHP104,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.9,,,16.1,22.1,C2,T15,NHP104,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,24.8,,,22.1,27.7,C2,T15,NHP104,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26,,,22.5,29.8,C2,T15,NHP104,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29.5,,,24.5,35.1,C2,T15,NHP104,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,11.1,,,9.1,13.6,C2,T15,NHP104,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,20.5,,,17.3,24.1,C2,T15,NHP104,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.9,,,14.3,29.4,C2,T15,NHP104,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.9,,,22.1,32.2,C2,T15,NHP104,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,22.7,,,20.3,25.3,C2,T15,NHP104,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,21.4,,,17.5,25.8,C2,T15,NHP104,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,8.2,,,6.8,9.9,C2,T15,NHP104,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18.3,,,16.1,20.8,C2,T15,NHP104,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,4.7,,,3.2,6.8,C2,T15,NHP104,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,21,,,18.9,23.4,C2,T15,NHP104,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,19.2,,,16.5,22.3,C2,T15,NHP104,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,20.1,,,18,22.4,C2,T15,NHP104,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,21.7,,,18.5,25.2,C2,T15,NHP104,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26,,,23.1,29.1,C2,T15,NHP104,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,8.2,,,6.3,10.6,C2,T15,NHP104,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.2,,,10.5,16.6,C2,T15,NHP104,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,Million Hearts,ABCS,None,None,Risk Factors,Smoking,Smoking: Prevalence of current smoking among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,16.1,,,12.7,20.2,C2,T15,NHP104,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP305,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.2,,,9.3,15.9,C2,T9,NHP305,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,37.9,,,33.7,42.4,C2,T9,NHP305,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.2,,,66.3,73.8,C2,T9,NHP305,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,38.2,,,34.7,41.9,C2,T9,NHP305,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,77.6,,,73.4,81.4,C2,T9,NHP305,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,29.3,,,25.3,33.5,C2,T9,NHP305,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30,,,27.7,32.5,C2,T9,NHP305,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.9,,,27.1,32.8,C2,T9,NHP305,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.3,,,24.9,32,C2,T9,NHP305,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,40.5,,,38.4,42.6,C2,T9,NHP305,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.5,,,25.9,31.2,C2,T9,NHP305,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,30.3,,,20,43.1,C2,T9,NHP305,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,3.3,,,2.1,5.1,C2,T9,NHP305,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,10.4,,,8.9,12.1,C2,T9,NHP305,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,37.6,,,33,42.5,C2,T9,NHP305,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.6,,,67.8,73.3,C2,T9,NHP305,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,37.8,,,34.6,41.1,C2,T9,NHP305,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,75.8,,,72.9,78.5,C2,T9,NHP305,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,27.7,,,25.3,30.2,C2,T9,NHP305,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.7,,,29,32.4,C2,T9,NHP305,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.4,,,27.7,31.2,C2,T9,NHP305,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28,,,26.1,30,C2,T9,NHP305,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.6,,,39.4,45.7,C2,T9,NHP305,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.9,,,22.1,25.9,C2,T9,NHP305,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,29.9,,,21.7,39.6,C2,T9,NHP305,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP305,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.4,,,10.7,14.4,C2,T9,NHP305,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,42.7,,,38.3,47.3,C2,T9,NHP305,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.1,,,65.8,74.1,C2,T9,NHP305,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.7,,,38.4,45,C2,T9,NHP305,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,74.2,,,68.7,78.9,C2,T9,NHP305,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32,,,29,35.1,C2,T9,NHP305,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.5,,,28.2,32.9,C2,T9,NHP305,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.4,,,29.2,33.6,C2,T9,NHP305,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.3,,,27.7,33,C2,T9,NHP305,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,41.5,,,38.1,45.1,C2,T9,NHP305,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,29.2,,,26,32.6,C2,T9,NHP305,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,32.2,,,25.2,40.2,C2,T9,NHP305,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,4.3,,,2.5,7.2,C2,T9,NHP305,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,11.7,,,9.3,14.7,C2,T9,NHP305,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.8,,,35.8,43.9,C2,T9,NHP305,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,68.9,,,66.7,71.1,C2,T9,NHP305,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,39.9,,,36.9,42.9,C2,T9,NHP305,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,71.8,,,69.1,74.3,C2,T9,NHP305,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,31.1,,,28.5,33.9,C2,T9,NHP305,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.7,,,28.1,31.3,C2,T9,NHP305,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.6,,,28.8,32.5,C2,T9,NHP305,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.4,,,27.3,31.7,C2,T9,NHP305,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.8,,,39.8,45.9,C2,T9,NHP305,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,23.2,,,20.6,26,C2,T9,NHP305,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,31.1,,,24.7,38.3,C2,T9,NHP305,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,2.8,,,1.9,4.2,C2,T9,NHP305,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,13.2,,,11.5,15.2,C2,T9,NHP305,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.8,,,37.3,42.3,C2,T9,NHP305,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,70.2,,,65.1,74.8,C2,T9,NHP305,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.2,,,39.3,43.2,C2,T9,NHP305,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,76.1,,,73,78.9,C2,T9,NHP305,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,31.4,,,30,32.9,C2,T9,NHP305,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,30.5,,,28.9,32.2,C2,T9,NHP305,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31.1,,,29.8,32.4,C2,T9,NHP305,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.4,,,28.5,32.4,C2,T9,NHP305,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.2,,,38.9,45.5,C2,T9,NHP305,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.2,,,24.8,31.9,C2,T9,NHP305,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,24.3,,,20.7,28.4,C2,T9,NHP305,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP305,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,10.7,,,9.5,12.1,C2,T9,NHP305,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,39.5,,,35.2,44,C2,T9,NHP305,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,71.3,,,67.6,74.7,C2,T9,NHP305,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41,,,37.5,44.5,C2,T9,NHP305,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,76.9,,,73.4,80.1,C2,T9,NHP305,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,30.8,,,28.2,33.5,C2,T9,NHP305,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.1,,,27.3,31,C2,T9,NHP305,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30,,,28.2,31.9,C2,T9,NHP305,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.8,,,26.4,31.4,C2,T9,NHP305,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.2,,,38.9,45.6,C2,T9,NHP305,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP305,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,27.8,,,25.8,30,C2,T9,NHP305,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,31.3,,,26.8,36.2,C2,T9,NHP305,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP305,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.6,,,10.1,15.5,C2,T9,NHP305,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,40.6,,,37.6,43.7,C2,T9,NHP305,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,67.3,,,63.5,71,C2,T9,NHP305,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,41.9,,,39.4,44.5,C2,T9,NHP305,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,77,,,73.9,79.9,C2,T9,NHP305,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,30.8,,,28.7,33.1,C2,T9,NHP305,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.5,,,27.9,31.3,C2,T9,NHP305,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28.8,31.7,C2,T9,NHP305,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29,,,27.4,30.7,C2,T9,NHP305,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,43.4,,,41.7,45.2,C2,T9,NHP305,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,25.5,,,22.4,28.9,C2,T9,NHP305,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.8,,,22,32.3,C2,T9,NHP305,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,27.1,,,23.9,30.5,C2,T9,NHP305,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,2.5,,,1.5,4,C2,T9,NHP305,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,12.9,,,11,15.1,C2,T9,NHP305,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,41.2,,,38.2,44.2,C2,T9,NHP305,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,69.5,,,66.6,72.3,C2,T9,NHP305,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,42.8,,,40.2,45.3,C2,T9,NHP305,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,75.1,,,70.4,79.3,C2,T9,NHP305,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32,,,30,34,C2,T9,NHP305,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,29.6,,,27.2,32.1,C2,T9,NHP305,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.8,,,29.1,32.6,C2,T9,NHP305,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.9,,,27.9,32,C2,T9,NHP305,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,42.4,,,39.4,45.4,C2,T9,NHP305,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,27.1,,,24.1,30.3,C2,T9,NHP305,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,25.2,31.1,C2,T9,NHP305,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 5: Prevalence of hypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,29.1,,,25.8,32.6,C2,T9,NHP305,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,27.7,,,22.8,33.2,C2,T10,NHP306,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,51.7,,,46.5,56.8,C2,T10,NHP306,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,77.6,,,74.4,80.5,C2,T10,NHP306,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.6,,,85.6,91,C2,T10,NHP306,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,74.2,,,71.4,76.8,C2,T10,NHP306,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,87.9,,,84.7,90.5,C2,T10,NHP306,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,63.9,,,61,66.8,C2,T10,NHP306,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,67.1,,,62.9,71.1,C2,T10,NHP306,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,62.7,68.2,C2,T10,NHP306,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,68.4,,,64.5,72,C2,T10,NHP306,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,59.1,,,55.2,62.9,C2,T10,NHP306,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,50.7,,,46.7,54.7,C2,T10,NHP306,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,54.2,,,48.2,59.9,C2,T10,NHP306,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,21.9,,,17.5,27.2,C2,T10,NHP306,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,53.9,,,51.2,56.6,C2,T10,NHP306,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,77.4,,,73.8,80.7,C2,T10,NHP306,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,88.3,,,84.5,91.2,C2,T10,NHP306,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,75.3,,,72.4,78,C2,T10,NHP306,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,86.5,,,82.2,89.8,C2,T10,NHP306,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,63.5,,,61.1,65.8,C2,T10,NHP306,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,67.8,,,64.9,70.5,C2,T10,NHP306,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,63.2,67.8,C2,T10,NHP306,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,67.9,,,65.1,70.6,C2,T10,NHP306,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,62,,,56.8,66.9,C2,T10,NHP306,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,51.5,,,46.8,56.2,C2,T10,NHP306,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,65.1,,,58,71.5,C2,T10,NHP306,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.2,,,20.6,32.6,C2,T10,NHP306,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,53.4,,,48.6,58.1,C2,T10,NHP306,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.1,,,76.9,82.9,C2,T10,NHP306,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,92.2,,,91.1,93.2,C2,T10,NHP306,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,77.4,,,75,79.7,C2,T10,NHP306,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,92.4,,,90.7,93.7,C2,T10,NHP306,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,64.6,,,61.9,67.2,C2,T10,NHP306,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,70,,,67.1,72.8,C2,T10,NHP306,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,67.3,,,64.8,69.8,C2,T10,NHP306,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,69.4,,,65.7,72.9,C2,T10,NHP306,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65.4,,,62.9,67.8,C2,T10,NHP306,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,52.4,,,46.7,58,C2,T10,NHP306,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,65.5,,,57.8,72.4,C2,T10,NHP306,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.9,,,25.1,35,C2,T10,NHP306,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,57.2,,,53,61.4,C2,T10,NHP306,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.9,,,77.8,83.7,C2,T10,NHP306,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,89.8,,,87.1,92,C2,T10,NHP306,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.1,,,76.4,81.5,C2,T10,NHP306,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,90.1,,,85.5,93.3,C2,T10,NHP306,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,65.9,,,63.1,68.6,C2,T10,NHP306,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.2,,,69.8,74.5,C2,T10,NHP306,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,68.9,,,66.6,71.2,C2,T10,NHP306,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,71.4,,,68.8,73.9,C2,T10,NHP306,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67.2,,,64.1,70.1,C2,T10,NHP306,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,49.6,,,45.1,54.1,C2,T10,NHP306,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,69,,,59.3,77.3,C2,T10,NHP306,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.3,,,24.2,35,C2,T10,NHP306,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,55.5,,,51.1,59.8,C2,T10,NHP306,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,80.4,,,77.6,82.9,C2,T10,NHP306,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,93.3,,,91.6,94.7,C2,T10,NHP306,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,78.9,,,77,80.7,C2,T10,NHP306,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,93.4,,,90.8,95.3,C2,T10,NHP306,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,65.3,,,62.7,67.9,C2,T10,NHP306,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.4,,,70,74.7,C2,T10,NHP306,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,68.9,,,66.8,70.9,C2,T10,NHP306,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,70.8,,,67.8,73.6,C2,T10,NHP306,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,70.3,,,67.5,72.9,C2,T10,NHP306,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,55.6,,,52.9,58.3,C2,T10,NHP306,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,66.2,,,58.9,72.8,C2,T10,NHP306,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,29.5,,,24.5,35.2,C2,T10,NHP306,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,56.8,,,53.4,60.2,C2,T10,NHP306,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,81,,,77.6,84,C2,T10,NHP306,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,91.2,,,89.4,92.8,C2,T10,NHP306,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,79.7,,,77,82.1,C2,T10,NHP306,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,90.1,,,86.7,92.7,C2,T10,NHP306,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,66.9,,,64.7,69,C2,T10,NHP306,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,71.1,,,68.7,73.3,C2,T10,NHP306,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,69,,,67.1,70.8,C2,T10,NHP306,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,71.7,,,69.9,73.4,C2,T10,NHP306,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,67,,,63.1,70.7,C2,T10,NHP306,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP306,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,53.6,,,49.9,57.3,C2,T10,NHP306,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,69.8,,,64.2,74.9,C2,T10,NHP306,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,34,,,26.6,42.2,C2,T10,NHP306,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,58.8,,,55.1,62.4,C2,T10,NHP306,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,81.6,,,78.4,84.5,C2,T10,NHP306,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,92.7,,,90.6,94.4,C2,T10,NHP306,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,80.9,,,78.5,83,C2,T10,NHP306,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,91.8,,,89.8,93.5,C2,T10,NHP306,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,68.1,,,66.2,69.9,C2,T10,NHP306,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,72.7,,,70,75.3,C2,T10,NHP306,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,70.5,,,68.5,72.4,C2,T10,NHP306,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,72.9,,,70.2,75.4,C2,T10,NHP306,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,72.8,,,67.8,77.3,C2,T10,NHP306,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,71.5,,,68,74.8,C2,T10,NHP306,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,57,,,52,61.8,C2,T10,NHP306,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,67.5,,,62.7,72,C2,T10,NHP306,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,37.2,,,30.8,44,C2,T10,NHP306,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,63.5,,,61.2,65.8,C2,T10,NHP306,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,85.3,,,83.6,86.9,C2,T10,NHP306,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,93.3,,,91.3,94.9,C2,T10,NHP306,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,83.7,,,82.9,84.6,C2,T10,NHP306,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,95.5,,,92.5,97.4,C2,T10,NHP306,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,71.1,,,68.4,73.7,C2,T10,NHP306,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,76.8,,,75.4,78.3,C2,T10,NHP306,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,74,,,72.6,75.3,C2,T10,NHP306,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,76,,,73.9,77.9,C2,T10,NHP306,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,73.9,,,70.5,77,C2,T10,NHP306,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,75.6,,,71.3,79.4,C2,T10,NHP306,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,64.9,,,62.2,67.6,C2,T10,NHP306,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 6: Prevalence of cholesterol screening in the past 5 years among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,74.5,,,70.7,78.1,C2,T10,NHP306,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.2,,,3.1,8.8,C2,T10,NHP307,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.6,,,10.9,16.8,C2,T10,NHP307,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.3,,,19.7,25.1,C2,T10,NHP307,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,25.6,,,23.6,27.7,C2,T10,NHP307,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,21.2,,,18.5,24.2,C2,T10,NHP307,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,20.7,,,18,23.7,C2,T10,NHP307,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,17.4,,,15.2,19.8,C2,T10,NHP307,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,18.5,,,16.1,21.2,C2,T10,NHP307,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,18.2,,,16.2,20.3,C2,T10,NHP307,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,19,,,16.9,21.4,C2,T10,NHP307,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,14.2,,,11.7,17,C2,T10,NHP307,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.7,,,13.8,17.9,C2,T10,NHP307,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,15.9,,,11.2,22,C2,T10,NHP307,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,208.1,,,204.5,211.6,C2,T10,NHP308,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.7,6,C2,T10,NHP307,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,12.8,,,10.8,15.2,C2,T10,NHP307,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.7,,,19.7,26.2,C2,T10,NHP307,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,19.4,,,16.1,23.2,C2,T10,NHP307,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.6,,,17.5,21.8,C2,T10,NHP307,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,19.7,,,16.4,23.5,C2,T10,NHP307,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,15.8,,,13.4,18.5,C2,T10,NHP307,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.6,,,15.1,18.2,C2,T10,NHP307,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.5,,,14.9,18.2,C2,T10,NHP307,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.3,,,14.2,18.6,C2,T10,NHP307,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,16.2,,,12.7,20.3,C2,T10,NHP307,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,14.8,,,11.9,18.2,C2,T10,NHP307,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,23.9,,,16.3,33.6,C2,T10,NHP307,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.7,,,2.8,7.7,C2,T10,NHP307,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,14.4,,,12.8,16.2,C2,T10,NHP307,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,22.2,,,20,24.7,C2,T10,NHP307,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,18.4,,,16.7,20.3,C2,T10,NHP307,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,19.9,,,18.3,21.5,C2,T10,NHP307,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,17.1,,,14.4,20.2,C2,T10,NHP307,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,16.4,,,14.9,17.9,C2,T10,NHP307,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,17.1,,,15.1,19.4,C2,T10,NHP307,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,16.9,,,15.8,18.2,C2,T10,NHP307,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,17.5,,,16.1,18.9,C2,T10,NHP307,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13.7,,,11.1,16.8,C2,T10,NHP307,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.2,,,13.5,17,C2,T10,NHP307,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,14.8,,,10.6,20.4,C2,T10,NHP307,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,4.1,,,2.4,6.8,C2,T10,NHP307,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,13.5,,,11,16.5,C2,T10,NHP307,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,20.9,,,18.2,23.9,C2,T10,NHP307,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.1,,,12.2,18.5,C2,T10,NHP307,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,18,,,16,20.1,C2,T10,NHP307,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.8,,,8.7,18.5,C2,T10,NHP307,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.8,,,12,15.9,C2,T10,NHP307,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,16.8,,,15.4,18.3,C2,T10,NHP307,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,15.5,,,14.2,16.9,C2,T10,NHP307,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,16.2,,,14.3,18.3,C2,T10,NHP307,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.6,,,9.4,12,C2,T10,NHP307,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.5,,,12.7,18.8,C2,T10,NHP307,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.1,,,11.5,27.4,C2,T10,NHP307,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5,,,2.7,9.1,C2,T10,NHP307,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,11.1,,,9.2,13.3,C2,T10,NHP307,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.7,,,16.8,23,C2,T10,NHP307,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,15.5,,,13.3,18,C2,T10,NHP307,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,17.2,,,15.5,19,C2,T10,NHP307,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,16.9,,,13.7,20.8,C2,T10,NHP307,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,13.3,,,11.3,15.5,C2,T10,NHP307,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,15.2,,,13.2,17.3,C2,T10,NHP307,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,14.4,,,12.9,16.1,C2,T10,NHP307,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,14.7,,,12.8,16.9,C2,T10,NHP307,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,13,,,10.4,16.1,C2,T10,NHP307,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,15.1,,,12.2,18.5,C2,T10,NHP307,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,13.8,,,9.8,18.9,C2,T10,NHP307,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,2.7,,,1.4,5.3,C2,T10,NHP307,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,10.3,,,9,11.9,C2,T10,NHP307,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.3,,,16.9,21.9,C2,T10,NHP307,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,13.7,,,11.3,16.5,C2,T10,NHP307,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,16.4,,,14.6,18.2,C2,T10,NHP307,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,12.1,,,9.3,15.7,C2,T10,NHP307,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,12.2,,,10.6,14.1,C2,T10,NHP307,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.8,15.8,C2,T10,NHP307,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,13.4,,,12,14.8,C2,T10,NHP307,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.6,,,12,15.3,C2,T10,NHP307,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10.4,,,8.1,13.2,C2,T10,NHP307,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T10,NHP307,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,13.9,,,12.4,15.6,C2,T10,NHP307,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,12.5,,,7.3,20.7,C2,T10,NHP307,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,5.5,,,3.1,9.7,C2,T10,NHP307,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,8.3,,,6.8,10.1,C2,T10,NHP307,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,19.5,,,16.4,23,C2,T10,NHP307,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,12.5,,,10.6,14.7,C2,T10,NHP307,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,15.8,,,13.8,18,C2,T10,NHP307,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,11.3,,,8.1,15.7,C2,T10,NHP307,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,11.1,,,9.6,12.8,C2,T10,NHP307,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,14.2,,,12.4,16.3,C2,T10,NHP307,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,12.8,,,11.4,14.4,C2,T10,NHP307,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,13.4,,,11.5,15.6,C2,T10,NHP307,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,10,,,8.5,11.6,C2,T10,NHP307,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.2,,,7.9,13.2,C2,T10,NHP307,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,12.2,,,9.2,16.2,C2,T10,NHP307,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,10,,,7.2,13.7,C2,T10,NHP307,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,3.2,,,1.5,6.6,C2,T10,NHP307,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,9.9,,,8.4,11.7,C2,T10,NHP307,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,14.3,,,12.3,16.6,C2,T10,NHP307,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,10.6,,,8.9,12.7,C2,T10,NHP307,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,13.1,,,11.9,14.5,C2,T10,NHP307,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,10.4,,,7.7,13.8,C2,T10,NHP307,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,10.1,,,9,11.3,C2,T10,NHP307,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,11.5,,,10.1,13,C2,T10,NHP307,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,10.9,,,10.1,11.9,C2,T10,NHP307,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,11.2,,,9.9,12.6,C2,T10,NHP307,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,7.7,,,6.7,8.9,C2,T10,NHP307,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12,,,9.5,15.2,C2,T10,NHP307,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,11,,,8.9,13.6,C2,T10,NHP307,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 7: Prevalence of high serum total cholesterol among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.1,,,9.1,13.5,C2,T10,NHP307,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,176.4,,,170.6,182.2,C2,T10,NHP308,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,196.1,,,192.5,199.7,C2,T10,NHP308,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,214.6,,,211.7,217.4,C2,T10,NHP308,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,215.5,,,213.5,217.5,C2,T10,NHP308,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,210.3,,,207,213.6,C2,T10,NHP308,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,209.1,,,207.1,211.1,C2,T10,NHP308,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,203.6,,,200.9,206.3,C2,T10,NHP308,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,204.6,,,202,207.2,C2,T10,NHP308,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,204.3,,,202,206.7,C2,T10,NHP308,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,205.6,,,202.6,208.6,C2,T10,NHP308,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,197.1,,,194.6,199.6,C2,T10,NHP308,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,203,,,200.4,205.7,C2,T10,NHP308,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,205,,,197.3,212.8,C2,T10,NHP308,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,172.8,,,167.3,178.3,C2,T10,NHP308,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,197.2,,,194.3,200.1,C2,T10,NHP308,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,213.6,,,209.8,217.5,C2,T10,NHP308,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,209.2,,,206.3,212,C2,T10,NHP308,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,208.2,,,203.2,213.2,C2,T10,NHP308,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,201.4,,,197.6,205.3,C2,T10,NHP308,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,202.6,,,200.8,204.4,C2,T10,NHP308,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,202.4,,,200.1,204.7,C2,T10,NHP308,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,202.3,,,199.7,204.9,C2,T10,NHP308,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,199.8,,,194.8,204.8,C2,T10,NHP308,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,200.2,,,195.9,204.5,C2,T10,NHP308,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,213.7,,,206.3,221.2,C2,T10,NHP308,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,172.9,,,169,176.9,C2,T10,NHP308,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,199,,,196.9,201.2,C2,T10,NHP308,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,210.2,,,207.1,213.3,C2,T10,NHP308,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,205.7,,,203.8,207.5,C2,T10,NHP308,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,207.5,,,205.3,209.8,C2,T10,NHP308,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,203.8,,,200,207.5,C2,T10,NHP308,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,200.5,,,199.1,201.9,C2,T10,NHP308,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,202.2,,,199.9,204.5,C2,T10,NHP308,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,201.7,,,200.3,203,C2,T10,NHP308,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,202.5,,,200.9,204.2,C2,T10,NHP308,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,197,,,194,200.1,C2,T10,NHP308,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,201,,,198.9,203,C2,T10,NHP308,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,196.1,,,189.6,202.6,C2,T10,NHP308,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,173.6,,,169.7,177.4,C2,T10,NHP308,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,196.2,,,193.3,199,C2,T10,NHP308,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,208.4,,,205.8,210.9,C2,T10,NHP308,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,196.7,,,193.6,199.9,C2,T10,NHP308,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,203.3,,,201.7,205,C2,T10,NHP308,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,192.4,,,187.1,197.7,C2,T10,NHP308,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,195.5,,,193.6,197.4,C2,T10,NHP308,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,200.6,,,199,202.2,C2,T10,NHP308,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,198.4,,,197,199.7,C2,T10,NHP308,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,198.9,,,197.2,200.6,C2,T10,NHP308,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,190.6,,,188.1,193.1,C2,T10,NHP308,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,201.4,,,197.4,205.4,C2,T10,NHP308,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,200.9,,,195.5,206.2,C2,T10,NHP308,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,176,,,170,182.1,C2,T10,NHP308,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,194.4,,,191.9,197,C2,T10,NHP308,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,206.2,,,202.9,209.4,C2,T10,NHP308,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,194.5,,,191.8,197.2,C2,T10,NHP308,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,201.7,,,199.9,203.5,C2,T10,NHP308,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,194.2,,,191.5,196.9,C2,T10,NHP308,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,194,,,191.6,196.4,C2,T10,NHP308,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,199.2,,,197,201.3,C2,T10,NHP308,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,197,,,195.3,198.6,C2,T10,NHP308,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,197.3,,,195.2,199.3,C2,T10,NHP308,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,193.3,,,190.2,196.4,C2,T10,NHP308,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,199.9,,,196.5,203.2,C2,T10,NHP308,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,196.4,,,190.6,202.2,C2,T10,NHP308,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,172.2,,,168.4,176,C2,T10,NHP308,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,192.9,,,191.4,194.3,C2,T10,NHP308,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,206.8,,,203,210.5,C2,T10,NHP308,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,193.1,,,189.3,196.9,C2,T10,NHP308,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,201.5,,,198.9,204.2,C2,T10,NHP308,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,189.2,,,185.5,192.9,C2,T10,NHP308,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,193.8,,,191.5,196.2,C2,T10,NHP308,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,197.3,,,194.9,199.6,C2,T10,NHP308,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,195.8,,,193.9,197.8,C2,T10,NHP308,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,196.2,,,193.7,198.6,C2,T10,NHP308,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,190.6,,,188.5,192.8,C2,T10,NHP308,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T10,NHP308,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,197.6,,,195.6,199.6,C2,T10,NHP308,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,194.3,,,186.1,202.5,C2,T10,NHP308,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,174.1,,,170.6,177.7,C2,T10,NHP308,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,190.5,,,188.6,192.5,C2,T10,NHP308,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,206.1,,,203.4,208.8,C2,T10,NHP308,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,192.9,,,188.7,197.2,C2,T10,NHP308,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,200.9,,,198.5,203.4,C2,T10,NHP308,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,189.8,,,185.4,194.3,C2,T10,NHP308,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,190.8,,,188.6,193.1,C2,T10,NHP308,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,198.5,,,196.6,200.4,C2,T10,NHP308,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,194.9,,,193.2,196.7,C2,T10,NHP308,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,195.9,,,193.4,198.3,C2,T10,NHP308,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,189.8,,,187.7,192,C2,T10,NHP308,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,191.6,,,188.4,194.8,C2,T10,NHP308,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,194.7,,,191.5,197.9,C2,T10,NHP308,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,190.7,,,187.1,194.2,C2,T10,NHP308,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,20-24,Mean,Mean,169.9,,,166.1,173.7,C2,T10,NHP308,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,25-44,Mean,Mean,187.4,,,184.6,190.3,C2,T10,NHP308,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,45-64,Mean,Mean,198.6,,,196.5,200.7,C2,T10,NHP308,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,65+,Mean,Mean,184.8,,,181.4,188.2,C2,T10,NHP308,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,35+,Mean,Mean,194,,,193,195,C2,T10,NHP308,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Age,75+,Mean,Mean,181.9,,,177.1,186.7,C2,T10,NHP308,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Male,Mean,Mean,186.1,,,183.6,188.5,C2,T10,NHP308,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Gender,Female,Mean,Mean,191.9,,,190.4,193.3,C2,T10,NHP308,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Overall,Overall,Mean,Mean,189.2,,,187.8,190.7,C2,T10,NHP308,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic White,Mean,Mean,189.6,,,187.8,191.4,C2,T10,NHP308,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Black,Mean,Mean,183.2,,,180.3,186.1,C2,T10,NHP308,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,191,,,187.6,194.3,C2,T10,NHP308,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Hispanic,Mean,Mean,191.2,,,187.3,195.2,C2,T10,NHP308,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Cholesterol Abnormalities,Heart Disease and Stroke Objective 8: Mean serum total cholesterol among US adults (20+); NHANES,Race,Other,Mean,Mean,188.3,,,185.8,190.8,C2,T10,NHP308,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,27.7,,,23,33,C2,T9,NHP309,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,33.7,,,30.2,37.4,C2,T9,NHP309,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,34.2,,,31.9,36.6,C2,T9,NHP309,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,21.6,,,18.2,25.3,C2,T9,NHP309,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,31.5,,,29.1,33.9,C2,T9,NHP309,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,17,,,13.7,20.8,C2,T9,NHP309,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,39.2,,,36.2,42.2,C2,T9,NHP309,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.6,,,20.7,24.6,C2,T9,NHP309,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,31,,,29.1,32.9,C2,T9,NHP309,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,31.5,,,28.9,34.1,C2,T9,NHP309,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,29,,,26.4,31.9,C2,T9,NHP309,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31.5,,,29.1,34,C2,T9,NHP309,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,30.4,,,22.9,39,C2,T9,NHP309,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,28.2,,,24.7,32.1,C2,T9,NHP309,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,29.9,36.1,C2,T9,NHP309,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,32.9,,,30.3,35.7,C2,T9,NHP309,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.6,,,15.8,21.9,C2,T9,NHP309,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,30.4,,,28.4,32.4,C2,T9,NHP309,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,16,,,13.1,19.3,C2,T9,NHP309,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,37.9,,,35,40.8,C2,T9,NHP309,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,21.4,,,19.5,23.5,C2,T9,NHP309,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,29.7,,,28,31.5,C2,T9,NHP309,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30,,,28,32.1,C2,T9,NHP309,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,27.5,,,23.3,32.1,C2,T9,NHP309,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,29.3,,,26.9,31.9,C2,T9,NHP309,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,40,,,32.1,48.5,C2,T9,NHP309,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,24.3,,,20.9,28.1,C2,T9,NHP309,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,30.7,,,26.7,34.9,C2,T9,NHP309,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,32.3,,,29.1,35.7,C2,T9,NHP309,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18,,,14.8,21.7,C2,T9,NHP309,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,28.9,,,26.8,31.1,C2,T9,NHP309,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,16.8,,,14.4,19.6,C2,T9,NHP309,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,30.6,36.1,C2,T9,NHP309,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.6,,,21.1,24.1,C2,T9,NHP309,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,28,,,26.3,29.9,C2,T9,NHP309,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.2,,,25.5,31,C2,T9,NHP309,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.3,,,24.2,28.5,C2,T9,NHP309,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.4,,,23.2,29.7,C2,T9,NHP309,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,32.4,,,25.5,40.2,C2,T9,NHP309,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,28.4,,,22.5,35,C2,T9,NHP309,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,31.6,,,28.2,35.3,C2,T9,NHP309,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,29.9,,,26,34.1,C2,T9,NHP309,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,17.4,,,15.7,19.1,C2,T9,NHP309,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,27.6,,,25,30.4,C2,T9,NHP309,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,18,,,16,20.3,C2,T9,NHP309,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.9,,,31.7,36.2,C2,T9,NHP309,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,21.6,,,18.2,25.5,C2,T9,NHP309,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,27.9,,,25.6,30.3,C2,T9,NHP309,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.9,,,25.8,32.1,C2,T9,NHP309,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,26.2,,,23.2,29.5,C2,T9,NHP309,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,31.2,,,28.7,33.9,C2,T9,NHP309,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,18,,,13.3,23.8,C2,T9,NHP309,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,25.2,,,20.4,30.7,C2,T9,NHP309,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,28.9,,,25.5,32.5,C2,T9,NHP309,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,29.7,,,27.1,32.4,C2,T9,NHP309,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.4,,,15,22.3,C2,T9,NHP309,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,27.2,,,25.7,28.7,C2,T9,NHP309,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,15.7,,,13.1,18.9,C2,T9,NHP309,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.2,,,30.9,35.6,C2,T9,NHP309,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,20.4,,,18.2,22.8,C2,T9,NHP309,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,26.9,,,25,28.8,C2,T9,NHP309,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,26.9,,,24.2,29.7,C2,T9,NHP309,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,23.5,,,21.4,25.8,C2,T9,NHP309,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,28.4,,,24.6,32.5,C2,T9,NHP309,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,28,,,21.8,35.3,C2,T9,NHP309,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,22.2,,,17.6,27.5,C2,T9,NHP309,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,29.7,,,26.6,32.9,C2,T9,NHP309,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,28,,,24.9,31.4,C2,T9,NHP309,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,15.5,,,13.2,18.1,C2,T9,NHP309,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,25.6,,,23.4,27.9,C2,T9,NHP309,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.7,,,11.7,16,C2,T9,NHP309,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,32.1,,,29.9,34.5,C2,T9,NHP309,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,19.1,,,17,21.3,C2,T9,NHP309,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,25.7,,,23.8,27.8,C2,T9,NHP309,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,25.5,,,23.2,27.9,C2,T9,NHP309,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,25.5,,,22.2,29,C2,T9,NHP309,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP309,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,27.1,,,24.9,29.5,C2,T9,NHP309,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,25.2,,,19.5,32,C2,T9,NHP309,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,25.8,,,21.5,30.6,C2,T9,NHP309,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,30.4,,,27.7,33.2,C2,T9,NHP309,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,31,,,27.2,35.1,C2,T9,NHP309,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.8,,,14.6,23.9,C2,T9,NHP309,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,28.1,,,25.9,30.4,C2,T9,NHP309,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.3,,,11.2,15.6,C2,T9,NHP309,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,33.3,,,31.2,35.5,C2,T9,NHP309,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,22.4,,,19.7,25.3,C2,T9,NHP309,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,28,,,26,30.2,C2,T9,NHP309,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.3,,,26.5,32.2,C2,T9,NHP309,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.7,,,21.5,28.3,C2,T9,NHP309,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,25.3,,,21.5,29.4,C2,T9,NHP309,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,24.7,,,21.2,28.6,C2,T9,NHP309,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,28.3,,,24.5,32.5,C2,T9,NHP309,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,18-24,Percentage,%,23.6,,,20.6,26.9,C2,T9,NHP309,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,25-44,Percentage,%,24.6,,,21.2,28.4,C2,T9,NHP309,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,45-64,Percentage,%,26.3,,,24,28.6,C2,T9,NHP309,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,65+,Percentage,%,18.2,,,16.2,20.4,C2,T9,NHP309,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,35+,Percentage,%,24.1,,,22.3,26,C2,T9,NHP309,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Age,75+,Percentage,%,13.4,,,10.6,16.9,C2,T9,NHP309,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Male,Percentage,%,29.4,,,27.2,31.7,C2,T9,NHP309,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Gender,Female,Percentage,%,18.5,,,16.8,20.2,C2,T9,NHP309,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Overall,Overall,Percentage,%,23.9,,,22.7,25.3,C2,T9,NHP309,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,23.3,,,21.5,25.1,C2,T9,NHP309,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,24.1,,,21.9,26.4,C2,T9,NHP309,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,21.7,,,18.8,25,C2,T9,NHP309,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Hispanic,Percentage,%,26.8,,,23.7,30.2,C2,T9,NHP309,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 9: Prevalence of prehypertension among US adults (18+) (Percentage); NHANES,Race,Other,Percentage,%,22.7,,,19.4,26.4,C2,T9,NHP309,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,43,,,31.4,55.5,C2,T9,NHP311,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,65.6,,,59.2,71.5,C2,T9,NHP311,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,60,,,53.8,66,C2,T9,NHP311,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,61.1,,,55.5,66.5,C2,T9,NHP311,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,58.1,,,50.6,65.3,C2,T9,NHP311,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,46.9,,,40.6,53.3,C2,T9,NHP311,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,51.1,,,42.4,59.7,C2,T9,NHP311,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,48.8,,,42.8,54.9,C2,T9,NHP311,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.7,,,46.1,55.4,C2,T9,NHP311,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,52.1,,,41.1,62.8,C2,T9,NHP311,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.8,,,27,34.9,C2,T13,NHP3N09,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,34.8,,,26.1,44.7,C2,T9,NHP311,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,36.4,,,26.2,48,C2,T9,NHP311,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,42.3,,,35.4,49.6,C2,T9,NHP311,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,61.3,,,57.1,65.3,C2,T9,NHP311,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,67.1,,,62.2,71.7,C2,T9,NHP311,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,61.9,,,58.3,65.3,C2,T9,NHP311,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,65.8,,,59.4,71.7,C2,T9,NHP311,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,45.1,,,41.8,48.5,C2,T9,NHP311,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,63.1,,,56.2,69.5,C2,T9,NHP311,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,51.8,,,48.4,55.2,C2,T9,NHP311,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.6,,,44.7,54.5,C2,T9,NHP311,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,60.8,,,57.4,64.1,C2,T9,NHP311,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,33.4,,,25.3,42.8,C2,T9,NHP311,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,40.9,,,30,52.8,C2,T9,NHP311,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,51.5,,,39.2,63.6,C2,T9,NHP311,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,61.8,,,54.6,68.5,C2,T9,NHP311,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,74,,,69.6,77.9,C2,T9,NHP311,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,66.5,,,61.7,71,C2,T9,NHP311,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,66.7,,,60.8,72.1,C2,T9,NHP311,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,54,,,46.5,61.3,C2,T9,NHP311,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,58.8,,,47.9,68.9,C2,T9,NHP311,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,55,,,47.8,62.1,C2,T9,NHP311,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,55.3,,,45,65.3,C2,T9,NHP311,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,55.8,,,47.8,63.5,C2,T9,NHP311,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,48.4,,,38.7,58.3,C2,T9,NHP311,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,60,,,42.1,75.6,C2,T9,NHP311,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,40.5,,,33.5,47.8,C2,T9,NHP311,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,70.2,,,66.2,74,C2,T9,NHP311,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,77.7,,,74.2,80.8,C2,T9,NHP311,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,70.7,,,67.2,73.9,C2,T9,NHP311,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,72.1,,,66.4,77.1,C2,T9,NHP311,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,48.6,,,44.5,52.6,C2,T9,NHP311,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,74.5,,,66.8,80.9,C2,T9,NHP311,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,54.1,,,49.8,58.3,C2,T9,NHP311,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,52.6,,,45.5,59.6,C2,T9,NHP311,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65,,,58.4,71,C2,T9,NHP311,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,41.4,,,31.2,52.4,C2,T9,NHP311,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,53.6,,,40.2,66.5,C2,T9,NHP311,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,57.3,,,48.2,66.1,C2,T9,NHP311,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,71.1,,,67.3,74.6,C2,T9,NHP311,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,79.7,,,77.2,82,C2,T9,NHP311,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,73.7,,,71.5,75.9,C2,T9,NHP311,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,79.4,,,75.2,83,C2,T9,NHP311,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,56.3,,,49.8,62.6,C2,T9,NHP311,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,73,,,67.2,78.2,C2,T9,NHP311,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,63.2,,,57.7,68.4,C2,T9,NHP311,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,64.9,,,57.6,71.7,C2,T9,NHP311,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,65.3,,,58.2,71.7,C2,T9,NHP311,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,52.1,,,45.9,58.2,C2,T9,NHP311,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,39.4,,,25.5,55.3,C2,T9,NHP311,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,56,,,47,64.6,C2,T9,NHP311,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,77.8,,,72.8,82.1,C2,T9,NHP311,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,82,,,78.2,85.3,C2,T9,NHP311,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,78.1,,,74.6,81.1,C2,T9,NHP311,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,81.2,,,75.7,85.7,C2,T9,NHP311,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,59.7,,,52.9,66.1,C2,T9,NHP311,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,75.4,,,67.3,82,C2,T9,NHP311,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,65.8,,,59.9,71.2,C2,T9,NHP311,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,66.3,,,59,72.9,C2,T9,NHP311,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,70.9,,,62.1,78.4,C2,T9,NHP311,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP311,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,55.7,,,46.4,64.7,C2,T9,NHP311,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,64.7,,,52.8,75,C2,T9,NHP311,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,54.6,,,46.2,62.7,C2,T9,NHP311,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75.4,,,68.9,81,C2,T9,NHP311,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,84,,,79.9,87.4,C2,T9,NHP311,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,77,,,72.7,80.8,C2,T9,NHP311,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,83.7,,,77.8,88.2,C2,T9,NHP311,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,55.2,,,50.1,60.3,C2,T9,NHP311,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,73.7,,,65.7,80.3,C2,T9,NHP311,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,63.7,,,58.6,68.6,C2,T9,NHP311,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,65.9,,,57.9,73.2,C2,T9,NHP311,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,68.8,,,63,74.1,C2,T9,NHP311,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48.7,,,38.6,58.9,C2,T9,NHP311,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,55.7,,,42.3,68.3,C2,T9,NHP311,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,43.5,,,34.6,52.8,C2,T9,NHP311,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP311,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,57.5,,,50.1,64.6,C2,T9,NHP311,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,75.8,,,70.7,80.2,C2,T9,NHP311,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,82.6,,,77.9,86.4,C2,T9,NHP311,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,76.8,,,72.4,80.8,C2,T9,NHP311,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,80.9,,,74.2,86.1,C2,T9,NHP311,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,60.6,,,54.1,66.8,C2,T9,NHP311,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,72.4,,,66.1,77.9,C2,T9,NHP311,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,65.5,,,60.4,70.2,C2,T9,NHP311,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,69.3,,,61.3,76.3,C2,T9,NHP311,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,63.6,,,59.4,67.5,C2,T9,NHP311,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,48.2,,,40.8,55.6,C2,T9,NHP311,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,58.4,,,48.9,67.3,C2,T9,NHP311,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 11: Prevalence of hypertension medication use among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,58.7,,,49.4,67.4,C2,T9,NHP311,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.6,,,20,39.2,C2,T9,NHP312,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.6,,,34,45.4,C2,T9,NHP312,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,24.2,,,19.8,29.3,C2,T9,NHP312,BOC03,AGE06,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,27.4,37.6,C2,T9,NHP312,BOC03,AGE07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,16.2,,,12.4,20.9,C2,T9,NHP312,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.4,,,22.5,35,C2,T9,NHP312,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,27,,,20.8,34.2,C2,T9,NHP312,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,27.3,,,22.7,32.3,C2,T9,NHP312,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.5,,,26,35.5,C2,T9,NHP312,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,22.3,,,16.1,30.1,C2,T9,NHP312,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,15.3,,,9.5,23.9,C2,T9,NHP312,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,28.8,,,23.5,34.7,C2,T9,NHP312,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,38.9,,,34.3,43.7,C2,T9,NHP312,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,32.1,,,28.8,35.7,C2,T9,NHP312,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,35.3,,,32.2,38.5,C2,T9,NHP312,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,30.6,,,24.8,37,C2,T9,NHP312,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,28.3,,,24.3,32.6,C2,T9,NHP312,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,42.9,,,36,50,C2,T9,NHP312,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,33.1,,,29.4,37,C2,T9,NHP312,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,33,,,28.1,38.3,C2,T9,NHP312,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,32.5,,,28.5,36.8,C2,T9,NHP312,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.5,,,28.7,36.4,C2,T13,NHP3N09,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,19,,,11.1,30.6,C2,T9,NHP312,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,20.4,,,11.7,33.3,C2,T9,NHP312,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,41.8,,,30.4,54.3,C2,T9,NHP312,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,39.3,,,33.2,45.7,C2,T9,NHP312,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,38.6,,,34.4,42.9,C2,T9,NHP312,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,40.3,,,36,44.8,C2,T9,NHP312,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,28.6,,,23.5,34.2,C2,T9,NHP312,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,36.8,,,29.9,44.2,C2,T9,NHP312,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,38.5,,,28.4,49.7,C2,T9,NHP312,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,36.2,,,29.5,43.6,C2,T9,NHP312,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,38.1,,,28.2,49,C2,T9,NHP312,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,31.5,,,27.2,36.2,C2,T9,NHP312,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.2,,,22.8,34.4,C2,T9,NHP312,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,34.4,,,24.4,46.1,C2,T9,NHP312,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,49.5,,,46.6,52.4,C2,T9,NHP312,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,30.9,,,23.9,39,C2,T9,NHP312,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,48.2,,,43.7,52.7,C2,T9,NHP312,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,43.9,,,40.5,47.5,C2,T9,NHP312,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,44.7,,,41.7,47.8,C2,T9,NHP312,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,39.1,,,33.3,45.2,C2,T9,NHP312,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,34.3,,,30.1,38.7,C2,T9,NHP312,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,51.4,,,41.6,61,C2,T9,NHP312,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,37.2,,,33.3,41.2,C2,T9,NHP312,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,37.9,,,31.8,44.3,C2,T9,NHP312,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.1,,,33.2,43.2,C2,T9,NHP312,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,27.7,,,20.1,37,C2,T9,NHP312,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.7,,,29.4,55.1,C2,T9,NHP312,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,47.8,,,39.2,56.5,C2,T9,NHP312,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,49.6,,,44.7,54.6,C2,T9,NHP312,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,48.1,,,44.3,51.9,C2,T9,NHP312,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,43.2,,,38.7,47.7,C2,T9,NHP312,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.9,,,35,47.1,C2,T9,NHP312,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,53.7,,,46,61.2,C2,T9,NHP312,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46,,,40.3,51.8,C2,T9,NHP312,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.1,,,44,56.3,C2,T9,NHP312,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,40,,,33.5,46.9,C2,T9,NHP312,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,37.2,,,32.1,42.5,C2,T9,NHP312,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,21.5,,,14.8,30.1,C2,T9,NHP312,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,36,,,27.9,45,C2,T9,NHP312,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57.1,,,52.5,61.6,C2,T9,NHP312,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,55.1,,,50.6,59.5,C2,T9,NHP312,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.5,,,51.2,57.8,C2,T9,NHP312,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,50.2,,,44.1,56.4,C2,T9,NHP312,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,40.5,,,34.3,47.1,C2,T9,NHP312,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.2,,,49.1,63,C2,T9,NHP312,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.5,,,41.3,51.8,C2,T9,NHP312,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,49.7,,,43.4,56.1,C2,T9,NHP312,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,43.4,,,34.7,52.7,C2,T9,NHP312,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T9,NHP312,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,28.1,,,21.5,35.8,C2,T9,NHP312,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,44.7,,,32.4,57.6,C2,T9,NHP312,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,45.9,,,35.5,56.7,C2,T9,NHP312,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,56.3,,,49.6,62.8,C2,T9,NHP312,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,50.1,,,45,55.2,C2,T9,NHP312,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,53.2,,,48.4,57.8,C2,T9,NHP312,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,41.7,,,33.5,50.4,C2,T9,NHP312,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,39.6,,,34.3,45.2,C2,T9,NHP312,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,55.6,,,46.9,64,C2,T9,NHP312,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,46.8,,,40.8,53,C2,T9,NHP312,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,50.3,,,41.4,59.2,C2,T9,NHP312,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.3,,,38.8,52,C2,T9,NHP312,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,35.6,,,26,46.5,C2,T9,NHP312,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,39.4,,,25.3,55.4,C2,T9,NHP312,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,33.7,,,25.9,42.4,C2,T9,NHP312,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,18-24,Percentage,%,,~,Statistically unstable estimates not presented [unstable by NCHS standards: (standard error/estimate>0.30)],,,C2,T9,NHP312,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,25-44,Percentage,%,46.3,,,39.9,52.9,C2,T9,NHP312,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,45-64,Percentage,%,57,,,49.7,64,C2,T9,NHP312,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,65+,Percentage,%,54.1,,,49.2,58.9,C2,T9,NHP312,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,35+,Percentage,%,54.8,,,49.6,59.9,C2,T9,NHP312,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Age,75+,Percentage,%,47.4,,,39.1,55.8,C2,T9,NHP312,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Male,Percentage,%,45,,,38.4,51.7,C2,T9,NHP312,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Gender,Female,Percentage,%,56.7,,,50.3,62.8,C2,T9,NHP312,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Overall,Overall,Percentage,%,49.6,,,44.4,54.9,C2,T9,NHP312,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,55.7,,,47.4,63.8,C2,T9,NHP312,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.9,,,34.4,45.6,C2,T9,NHP312,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,34.5,,,26.4,43.6,C2,T9,NHP312,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Hispanic,Percentage,%,40.6,,,33.1,48.5,C2,T9,NHP312,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Hypertension,Heart Disease and Stroke Objective 12: Prevalence of medication control of blood pressure among US adults (18+) with hypertension (Percentage); NHANES,Race,Other,Percentage,%,41.3,,,28.9,54.9,C2,T9,NHP312,BOC04,RAC07,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,18.6,,,14.1,24.2,C2,T13,NHP3N09,BOC03,AGE02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,28.2,,,24.9,31.8,C2,T13,NHP3N09,BOC03,AGE04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.6,,,30.7,40.9,C2,T13,NHP3N09,BOC03,AGE05,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.2,,,18.9,28.1,C2,T13,NHP3N09,BOC03,AGE08,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.2,,,24.2,30.3,C2,T13,NHP3N09,BOC02,GEN01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33.5,,,30,37.1,C2,T13,NHP3N09,BOC02,GEN02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.4,,,27.4,33.6,C2,T13,NHP3N09,BOC01,OVR01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,28.6,,,25,32.6,C2,T13,NHP3N09,BOC04,RAC01,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,39.6,,,36.3,43,C2,T13,NHP3N09,BOC04,RAC02,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,34.2,,,29.4,39.3,C2,T13,NHP3N09,BOC04,RAC04,00,
1999-2000,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,27.8,,,18.9,39,C2,T13,NHP3N09,BOC04,RAC07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24,,,17.9,31.3,C2,T13,NHP3N09,BOC03,AGE02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,27.9,,,25.3,30.7,C2,T13,NHP3N09,BOC03,AGE04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.2,,,31.8,38.8,C2,T13,NHP3N09,BOC03,AGE05,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,28.1,,,25.6,30.7,C2,T13,NHP3N09,BOC03,AGE06,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,32.3,,,29.5,35.2,C2,T13,NHP3N09,BOC03,AGE07,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,18.9,,,14.7,24,C2,T13,NHP3N09,BOC03,AGE08,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,27.4,,,25.4,29.5,C2,T13,NHP3N09,BOC02,GEN01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,32.9,,,30.1,35.8,C2,T13,NHP3N09,BOC02,GEN02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,30.2,,,28,32.4,C2,T13,NHP3N09,BOC01,OVR01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,29.8,,,27.4,32.3,C2,T13,NHP3N09,BOC04,RAC01,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,38.7,,,35.2,42.3,C2,T13,NHP3N09,BOC04,RAC02,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,30.9,,,27.3,34.8,C2,T13,NHP3N09,BOC04,RAC04,00,
2001-2002,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,11.2,,,5.3,22.1,C2,T13,NHP3N09,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.4,,,21.2,30,C2,T13,NHP3N09,BOC03,AGE02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,31.5,,,28.6,34.5,C2,T13,NHP3N09,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,35.7,,,31.6,39.9,C2,T13,NHP3N09,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,29.7,,,26.5,33.2,C2,T13,NHP3N09,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,34.3,,,31.9,36.7,C2,T13,NHP3N09,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,23.5,,,19.5,28.1,C2,T13,NHP3N09,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,30.9,,,28.5,33.4,C2,T13,NHP3N09,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,33,,,29.8,36.5,C2,T13,NHP3N09,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,32,,,29.7,34.4,C2,T13,NHP3N09,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,30.6,,,28.1,33.1,C2,T13,NHP3N09,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44.7,,,40.6,48.8,C2,T13,NHP3N09,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,36.6,,,33,40.4,C2,T13,NHP3N09,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,18.5,,,12.2,27.2,C2,T13,NHP3N09,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,24.1,,,16.9,33,C2,T13,NHP3N09,BOC03,AGE02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.9,,,28.7,37.4,C2,T13,NHP3N09,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,40.3,,,35.8,44.8,C2,T13,NHP3N09,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,30.4,,,27.5,33.5,C2,T13,NHP3N09,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,36.6,,,33.7,39.5,C2,T13,NHP3N09,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,24.7,,,20.5,29.5,C2,T13,NHP3N09,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.9,,,29,37,C2,T13,NHP3N09,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.2,,,32.6,38,C2,T13,NHP3N09,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,34.1,,,31.5,36.8,C2,T13,NHP3N09,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.7,,,29.7,36,C2,T13,NHP3N09,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,45.9,,,42.5,49.3,C2,T13,NHP3N09,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,33.9,,,32,35.9,C2,T13,NHP3N09,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,25.4,,,18.2,34.2,C2,T13,NHP3N09,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,26.2,,,19.6,34.1,C2,T13,NHP3N09,BOC03,AGE02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,32.8,,,29.3,36.6,C2,T13,NHP3N09,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,37.3,,,34.2,40.6,C2,T13,NHP3N09,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,31.9,,,28.9,34.9,C2,T13,NHP3N09,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,35.6,,,33.3,38.1,C2,T13,NHP3N09,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,26.2,,,22.5,30.3,C2,T13,NHP3N09,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,32.3,,,29.7,35,C2,T13,NHP3N09,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,35.3,,,33.1,37.5,C2,T13,NHP3N09,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,33.7,,,31.6,35.8,C2,T13,NHP3N09,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.3,,,29,35.9,C2,T13,NHP3N09,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,44,,,40.1,48,C2,T13,NHP3N09,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.2,,,34.4,46.4,C2,T13,NHP3N09,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,11.5,31.3,C2,T13,NHP3N09,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,23.2,,,17.3,30.4,C2,T13,NHP3N09,BOC03,AGE02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.9,,,32.6,37.4,C2,T13,NHP3N09,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39,,,36.2,41.9,C2,T13,NHP3N09,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,37.4,,,34.3,40.7,C2,T13,NHP3N09,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,38.4,,,36.6,40.2,C2,T13,NHP3N09,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.8,,,24.9,33.1,C2,T13,NHP3N09,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.3,,,32,38.8,C2,T13,NHP3N09,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.1,,,34.3,37.8,C2,T13,NHP3N09,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.8,,,34,37.6,C2,T13,NHP3N09,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,34.4,,,32.1,36.7,C2,T13,NHP3N09,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,49.5,,,45.2,53.8,C2,T13,NHP3N09,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,,-,Data not available,,,C2,T13,NHP3N09,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,40.4,,,37,44,C2,T13,NHP3N09,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.6,,,15.5,24.3,C2,T13,NHP3N09,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.2,,,20.5,30.6,C2,T13,NHP3N09,BOC03,AGE02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,34.4,,,31.4,37.4,C2,T13,NHP3N09,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,39.4,,,34.8,44.2,C2,T13,NHP3N09,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,33.4,,,29.5,37.6,C2,T13,NHP3N09,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,37.1,,,34.1,40.1,C2,T13,NHP3N09,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,28.7,,,24.4,33.4,C2,T13,NHP3N09,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,33.7,,,31.1,36.3,C2,T13,NHP3N09,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,36.3,,,32.9,39.9,C2,T13,NHP3N09,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,35.1,,,32.4,37.9,C2,T13,NHP3N09,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,32.9,,,29.5,36.5,C2,T13,NHP3N09,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,47.9,,,44.7,51.1,C2,T13,NHP3N09,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,10.8,,,8.3,13.9,C2,T13,NHP3N09,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.8,,,42.5,51.2,C2,T13,NHP3N09,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,19.4,,,14.8,25,C2,T13,NHP3N09,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,20-24,Percentage,%,25.3,,,20.9,30.3,C2,T13,NHP3N09,BOC03,AGE02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,25-44,Percentage,%,39.1,,,36.7,41.6,C2,T13,NHP3N09,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,45-64,Percentage,%,41.1,,,37,45.4,C2,T13,NHP3N09,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,65+,Percentage,%,35.9,,,32,40,C2,T13,NHP3N09,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,35+,Percentage,%,40.2,,,37.9,42.6,C2,T13,NHP3N09,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Age,75+,Percentage,%,29.3,,,25.1,33.9,C2,T13,NHP3N09,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Male,Percentage,%,35.2,,,33.1,37.4,C2,T13,NHP3N09,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Gender,Female,Percentage,%,40.5,,,37.8,43.2,C2,T13,NHP3N09,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Overall,Overall,Percentage,%,37.9,,,36.1,39.7,C2,T13,NHP3N09,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic White,Percentage,%,36.6,,,34.5,38.9,C2,T13,NHP3N09,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Black,Percentage,%,48.5,,,44.5,52.5,C2,T13,NHP3N09,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Non-Hispanic Asian,Percentage,%,12.4,,,10,15.2,C2,T13,NHP3N09,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Hispanic,Percentage,%,46.5,,,42.4,50.6,C2,T13,NHP3N09,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Obesity,Nutrition and Weight Status Objective 9:  Prevalence of obesity among US adults (20+) (Percentage); NHANES,Race,Other,Percentage,%,20.5,,,16.5,25.2,C2,T13,NHP3N09,BOC04,RAC07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,3863.4,,,3698.9,4027.8,C2,T12,NHP3N19,BOC03,AGE01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,3923.5,,,3804.4,4042.5,C2,T12,NHP3N19,BOC03,AGE04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3533.7,,,3424.2,3643.2,C2,T12,NHP3N19,BOC03,AGE05,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,2980.8,,,2879.6,3082.1,C2,T12,NHP3N19,BOC03,AGE06,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3461.8,,,3381.6,3542,C2,T12,NHP3N19,BOC03,AGE07,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2734.5,,,2631,2837.9,C2,T12,NHP3N19,BOC03,AGE08,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4240.3,,,4138.6,4342,C2,T12,NHP3N19,BOC02,GEN01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,3025.9,,,2958.6,3093.1,C2,T12,NHP3N19,BOC02,GEN02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3615.9,,,3553.9,3677.9,C2,T12,NHP3N19,BOC01,OVR01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3691.3,,,3613.7,3769,C2,T12,NHP3N19,BOC04,RAC01,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3258.3,,,3077.9,3438.6,C2,T12,NHP3N19,BOC04,RAC02,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T12,NHP3N19,BOC04,RAC03,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3462.3,,,3295.5,3629,C2,T12,NHP3N19,BOC04,RAC04,00,
2003-2004,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3756.1,,,3472,4040.2,C2,T12,NHP3N19,BOC04,RAC07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,3781.7,,,3618.8,3944.6,C2,T12,NHP3N19,BOC03,AGE01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,4052.6,,,3940,4165.2,C2,T12,NHP3N19,BOC03,AGE04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3604.8,,,3457.3,3752.3,C2,T12,NHP3N19,BOC03,AGE05,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,3057.9,,,2904.3,3211.6,C2,T12,NHP3N19,BOC03,AGE06,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3597.2,,,3485.7,3708.8,C2,T12,NHP3N19,BOC03,AGE07,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2809.9,,,2708.8,2911.1,C2,T12,NHP3N19,BOC03,AGE08,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4345.3,,,4222.9,4467.7,C2,T12,NHP3N19,BOC02,GEN01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,3070,,,2977.2,3162.9,C2,T12,NHP3N19,BOC02,GEN02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3687.5,,,3594.7,3780.3,C2,T12,NHP3N19,BOC01,OVR01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3789.3,,,3681,3897.6,C2,T12,NHP3N19,BOC04,RAC01,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3427.8,,,3287.1,3568.4,C2,T12,NHP3N19,BOC04,RAC02,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T12,NHP3N19,BOC04,RAC03,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3285.8,,,3099.9,3471.8,C2,T12,NHP3N19,BOC04,RAC04,00,
2005-2006,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3611.6,,,3325.2,3898,C2,T12,NHP3N19,BOC04,RAC07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,3788.5,,,3495,4081.9,C2,T12,NHP3N19,BOC03,AGE01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,3838.3,,,3707.9,3968.8,C2,T12,NHP3N19,BOC03,AGE04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3584.3,,,3414.1,3754.5,C2,T12,NHP3N19,BOC03,AGE05,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,2912.8,,,2802.3,3023.3,C2,T12,NHP3N19,BOC03,AGE06,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3515.7,,,3382.3,3649.1,C2,T12,NHP3N19,BOC03,AGE07,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2733.7,,,2568.2,2899.2,C2,T12,NHP3N19,BOC03,AGE08,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4207.8,,,4028.3,4387.3,C2,T12,NHP3N19,BOC02,GEN01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,3015.5,,,2928.6,3102.5,C2,T12,NHP3N19,BOC02,GEN02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3582.6,,,3460.4,3704.8,C2,T12,NHP3N19,BOC01,OVR01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3662.6,,,3520.2,3805.1,C2,T12,NHP3N19,BOC04,RAC01,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3344.1,,,3194.6,3493.5,C2,T12,NHP3N19,BOC04,RAC02,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T12,NHP3N19,BOC04,RAC03,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3268.3,,,3121.6,3414.9,C2,T12,NHP3N19,BOC04,RAC04,00,
2007-2008,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3683.8,,,3272.4,4095.2,C2,T12,NHP3N19,BOC04,RAC07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,3749.1,,,3561.1,3937.1,C2,T12,NHP3N19,BOC03,AGE01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,3777.1,,,3688.9,3865.3,C2,T12,NHP3N19,BOC03,AGE04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3640.3,,,3542.9,3737.6,C2,T12,NHP3N19,BOC03,AGE05,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,2992.4,,,2880.1,3104.8,C2,T12,NHP3N19,BOC03,AGE06,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3506.8,,,3437.8,3575.8,C2,T12,NHP3N19,BOC03,AGE07,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2741,,,2592.9,2889,C2,T12,NHP3N19,BOC03,AGE08,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4234.3,,,4147.5,4321.2,C2,T12,NHP3N19,BOC02,GEN01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,2981,,,2926.8,3035.3,C2,T12,NHP3N19,BOC02,GEN02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3591.1,,,3536.5,3645.7,C2,T12,NHP3N19,BOC01,OVR01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3656.9,,,3595.1,3718.6,C2,T12,NHP3N19,BOC04,RAC01,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3321.2,,,3199.6,3442.8,C2,T12,NHP3N19,BOC04,RAC02,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,,-,Data not available,,,C2,T12,NHP3N19,BOC04,RAC03,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3297.3,,,3150.9,3443.7,C2,T12,NHP3N19,BOC04,RAC04,00,
2009-2010,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3849.3,,,3580.5,4118.2,C2,T12,NHP3N19,BOC04,RAC07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,4081.1,,,3815.4,4346.8,C2,T12,NHP3N19,BOC03,AGE01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,3832.9,,,3700.8,3965,C2,T12,NHP3N19,BOC03,AGE04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3506.8,,,3367.1,3646.6,C2,T12,NHP3N19,BOC03,AGE05,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,3048,,,2948.6,3147.3,C2,T12,NHP3N19,BOC03,AGE06,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3473.7,,,3389.1,3558.3,C2,T12,NHP3N19,BOC03,AGE07,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2860.7,,,2725.5,2995.9,C2,T12,NHP3N19,BOC03,AGE08,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4240.5,,,4137.8,4343.2,C2,T12,NHP3N19,BOC02,GEN01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,3014.6,,,2950.1,3079,C2,T12,NHP3N19,BOC02,GEN02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3620.6,,,3571.8,3669.5,C2,T12,NHP3N19,BOC01,OVR01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3647.7,,,3577.4,3718.1,C2,T12,NHP3N19,BOC04,RAC01,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3489.2,,,3386.6,3591.7,C2,T12,NHP3N19,BOC04,RAC02,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,3807.6,,,3573,4042.1,C2,T12,NHP3N19,BOC04,RAC03,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3704,,,3563.8,3844.3,C2,T12,NHP3N19,BOC04,RAC04,00,
2011-2012,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3692,,,3496.1,3887.9,C2,T12,NHP3N19,BOC04,RAC07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,18-24,Mean,Mean,3796.2,,,3574.8,4017.7,C2,T12,NHP3N19,BOC03,AGE01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,25-44,Mean,Mean,3769.7,,,3709,3830.3,C2,T12,NHP3N19,BOC03,AGE04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,45-64,Mean,Mean,3469.3,,,3331.6,3607,C2,T12,NHP3N19,BOC03,AGE05,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,65+,Mean,Mean,3014.4,,,2925.1,3103.7,C2,T12,NHP3N19,BOC03,AGE06,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,35+,Mean,Mean,3400.9,,,3322.8,3479,C2,T12,NHP3N19,BOC03,AGE07,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Age,75+,Mean,Mean,2934.5,,,2766,3103,C2,T12,NHP3N19,BOC03,AGE08,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Male,Mean,Mean,4093.9,,,3986.2,4201.6,C2,T12,NHP3N19,BOC02,GEN01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Gender,Female,Mean,Mean,3013.6,,,2964.1,3063.1,C2,T12,NHP3N19,BOC02,GEN02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Overall,Overall,Mean,Mean,3540.7,,,3475.6,3605.8,C2,T12,NHP3N19,BOC01,OVR01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic White,Mean,Mean,3545.3,,,3474.1,3616.5,C2,T12,NHP3N19,BOC04,RAC01,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Black,Mean,Mean,3492.1,,,3353.7,3630.6,C2,T12,NHP3N19,BOC04,RAC02,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Non-Hispanic Asian,Mean,Mean,3650.8,,,3407.7,3893.9,C2,T12,NHP3N19,BOC04,RAC03,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Hispanic,Mean,Mean,3647.3,,,3411.2,3883.3,C2,T12,NHP3N19,BOC04,RAC04,00,
2013-2014,US,United States,NHANES,None,None,Healthy People 2020,None,Risk Factors,Nutrition,Nutrition and Weight Status Objective 19: Mean dietary sodium intake (mg/day) among US adults (18+); NHANES,Race,Other,Mean,Mean,3585.3,,,3390.4,3780.3,C2,T12,NHP3N19,BOC04,RAC07,00,
